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Abstract 
 
Despite the diverse structures and functions sampled by the proteome, all proteins 
comprise 20 canonical amino acids that sample only a small percentage of available 
chemistry. This limitation is lifted somewhat through the use of post-translational 
modifications, however the limit imposed by the restricted number of amino acids 
inherently limits the variety of protein function and control that can be accessed. One 
powerful route to diversify the chemistry sampled by proteins is through genetically 
encoded unnatural amino acid (uAA) incorporation. The uAA p-azido-L-
phenylalanine (AzPhe) can introduce two novel methods of control, photochemical 
covalent rearrangement and Click chemistry. AzPhe incorporation combined with 
these two methods of novel post-translational control were used to modulate the 
function of two distinct proteins; TEM β-lactamase and sfGFP. 
 
This thesis introduces the use of uAAs and the technical modifications required to 
enable uAA incorporation in vivo. It describes the in silico approach taken to evaluate 
potential mutations based on the likelihood of them imparting novel changes to 
protein function. Nine positions in TEM β-lactamase were chosen for uAA 
incorporation and the effect on activity was then determined using kinetic analyses. 
AzPhe incorporation alone resulted in a variety of effects on enzyme activity, ranging 
from small increases to complete loss of activity. Subsequent post-translational 
modification using UV light resulted in only slight changes in activity. Modification 
via Click chemistry using dibenzyl cyclo-octyne (DBCO) derivatives resulted in 
either inhibition or increased catalytic activity, depending on the position of AzPhe 
incorporation and the type of adduct used.  
 
Click chemistry was then used to modify TEM β-lactamase with other chemical 
modifications that enable the immobilization of proteins onto two different surfaces. 
The π-π stacking interaction between a DBCO-pyrene moiety and graphene was 
exploited to attach TEM β-lactamase to graphene in a defined and controlled manner, 
placing the active site in close proximity to the electron cloud of the sp2-bonded 
material. TEM β-lactamase was then modified using two DNA oligonucleotides that 
define assembly of a DNA origami “tile”. DNA origami can be used to immobilize 
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multiple proteins at several defined positions, enabling the re-creation of enzyme 
pathways or signalling cascades in vitro. 
 
Finally, AzPhe was incorporated into sfGFP and the effects of its incorporation and 
subsequent modification on fluorescence were explored. The incorporation of AzPhe 
resulted in a blue shifted λmax, a change that was reversed upon UV irradiation. X-ray 
crystallography suggested that a hydrogen-bonding network involving the 
chromophore and surrounding residues was disrupted upon AzPhe incorporation, but 
then reformed upon modification of the uAA. Click chemistry had a variable effect on 
fluorescence depending on the modification used. Modification of AzPhe with a large 
fluorescent dye had no effect on the sfGFP fluorescence spectrum, but enabled FRET 
between the two chromophores. Modification with a DBCO-amine had the same 
effect as UV irradiation.  
 
Overall, this thesis has shown that the use of genetically encoded uAA incorporation 
coupled with novel post-translational modifications is a powerful approach for 
modifying protein function, and facilitating defined interfacing with new and useful 
materials. 
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1. Introduction 
 
1.1. Protein function and the genetic code 
The central dogma of molecular biology describes the relationship and flow of 
information between DNA, RNA and proteins [1]. It outlines how DNA is used as a 
storage system, encoding all the critical information required by the cell until it is 
needed. RNA then acts as an interface, used to access the correct information at the 
correct time. The final and most critical part of the dogma outlines how this 
information is then translated into function by the proteome, performing the tasks 
required by the cell for survival. There are a vast array of processes needed to ensure 
survival, from metabolism and energy production, to defense and immunity, and this 
huge variety in cellular function requires a large and diverse repertoire of proteins.  
 
Critical is the control of protein activity. The ability to regulate protein activity is 
pivotal to the cell’s ability to respond to the changes presented to it. The system used 
to access protein sequence, and hence function, using both DNA and RNA offers a 
level of coarse control over temporal and spatial action (e.g. regulation of gene 
transcription). However this can be relatively slow to implement the effects of the loss 
or gain of a particular protein. A more rapid, direct and tunable response can be 
achieved by modulating activity directly at the protein level. Many proteins can be 
regulated through post-translational modification, which ranges from proteolytic 
cleavage (e.g. TEM β-lactamase signal sequence processing – [2]) to adduct addition 
(e.g. phosphorylation – [3]) to covalent rearrangement (e.g. GFP chromophore 
formation – [4]). 
 
Despite the incredible diversity in protein structure and function, all proteins are 
synthesized using the 20 canonical amino acids, with the rare exceptions of 
pyrrolysine [5] and selenocysteine [6]. This limited diversity is despite the availability 
of 61 amino acid encoding trinucleotide codons (three codons are designated as stop 
codons). However, the genetic code is degenerate, with some trinucleotide codons 
coding for the same amino acid [7]. Arginine for example uses six different codons, 
isoleucine uses three, and phenylalanine uses two. This system of redundancy, whilst 
ensuring maximum fidelity (single base changes at the DNA level often result in 
 2 
silent mutations – particularly at the third base of the codon), reduces the amino acid 
repertoire available to the cell. 
 
This limitation on the number of amino acids that can be incorporated into proteins in 
vivo limits the chemistry that can be sampled. Given the diversity of organic 
chemistry, the 20 canonical amino acids only contain very rudimentary chemical 
groups and reactivity. Amine, methyl and hydroxyl groups offer some basic chemical 
functionality, and more complex chemical groups such as thiol, indole and carboxyl 
groups are present in some amino acid side chains, however these still represent only 
a tiny proportion of the physiologically stable chemical moieties that could be 
accessed within proteins. Alkenyl, carbonyl and imine groups are just three examples 
of basic chemical structures not present in any of the canonical amino acids. The 
opportunity to add further reactivity via other elements is also missed, as amino acids 
are largely composed of only carbon, nitrogen, oxygen and hydrogen (with the 
addition of sulphur in cysteine and methionine). These factors combined mean the 
chemical diversity of proteins, despite their functional and structural diversity, is 
actually quite limited. Thus, proteins often have to recruit new chemistry from other 
sources via post-translational modifications. 
 
1.2. Post-translational modifications 
The restricted chemical diversity sampled by the proteome is often expanded to an 
extent by the addition of specific chemical groups to particular amino acids, or amino 
acid sequences, in the form of post-translational modifications [8]. Phosphorylation is 
a common post-translational modification that adds a phosphate group to specific 
residues such as serine and threonine, resulting in increases or decreases in protein 
activity, depending on the target protein and the position of the modification. 
Phosphorylation provides a method of fine-tuning protein activity without large-scale 
protein production/degradation; the cells can respond quickly to changing conditions 
using a common metabolite (normally ATP). As well as phosphorylation, proteins can 
be acetylated, methylated and glycosylated, all of which have different effects on 
different proteins. Lysine acetylation of histones results in chromatin loosening and is 
associated with DNA transcription [9]. Methylation, although more commonly 
associated with DNA, can also occur to proteins including histones [10]. 
Glycosylation can be used to aid protein folding, increase protein stability, or is used 
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in cell-cell interactions [11]. Other mechanisms of control are available such as co-
factor binding, protein-protein interactions, and pro-protein processing to modulate 
protein expression and activity. 
 
Post-translational modifications have evolved to be highly accurate and reliable to 
help proteins function properly when and where they are required. However the fine-
tuning of protein activity is very complex, often needing associated protein machinery 
to complete the modification [8]. Post-translational modifications can also be used in 
conjunction with other methods of protein control, adding a further level of control 
and complexity. This means that although post-translational mechanisms of protein 
control are used extensively in nature to modulate the activity of specific proteins in 
real time, natural post-translational modifications cannot be harnessed to modulate the 
activity of a single target protein in the laboratory, due to its diverse effects on the 
entire proteome. 
 
1.3. Unnatural amino acids 
One way to overcome the limited range of chemical properties sampled by proteins, 
and introduce novel post-translational modifications is to expand the amino acid 
repertoire available to the cell. Over recent years many unnatural amino acids (uAAs) 
have been synthesized that have a variety of chemical properties (some of which are 
shown in Table 1-1). 
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Table 1-1. Some of the uAAs that have been incorporated into proteins  
Name Structure Feature Ref. 
o-methyltyrosine 
 
First uAA genetically 
encoded 
[12] 
p-iodophenylalanine 
 
Used in X-ray 
crystallography 
[13] 
p-cyanophenylalanine 
 
Probe for IR imaging [14] 
p-azidophenylalanine 
 
Photo-reactive and Click 
chemistry 
[15] 
p-benzoyl 
phenylalanine 
 
Photo-reactive [16] 
p-azophenyl 
phenylalanine 
 
Photo-isomerisable [17] 
o-nitrobenzyltyrosine 
 
Photo-caged [18] 
p-acetylphenylalanine 
 
Chemical modifications 
and labelling 
[19] 
p-carboxymethyl 
phenylalanine 
 
Analog of phospho-
tyrosine 
[20] 
 
H2N COOH
O
CH3
H2N COOH
I
H2N COOH
CN
H2N COOH
N3
H2N COOH
O
H2N COOH
N
N
H2N COOH
O
NO2
H2N COOH
O
H2N COOH
OH
O
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For example, uAAs can be designed to mimic some of the specific post-translational 
modifications that occur naturally, such as phosphorylation and methylation [12]. 
Incorporation of a phosphotyrosine mimetic into a transcriptional activator was used 
to determine the effect that tyrosine phosphorylation had on protein activity and DNA 
binding [20]. Similar experiments have been performed using a phosphoserine uAA to 
analyze the effect of serine phosphorylation on protein activity [21]. uAAs can also be 
used to incorporate some of those chemical groups that are missing from the 20 
canonical amino acids. The keto chemical group can be incorporated into proteins 
using uAAs, and then used to post-translationally modify the protein with several 
biomolecules [19]. 
 
The useful reactivity of some uAAs not present in the native amino acid set but 
compatible with biological systems can be utilized to introduce novel reactivity into 
proteins. One example is the addition of photo-reactive uAAs into normally non-
photo-reactive proteins. This provides the opportunity to modulate protein activity 
using light. Light is an ideal method to control protein activity, as it is a gentle, non-
invasive and highly compatible effector but can provide high spatial and temporal 
resolution so that specific areas of the cell can be targeted [22]. uAAs that can alter 
their structure upon illumination with light include photo-caged residues that can 
release part of their side chain upon irradiation [18], photo crosslinkers [16], and 
photo-isomerisable residues that can switch between cis and trans bond formations 
[17]. A photo-caged tyrosine was incorporated into an enzyme with a tyrosine in its 
active site to allow light-sensitive activation of the enzyme upon release of the photo-
cage due to irradiation at a defined wavelength [18]. Photo-crosslinking using uAAs 
is a powerful technique to study many facets of protein behaviour. The uAA p-azido-
L-phenylalanine, containing the photo-reactive azide chemical group, has been 
incorporated into several proteins to study protein-protein interactions [15], as well as 
the intrinsic properties of proteins [23]. Other uAAs utilize the light-sensitive benzoyl 
group and have been incorporated into multiple proteins allowing crosslinking upon 
photo-activation with both other proteins and DNA. It was used to probe the specific 
interactions between the subunits of the RNA polymerase II transcription initiation 
complex [24] and to probe the DNA binding of the catabolite repressor protein [25]. 
Isomerisable chemical structures have historically been used in membrane biology to 
introduce light-mediated control of membrane proteins [26, 27], however the 
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incorporation of the azobenzene group into a uAA has increased the versatility of this 
method, and has introduced light sensitive, and reversible, modulation of cellular 
proteins in vivo [17]. 
 
1.4. Incorporating uAAs 
Whilst the use of uAAs as a means to introduce novel functionality into a target 
protein is attractive, this is only feasible if incorporation of the uAA is efficient and 
reliable. Originally, uAAs could only be incorporated into target proteins by chemical 
synthesis [28], however this is a slow and expensive process. Over recent years, many 
advances have been made that allow the incorporation of uAAs co-translationally, 
utilizing the natural machinery for protein synthesis [29]. To do this, several additions 
to the cellular machinery are required, and some modifications to the genetic code are 
needed to ensure uAA incorporation is effective. The successful translation of mRNA 
into a peptide sequence requires the accurate and reliable interactions between an 
amino-acyl tRNA-synthetase (aaRS) and its cognate transfer RNA (tRNA), and 
between the tRNA and the codon (Figure 1-1). For each of the 20 canonical amino 
acids there are specific tRNAs that work with a cognate aaRS to ensure maximum 
fidelity during translation [30]. The sequences of each tRNA differ from each other in 
several ways, including their anticodon that is used to align with the trinucleotide 
codons of the mRNA, and their 5’ and 3’ termini. In addition, prokaryote tRNAs have 
a long variable arm that aids recognition between the tRNA and the aaRS [31]. The 
aaRS enzymes differ in their amino acid substrate-binding site, all of which have 
evolved to bind only a single amino acid. Incorporating uAAs in vivo requires several 
adaptations to be made to this endogenous system so that the uAA can be reliably 
incorporated at defined positions, without perturbing the existing machinery. Firstly, 
the uAA needs to be assigned a codon that would result in minimal disruption to the 
existing genetic code. Of the 64 possible trinucleotide codons, 61 already code for an 
endogenous amino acid. This leaves only the three stop codons; TGA (opal), TAA 
(ochre) and TAG (amber). In Escherichia coli, the amber stop codon is used in only 
7% of genes [32], which makes reprogramming the TAG codon the most desirable 
option. Very recently, whole genome approaches such as the removal of all TAG 
codons from the E. coli genome [33], or the recoding of TAG into a sense codon by 
removal of release factor-1 [34] have been used to completely eliminate the amber 
stop codon and increase the efficiency of uAA incorporation in response to TAG. 
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Figure 1-1. Schematic of the incorporation of unnatural amino acids into proteins. (A) 
The orthogonal amino-acyl tRNA-synthetase (red) charges its cognate tRNA with the 
unnatural amino acid (blue) during translation whilst the endogenous synthetases 
(green) charge their cognate tRNAs with the appropriate amino acid (black). (B) The 
orthogonal tRNA lines up with the amber stop codon in the mRNA. (C) The unnatural 
amino acid is incorporated into the linear sequence of amino acids. 
 
 
CUA UAU 
UAU AUC 
GAC AUA GCU AAU GAU AUA GCC UAG AGU UGC GGU CAU  mRNA 
A 
B 
C 
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Once a codon has been assigned for uAA incorporation, a corresponding tRNA that 
can recognize it is required. Initial attempts to incorporate uAAs into proteins in vivo 
were based around modifying endogenous tRNA/aaRS pairs so that they would no 
longer recognize their canonical amino acid, but would incorporate the uAA in 
response to the TAG codon instead [35]. This involved mutating specific bases of the 
glutaminyl tRNA (along with its anticodon) so that it had reduced affinity for its 
cognate aaRS. A library of mutant aaRSs were then tested to generate an enzyme that 
efficiently charged the mutant tRNA. This was completed successfully, however there 
remained a high level of endogenous amino acids incorporated in response to the 
TAG codon. Failure of this approach prompted the use of tRNA/aaRS pairs from 
other organisms as a method to incorporate uAAs. The first pair to be tested was the 
glutaminyl pair from Saccharomyces serevisiae (Sc). The Sc tRNA/Sc glutaminyl 
aaRS pair was found to work efficiently during translation in E. coli [36], however 
attempts to incorporate a uAA in place of glutamine once again proved impossible. 
The third strategy was to use a tRNA/aaRS pair from an archaeal species of bacteria, 
and the shift in focus from eukaryotic organisms to prokaryotic was accompanied by a 
shift in focus from the glutaminyl tRNA/aaRS pair to the tyrosyl tRNA/aaRS pair. 
The tyrosyl tRNA/aaRS pair from Methanococcus jannaschii (Mj) was found to 
efficiently incorporate tyrosine in response to the TAG codon (the anticodon was 
mutated to CUA) in E. coli [37]. The Mj aaRS was also found to be unable to amino-
acylate any E. coli tRNAs, due to a difference in the 5’ and 3’ base pairing that is one 
of the elements crucial in tRNA/aaRS recognition [38], however the E. coli aaRS was 
found to amino-acylate the Mj tRNA. This work provided the basic elements that 
were required to enable uAA incorporation in vivo. 
 
Before this tRNA/aaRS pair could be used effectively, several changes to the tRNA 
and the aaRS had to be made. The anticodon of the Mj tyrosyl tRNA was mutated to 
CUA to correspond to the amber stop codon, and specific nucleotides in the tRNA 
anticodon loop and other non-conserved nucleotides were randomized to reduce the 
recognition between the Mj tRNA and E. coli aaRSs, but preserve the recognition 
with other factors required for in vivo translation such as the ribosome and elongation 
factor Tu (EF-Tu) [12]. The mutants were then screened using a “negative and 
positive” selection process to identify a tRNA variant with reduced affinity for E. coli 
aaRSs. The negative selection was performed first without a cognate aaRS from Mj, 
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and involved the suppression of amber stop codons introduced into barnase, a lethal 
RNase. This selection step ensured any tRNA variants that were charged by E. coli 
aaRSs were removed from the library, because amino-acylation of the tRNA would 
result in the production of barnase leading to cell death. Any surviving cells contained 
tRNA variants that were either orthogonal to E. coli aaRSs or were non-functional. 
Non-functional tRNA sequences were then removed from the library in the positive 
selection, performed along with a cognate aaRS from Mj. This step required the 
suppression of an amber stop codon in β-lactamase, required for resistance against 
ampicillin. Surviving cells after the second step contained tRNA variants that were 
functional, but only functional when paired with their cognate aaRS. 
 
A similar strategy was then used to engineer the Mj tyrosyl aaRS to switch its affinity 
from tyrosine to the chosen uAA (in the first instance this was o-methyl-tyrosine – 
[12]). Using available structures for aaRSs from other organisms as models [39], 
selected residues responsible for defining amino acid specificity were randomized 
(Figure 1-2). The resulting mutant library was then screened using an alternating 
positive and negative selection strategy. The positive selection (performed first) 
involved incorporating uAAs in response to amber stop codons inserted into 
chloramphenicol acetyl transferase, which confers bacterial resistance to 
chloramphenicol. This selected for aaRS variants that were able to charge its cognate 
tRNA with an amino acid, whether it was unnatural or not. The negative selection 
involved barnase and was performed in the absence of the uAA. This selected against 
aaRS variants that incorporate any of the 20 canonical amino acids in response to the 
amber stop codon, as incorporation of a canonical amino acid resulted in barnase 
production and cell death. The result of multiple rounds of positive and negative 
selection were aaRSs that charged the mutated tRNA with the desired uAA in E. coli, 
and none of the canonical amino acids. This process has been repeated for many 
different synthetases to optimize its recognition of a single uAA [40]. This has 
resulted in the generation of a library of synthetase sequences (Figure 1-2), which 
efficiently bind a single uAA at the expense of all 20 canonical amino acids, as well 
as other unnatural ones. Recent work however has highlighted the promiscuity of 
some of these evolved aaRSs. One study found aaRSs that still had a high affinity for 
tyrosine, despite mutations to change its substrate specificity [41], while another 
found an aaRS that could recognize and incorporate up to 18 different uAAs [42]. 
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Figure 1-2. Structure of the amino-acyl tRNA-synthetase (aaRS) amino acid binding 
pocket [39] with the initially randomized residues highlighted in red and further 
randomized residues highlighted in blue. The sequences of the first 180 residues of 
five evolved aaRSs are aligned and the same residues are highlighted. 
 
 
Tyrosyl MDEFEMIKRNTSEIISEEELREVLKKDEKSAYIGFEPSGKIHLGHYLQIKKMIDLQNAGF 60 
Napthyl MDEFEMIKRNTSEIISEEELREVLKKDEKSALIGFEPSGKIHLGHYLQIKKMIDLQNAGF 60 
Acetyl  MDEFEMIKRNTSEIISEEELREVLKKDEKSALIGFEPSGKIHLGHYLQIKKMIDLQNAGF 60 
Benzo   -DEFEMIKRNTSEIISEEELREVLKKDEKSAGIGFEPSGKIHLGHYLQIKKMIDLQNAGF 60  
Cyano   MDEFEMIKRNTSEIISEEELREVLKKDEKSALIGFEPSGKIHLGHYLQIKKMIDLQNAGF 60 
         ****************************** **************************** 
  
Tyrosyl DIIILLADLHAYLNQKGELDEIRKIGDYNKKVFEAMGLKAKYVYGSEFQLDKDYTLNVYR 120 
Napthyl DIIILLADLHAYLNQKGELDEIRKIGDYNKKVFEAMGLKAKYVYGSSFQLDKDYTLNVYR 120 
Acetyl  DIIILLADLHAYLNQKGELDEIRKIGDYNKKVFEAMGLKAKYVYGSEFQLDKDYTLNVYR 120 
Benzo   DIIILLADLHAYLNQKGELDEIRKIGDYNKKVFEAMGLKAKYVYGSPFQLDKDYTLNVYR 120 
Cyano   DIIIVLADLHAYLNQKGELDEIRKIGDYNKKVFEAMGLKAKYVYGSEWMLDKDYTLNVYR 120 
        ****:***************************************** : *********** 
  
Tyrosyl LALKTTLKRARRSMELIAREDENPKVAEVIYPIMQVNDIHYLGVDVAVGGMEQRKIHMLA 180 
Napthyl LALKTTLKRARRSMELIAREDENPKVAEVIYPIMQVNPAHYQGVDVVVGGMEQRKIHMLA 180 
Acetyl  LALKTTLKRARRSMELIAREDENPKVAEVIYPIMQVNGCHYRGVDVAVGGMEQRKIHMLA 180 
Benzo   LALKTTLKRARRSMELIAREDENPKVAEVIYPIMQVNTSHRLGVDVAVGGMEQRKIHMLA 180 
Cyano   LALKTTLKRARRSMELIAREDENPKVAEVIYPIMQVNGAHYLGVDVAVGGMEQRKIHMLA 180 
        *************************************  *  ****.************* 
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After the initial attempts at evolving the glutaminyl tRNA and AARS to incorporate 
uAAs, all of the subsequent work was done using the tyrosyl tRNA/aaRS pair. As the 
variety of uAA structures increased, the need for more relevant starting structures 
increased as well. This has resulted in the evolution of orthogonal tRNA/aaRS pairs 
that formerly incorporated different canonical amino acids. After the Mj tyrosyl 
tRNA/aaRS pair, the next tRNA/aaRS pair to be exploited was a glutamyl pair [43]. 
The tRNA was developed using sequence alignments of multiple archaeal tRNA 
sequences that use glutamic acid as their substrate, and the aaRS was from 
Pyrococcus horikoshii. Evolution of a leucyl tRNA/aaRS pair enabled uAA 
incorporation in response to the opal stop codon (TGA) and quadruplet codons, as 
well as the amber stop codon [44]. This required extensive mutation of the anticodon 
loop to permit four-base recognition. The desire to use quadruplet codons led to the 
evolution of a lysyl tRNA/aaRS pair that successfully decoded the quadruplet codon, 
AGGA [45]. This system was shown to work in conjunction with the existing tyrosyl 
tRNA/aaRS pair to incorporate two different uAAs into the same protein at the same 
time. The discovery of pyrrolysine and its incorporation in response to the TAG/UAG 
codon in Methanosarcina barkeri [46] sparked interest in the use of this machinery to 
incorporate uAAs. Since this discovery, the pyrrolysine tRNA/aaRS pair from M. 
barkeri has been used to incorporate large lysine analogues into proteins co-
translationally [47]. The evolution of a prolyl tRNA/aaRS pair [48] that successfully 
incorporated uAAs in response to the amber stop codon, as well as quadruplet codons, 
further increased the versatility of uAA design, as the structure of proline represents a 
large change from the structures of tyrosine, glutamic acid and pyrrolysine, whose 
translational machinery had been previously used. As the largest canonical amino 
acid, the tryptophanyl machinery is another appealing target for uAA incorporation. 
Evolution of a trytophanyl tRNA/aaRS pair from Saccharomyces cerevisiae was 
shown to be orthogonal in E. coli, and was used to incorporate multiple large uAAs 
[49]. The development of so many orthogonal tRNA/aaRS pairs gives chemists and 
biologists a huge library of potential structures to design evermore intricate and 
elaborate uAAs, enabling the incorporation of a vast array of useful functionalities 
into proteins. 
 
The directed evolution approach has been applied to other components of the 
translation machinery as well in order to increase the efficiency of uAA incorporation. 
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Elongation factor-Tu (EF-Tu) is responsible for delivering the charged tRNA to the 
ribosome and this can hamper the incorporation of uAAs, especially ones with large 
aromatic groups, such as those based on the structure of phenylalanine, tyrosine or 
tryptophan [50]. The binding pocket can be mutated, in a similar manner to the 
binding pocket of the aaRSs, to increase the ability of EF-Tu to associate with large, 
aromatic uAAs [51]. One histidine residue was identified as a key component in the 
recognition and binding of phenylalanine and mutation affected the binding of several 
large amino acids, but had no effect on the binding of alanine and glycine [52]. These 
studies show that as well as a tailored aaRS for each uAA, a specific variant of EF-Tu 
could be used to increase the efficiency and selectivity of uAA incorporation. In 
addition to modification of EF-Tu, the ribosome has also undergone changes to enable 
greater incorporation of uAAs by increasing the number of codons available for uAA 
incorporation. A designer ribosome was created to work alongside the ever-increasing 
number of tRNA/aaRS pairs that are able to recognize quadruplet codons [53]. This 
technology allowed the incorporation of multiple uAAs simultaneously in response to 
several different quadruplet codons and greatly increases the efficiency of 
incorporating multiple uAAs into one protein. 
 
Most of the work described above was completed in E. coli, however uAA 
incorporation has been developed for use in more complex model organisms as well. 
The incorporation of uAAs into yeast utilized an orthogonal tRNA/aaRS pair from E. 
coli [54]. This was found to function similarly to the Mj tRNA/aaRS pair in bacteria. 
Using this method, five disparate amino acids were incorporated in response to the 
amber stop codon. Unnatural amino acid technology was successfully transferred into 
mammalian cells, when an evolved aaRS from E. coli was coupled to a tRNA from 
Bacillus stearothermophilus [13]. This enabled incorporation of a uAA in response to 
the amber stop codon in mammalian cells, with a fidelity and incorporation efficiency 
of over 95%. More recently, uAAs have been incorporated co-translationally in 
Drosophila melanogaster [55]; uAA incorporation was targeted to different tissues, 
different subsets of cells within a single tissue, and to different stages of development. 
One final hurdle was passed when genetic code expansion and uAA incorporation was 
introduced into a whole organism. The genetic code of Caenorhabditis elegans was 
expanded to incorporate uAAs in response to the amber stop codon using three 
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orthogonal tRNA/aaRS pairs, two from E. coli, and the pyrrolysyl pair from 
Methanosarcina [56]. 
 
Recent advances have also been made that enable the incorporation of uAAs via cell-
free protein synthesis, which allows greater yields of proteins but can be expensive. E. 
coli based cell-free expression systems have been utilized to incorporate uAAs using 
the Mj tRNA/aaRS, similar to the in vivo system of protein expression. One system 
used a tRNA derived from a linearized plasmid or PCR product to increase the 
concentration of orthogonal tRNA available [57], whereas another increased the 
concentration of orthogonal aaRS available [58]. These methods produced up to 600 
µg/ml protein, compared with 5-20 µg/ml produced using traditional cellular based 
methods [59]. This increase in efficiency has also allowed the incorporation of 
multiple uAAs into a single protein using cell-free synthesis [60]. Cell-free systems of 
expression also represent an ideal target for quick screening of proteins containing 
uAAs due to their ability to quickly generate large quantities of the desired protein 
[61]. Additionally, due to the nature of using linearized plasmids as expression 
templates, this technique may be suitable for the further directed evolution of tRNAs 
and aaRSs for the incorporation of current, and future uAAs, as the products of error-
prone PCR can be directly supplied to the expression system. 
 
1.5. p-Azido-L-phenylalanine 
One uAA that has been successfully incorporated into a variety of proteins [15, 23], 
and in a variety of organisms [15, 62], is p-azido-L-phenylalanine (AzPhe – Table 1-
1). It is a popular choice for incorporation as it has several interesting properties that 
make it an ideal candidate for controlling proteins post-translationally. It is an 
analogue of phenylalanine, with an azide functional group (N3) at the para position of 
the benzene group (a phenyl azide). It is the azide, or more accurately the phenyl 
azide that makes this uAA particularly useful as it introduces a new set of non-native 
chemistry into proteins. 
 
Phenyl azides are particularly sensitive to UV light, a feature that can be used to 
modulate a target protein. Upon radiation with light below 310 nm [15], phenyl azides 
lose N2 and convert to a reactive nitrene species with two lone pairs of electrons. This 
nitrene radical can follow various routes depending on its immediate environment 
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(Figure 1-3). One route is ring expansion to form a dehydroazepine that can be 
attacked by a nucleophile (such as an amine group). Alternatively, the nitrene can be 
protonated to form a nitrenium ion or can insert into carbon-hydrogen bonds [63]. 
This particular reaction mechanism can result in photo-crosslinking to nearby amino 
acids in a protein’s folded state which can cause local structural changes, leading to 
changes in protein stability or activity. This feature of AzPhe has been utilized in the 
past for studying protein-protein and protein-ligand interactions [64]. Similarly, the 
cross-linking feature of AzPhe has been utilized to aid the functional analysis of 
native proteins by immobilizing proteins on surfaces for surface plasmon resonance 
analysis [65]. The crosslinking reaction has been recently characterized by X-ray 
crystallography [23]. 
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Figure 1-3. Photolysis of p-azido-L-phenylalanine (AzPhe). Irradiation using light 
below 310 nm results in the formation of the nitrene radical caused by the loss of 
molecular nitrogen. This species can then go down several reaction pathways such as 
insertion reactions with both N-H and C-H bonds and addition reactions with C=C 
double bonds. Photolysis at room temperature in physiological conditions promotes 
the formation of the dehydroazepine, which can subsequently react with nucleophiles. 
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A second useful feature of AzPhe is Click chemistry. Click chemistry is a term used 
to encompass a wide range of chemical reactions that generate high yields of non-
toxic products and byproducts [66]. In addition, Click reactions are compatible with 
physiological conditions, are generally quick and end with a single, stereospecific, 
and physiologically stable product. Therefore, many Click reactions can occur in vivo. 
One such “Click” reaction is strain-promoted azide-alkyne cycloaddition (SPAAC). 
The phenyl azide chemical handle found in AzPhe is able to undergo highly specific 
reactions with alkyne groups under ring strain without the need for any catalyst to 
form a triazole link (Figure 1-4). The original azide-alkyne cycloaddition reactions 
required cytotoxic levels of copper as a catalyst, but putting the alkyne under ring 
strain alleviates the need for this catalyst, allowing the reaction to occur under 
physiological conditions [67]. A huge variety of chemical modifications is available 
that contain ring strained alkyne groups [68]. This means a single residue in a single 
protein can be targeted with a wide variety of post-translational modifications that can 
add a diverse and complex variety of chemical functionality, adding new protein 
function or modulating existing protein activity. For example, proteins can be 
modified with two different fluorescent probes in a site-specific manner to enable 
single molecule FRET (Forster resonance energy transfer), a technique used to 
interrogate protein structure and dynamics [69]. 
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Figure 1-4. Schematic of strain promoted azide-alkyne cyclo-addition (SPAAC) 
forming a triazole. The dibenzyl cyclo-octyne (DBCO) group can be functionalized 
with many different chemical groups at the R position such as fluorescent dyes, 
pyrene and PEG (polyethylene glycol) chains. 
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1.6. TEM β-lactamase 
The β-lactamases are a family of enzymes responsible for the breakdown of many 
commonly used β-lactam antibiotics such as the penicillins through hydrolysis of the 
amide bond of the β-lactam ring [70]. β-lactamase enzymes are split into four classes: 
A, B, C and D.  Classes A, C and D hydrolyze the amide ring of the β-lactam ring via 
a catalytic serine residue whereas class B β-lactamases are metallo-enzymes and 
require zinc to function [71]. TEM (named after the patient who provided the first 
sample) is a class A β-lactamase and is the most widely prevalent enzyme responsible 
for bacterial antibiotic resistance [72]. It is highly efficient at hydrolyzing penicillin-
type β-lactam antibiotics such as ampicillin, but is less active against others groups of 
β-lactam antibiotics such as the cephalosporin family of antibiotics. The structure of 
TEM is made up of two distinct domains, an α domain (consisting of six α-helices) 
and an α/β domain that is formed of both the N and C-termini regions (Figure 1-5A). 
The catalytic residue (Ser70) is located in the α domain on helix 2, with the catalytic 
pocket formed at the sub-domain interface. The structure of the protein and the 
position of the active site within the cleft formed by the two domains means there are 
a number of residues that either directly influence the catalytic process, or are in such 
close proximity that they contribute indirectly to the hydrolysis reaction and/or 
substrate recognition and binding (Figure 1-5B). One key feature of the enzyme 
structure is the omega loop (Ω-loop – residues 161-179), which sits above the active 
site formed by the two domains (Figure 1-5C). This structure has a major role in 
substrate specificity and catalysis [73]. 
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Figure 1-5. (A) Structure of TEM β-lactamase (PDB code 1BTL – [74]) indicating the 
location of the active serine (red) and the Ω-loop (blue). (B) Residues and interactions 
involved in catalysis. (C) Residues involved in formation of salt bridges on the Ω-
loop 
A 
B C 
Glu166 
Ser70 
Lys234 
Lys73 
Ser130 Glu166 
Lys73 
Ser130 Lys234 
Ser70 
W 
W 
Arg164 
Arg178 
Asp179 
Asp176 
 20 
The first step of the catalytic mechanism of TEM β-lactamase is the attack on the β-
lactam ring of the antibiotic by the hydroxyl group of the active serine residue (Figure 
1-6). This results in the formation of a high-energy intermediate, quickly proceeding 
to the formation of the briefly stable acyl enzyme as the serine forms an ester with the 
antibiotic. A hydrolytic water molecule subsequently attacks the acyl-enzyme, 
resulting in another high-energy intermediate that decays to form the hydrolyzed 
antibiotic (Figure 1-6). The hydroxyl group on the serine is regenerated and the 
enzyme is able to hydrolyze more substrate upon product release. Although the 
general mechanism of action is widely accepted, there remains debate over the precise 
residue that serves as the general base in the acylation and deacylation steps. It is 
generally considered to be Glu166, present on the Ω-loop, that functions as the base in 
the deacylation step of the reaction mechanism, however there is still controversy 
over that role in the initial acylation step of the mechanism [75, 76]. It is thought the 
carboxylate group of Glu166 activates the hydrolytic water that attacks the acyl-
enzyme, thereby serving as the catalytic base in the deacylation step. This theory has 
been supported by numerous experimental techniques including site-directed 
mutagenesis [77]. There have been two mechanisms of acylation proposed however. 
One suggests the deprotonated form of Lys73 acts as the general base [78], whereas 
another suggests it is Glu166, acting through a bound water molecule [79]. Apart 
from Ser70, Lys73 and Glu166, other residues are involved either directly or 
indirectly in the catalytic mechanism. Ser130 is a part of the “SDN” loop that is found 
in a loop between helices 3 and 4. These three residues are highly conserved in β-
lactamases and are associated with having roles in active site formation and transition 
state stabilization [80]. Lys234 is part of another conserved trio of residues and is the 
fifth member of the active site to have a role in catalysis. It has been suggested 
Lys234 also has a role in transition state stabilization [81].  
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Figure 1-6. Catalytic mechanism of TEM β-lactamase. (1) The enzyme attacks the β-
lactam ring of the antibiotic via the hydroxyl group of a serine. (2) This results in the 
formation of a high-energy intermediate, (3) and then a briefly stable acyl enzyme. (4) 
A hydrolytic water molecule attacks the acyl-enzyme. (5) This forms a second high-
energy intermediate that decays to form the hydrolyzed antibiotic (6).  
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Due to its role in conferring resistance to some of the most common clinically used 
antibiotics, β-lactamase structure and function has been investigated extensively. 
These studies have led to the discovery of “extended spectrum” variants, which are 
active towards synthetic β-lactams developed to overcome original resistance. The 
increased ability of TEM β-lactamase variants to hydrolyze synthetic β-lactams such 
as cephalosporins is permitted largely by the flexibility of the Ω-loop. The Ω-loop 
comprises residues 161 to 179 [82] and sits over the gap between the two domains of 
the protein. Four residues, Arg164, Asp176, Arg178 and Asp179, are involved in 
forming salt bridges that are integral to maintaining the structure of the Ω-loop 
(Figure 1-5). Several mutations in the Ω-loop are associated with increased spectrum 
variants of TEM β-lactamase and these include Trp165Ser [83] and Arg164Ser [84]. 
These mutations, and other mutations [85], not only show that the Ω-loop has a key 
role in determining extended spectrum activity, possibly by increasing the flexibility 
of the Ω-loop, enlarging the size of the substrate-binding site, but also that the Ω-loop 
is tolerant to mutations at key sites in its structure. 
 
1.7. Green Fluorescent Protein 
Green Fluorescent Protein (GFP) from Aequorea victoria [86] is another protein that 
has been shown to tolerate the incorporation of uAAs [87], and that novel functional 
aspects can be accessed with uAAs [23]. GFP is formed by 11 β-sheets that wrap 
around each other to form a β-barrel, with a single α-helix running through the centre 
of the barrel (Figure 1-7A). The chromophore is a p-
hydroxybenzylideneimidazolinone formed by the rearrangement of Ser65, Tyr66 and 
Gly67, which are found in the middle of the barrel [88]. The rearrangement of the 
chromophore occurs spontaneously in the presence of O2 and without any co-factors 
or other proteins (Figure 1-7B). Since its discovery, GFP has been extensively studied 
and engineered for new passive and active uses. Its most widely used role is as a 
passive, genetically encoded probe for monitoring many cellular functions such as 
protein trafficking and cell migration [89]. As a result of this, the original GFP 
sequence has been modified and mutated to increase both its fluorescence and its 
stability under cellular conditions. This includes the generation of two variants in 
particular that have been widely used due to their improved properties. Firstly, the 
chromophore was mutated from the original serine to a threonine (Ser65Thr) to 
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produce a simplified excitation spectrum [90]. This resulted in the generation of 
EGFP (enhanced GFP), which included one other mutation (Phe64Leu) designed to 
improve folding at 37°C [91]. EGFP was then the template for directed evolution 
which resulted in the generation of superfolder GFP (sfGFP), a variant that folds 
efficiently when fused to other proteins, including those with poor overall stability 
and solubility [92]. Like EGFP, sfGFP has a major excitation peak at 475 nm, 
corresponding to the phenolate form of the Tyr66 moiety in the chromophore, and an 
emission peak at 508 nm. 
 
As previously said, the chromophore of GFP is able to rearrange itself into a 
fluorescent structure without the need for co-factors or other proteins (Figure 1-7B). 
The first step is a series of torsional rotations that results in Thr65 being brought into 
close proximity to Glu67. Secondly, nucleophilic attack on Thr65 by the amide 
nitrogen of Glu67 results in cyclisation, releasing water in the process. Fluorescence 
is gained after oxidation of the α-β carbon bond in Tyr66 by molecular oxygen, 
forming an extended delocalized π-electron system. Critically, only the folded protein 
is fluorescent; unfolded GFP is no longer fluorescent, despite the presence of the 
chromophore. A network of hydrogen bonds formed with residues and integral water 
molecules found within the barrel of the protein supports this structure and helps 
maintain and define fluorescence. Key residues include Thr203 (whose mutation to 
tyrosine results in YFP – yellow fluorescent protein [93]), His148 and Glu222. 
His148, along with Thr203, forms a hydrogen bond with Tyr66 and plays a key role 
in determining the protonation state of its hydroxyl group [94]. Glu222 fulfills a 
variety of roles in defining fluorescence by affecting the protonation state of the 
chromophore and stabilizing intermediates during chromophore maturation [95]. 
 
 24 
 
Figure 1-7. (A) Structure of sfGFP (PDB code 2B3P – [92]) consisting of a β-barrel 
with a single helix in the middle. (B) Maturation of the GFP chromophore. A series of 
torsional rotations results in Thr65 being brought into close proximity to Gly67. 
Nucleophilic attack on Thr65 by the amide nitrogen of Gly67 results in cyclisation, 
releasing water in the process. The α-β carbon bond in Tyr66 is oxidized by molecular 
oxygen, forming a delocalized π-electron system and fluorescence. 
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1.8. Aims & Objectives 
The limit placed on proteins by using only 20 naturally occurring amino acids restricts 
the chemical diversity that can be sampled by proteins and ultimately their 
functionality. The incorporation of uAAs into proteins can be used to lift this 
restriction. The overall aim of the project is to demonstrate that incorporation of uAAs 
via a reprogrammed genetic code can introduce novel and useful properties into 
proteins, which can be subsequently used to modulate protein activity at two levels; 
firstly, co-translational control through the presence and absence of the uAA, and 
secondly, post-translational control through the location and modification of the uAA. 
The latter will be the focus of this thesis. 
 
The first objective is to use TEM β-lactamase as a model protein to show that AzPhe 
can be incorporated into enzymes and new chemical reactivity can be used to 
modulate protein function. TAG mutations will be incorporated into the bla gene 
using site-directed mutagenesis and protein containing a uAA at a single, defined 
position will be isolated. Activity assays will then be used to determine the effect of 
uAA incorporation on enzyme kinetics. UV irradiation will then be used to activate 
the azide group of AzPhe and the effect of this process on enzyme activity will also be 
investigated. Click chemistry will be used to attach a range of chemical groups to the 
protein at key residues and the impact these have on enzyme activity will be 
investigated. Click chemistry will also be used to enable defined attachment onto 
surfaces for use in single molecule studies. 
 
AzPhe incorporation and Click chemistry will also be used to modulate the function 
of sfGFP. The effect of AzPhe incorporation near the chromophore will be assessed, 
as well as the effect of UV irradiation and Click chemistry on sfGFP fluorescence. X-
ray crystallography will be used to determine the precise molecular events that give 
rise to any changes in fluorescence caused by AzPhe incorporation and subsequent 
modification via UV irradiation. 
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2. Materials & Methods 
 
2.1. Materials 
2.1.1. Specialized chemicals 
p-Azido-L-phenylalanine (AzPhe) was purchased from Bachem (Bubendorf, 
Switzerland). It was prepared by suspending the appropriate weight required for a 1 
mM concentration in MilliQ water. The amino acid was then dissolved by titrating 1 
M NaOH until fully dissolved. This solution was then added to the growth medium to 
give the final concentration of 1 mM. Nitrocefin (BD, Maryland, USA) for enzyme 
assays was prepared by dissolving 1 mg in 100 µL DMSO (Sigma-Aldrich). 1.9mL 
reaction buffer (see Section 2.5.1.1.) was added to generate a working concentration 
of 500 µg/mL. All buffers/solutions were dissolved in MilliQ water and autoclaved or 
filter sterilized using a 0.2 µm filter prior to use. For antibiotics used in enzyme 
assays see Section 2.1.4. 
 
2.1.2. Cells 
Escherichia coli cells were used throughout the work for this thesis. Plasmids for use 
in cloning and mutagenesis were grown in either E. coli DH5α cells (Invitrogen, 
Paisley, UK) or E. coli NEB5α cells (New England Biolabs – NEB, Hitchin, UK). 
Protein production was performed in the araD (arabinose catabolism) deficient E. coli 
Top10 cells (Invitrogen). 
 
2.1.3. Media 
LB (Lysogeny broth) agar (Melford, Ipswich, UK) was prepared to a concentration of 
37 g/L in MilliQ water and autoclaving. LB broth (Melford) was prepared to a 
concentration of 20 g/L in MilliQ water and autoclaving. Auto-induction medium was 
prepared in a similar fashion to that described by Studier [96]. Briefly, tryptone and 
yeast extract (both Melford) were prepared to a concentration of 10 g/L and 5 g/L 
respectively in MilliQ water and autoclaved. Buffers and chemicals were then added 
according to Table 2-1. SOC (Super optimal broth with catabolite repression) medium 
(Melford) was prepared to a concentration of 30.5 g/L SOB (Super optimal broth) in 
MilliQ water and autoclaving, followed by the addition of 0.4% (w/v) glucose. 
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Table 2-1. Components used in the auto-induction media 
Component Concentration 
Tryptone 1% w/v 
Yeast extract 0.5% w/v 
Glycerol 0.5% v/v 
Glucose 0.025% w/v 
Lactose 0.2% w/v 
Na2HPO4 25 mM 
KH2PO4 25 mM 
NH4Cl 50 mM 
Na2SO4 5 mM 
MgSO4 2 mM 
Trace metalsa 1x 
L-arabinose 0.05% w/v 
a 4 µM CaCl2, 2 µM MnCl2, 2 µM ZnSO4, 0.4 µM CoCl2, 0.4 µM CuCl2, 0.4 µM 
NiCl2, 0.4 µM Na2MoO4, 0.4 µM H3BO3 and 10 µM FeCl3 
 
2.1.4. Antibiotics 
Antibiotics for use in cell culture were prepared as follows. Ampicillin and 
kanamycin (both Melford) were prepared by dissolving 100 mg/mL or 25 mg/mL 
respectively in MilliQ water and then filter sterilizing using a 0.2 µm filter. 
Tetracycline (Fluka) was prepared by dissolving 5 mg/mL in 100% ethanol and filter 
sterilizing using a 0.2 µm filter. Stocks were stored at -20°C. The final working 
concentrations of ampicillin, kanamycin and tetracycline were 100 µg/mL, 25 µg/mL 
and 25 µg/mL respectively. 
 
Antibiotics for use in β-lactamase activity assays (see Section 2.5.1.2) were prepared 
as follows. Ampicillin was dissolved at a stock concentration of 100 mM in MilliQ 
water, filter sterilized using a 0.2 µm filter and stored at -20°C. Cephalothin (Sigma-
Aldrich) was prepared at a stock concentration of 10 mM by dissolving in MilliQ 
water, filter sterilizing using a 0.2 µm filter and storage at -20°C. The ampicillin and 
cephalothin stocks were diluted to 10 mM and 1 mM respectively for use in the β-
lactamase activity assays. 
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2.2. Molecular Biology 
2.2.1. Oligonucleotides 
The sequences of the synthetic oligonucleotides (Integrated DNA Technologies – 
IDT) used as primers for PCR are found in Table 2-2. The melting temperatures of 
designed primers were calculated using an on-line Tm calculator, which determines 
the melting temperature of primers in the particular buffer used 
(https://www.neb.com/tools-and-resources/interactive-tools/tm-calculator).  
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Table 2-2. Sequences of primers used. Restriction sites are underlined, TAG 
mutations are capitalized, and His-tags are in bold. 
Name Sequence Tm (°C) Comments 
Remove ampicillin resistance from pBAD 
AHpBADf gcggccgcatttatcagggttattgtctc 61 Remove 
ampR from 
pBAD 
AHpBADr cagctggtaactgtcagaccaagtttactc 
 
61 
Insert amber stop codons 
AHtem105f 
AHtem105r 
ggttgagtaGtcaccagtcacag	  
aagtcattctgagaatagtgtatgcg	   62 64 Insert TAG at Tyr105 
AHtem164f 
AHtem164r 
ccttgatTAGtgggaaccgg	  
cgagttacatgatcccccatg	   65 67 Insert TAG at Arg164 
AHtem237f 
AHtem237r 
aatctggaTAGggtgagcgtg	  
tatcagcaataaaccagccag	   62 62 Insert TAG at Ala237 
AHtem72f 
AHtem72r 
gatgagcactTAGaaagttctgctatg	  
attggaaaacgttcttcgg	   62 62 Insert TAG at Phe72 
AHtem179f 
AHtem179r 
cgagcgtTAGaccacgatg	  
tcgtttggtatggcttcattc	   62 64 Insert TAG at Asp179 
AHtem235f 
AHtem235r 
ctgataaaTAGggagccggtg	  
caataaaccagccagccg	   64 65 Insert TAG at Ser235 
AHtem65f 
AHtem65r 
ccgaagaaTAGtttccaatgatg	  
ggcgaaaactctcaaggatc	   62 63 Insert TAG at Arg65 
AHtem174f 
AHtem174r 
gaagccataTAGaacgacgagc	  
attcagctccggttccc	   63 63 Insert TAG at Asp174 
AHtem165f 
AHtem165r 
gatcgtTAGgaaccggagc	  
aaggcgagttacatgatcccc	   66 66 Insert TAG at Trp165 
AHtem79f 
AHtem79r 
gcaatgaaaTAGggtgagctgg	  
catacggaattccggatgag	   65 65 Insert TAG at Ala79 
Remove bla from another plasmid 
AHblaf ccatggatgagtattcaacatttccgtgtcg	    67 Add NcoI site 
AHblar 
ggtaccttaatggtgatgatgatggtggctg
ccccaatgcttaatcagtgaggcac	    67 Add KpnI site/His tag 
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2.2.2. Polymerase chain reaction 
Polymerase chain reaction (PCR) was performed using the Phusion Site-Directed 
Mutagenesis kit (NEB). All components were mixed according to manufacturer’s 
instructions. Briefly, dNTPs (0.4 mM each), oligonucleotide primers (1 µM each), 
template DNA (10 pg) and polymerase (1 unit) were mixed in reaction buffer (10 mM 
Tris-HCl, 0.1% (v/v) Triton X-100, pH 8.8). Thermocycling was performed using a 
Techne TC-3000 thermocycler, using a 3-step program as recommended by the 
Phusion DNA polymerase suppliers for performing whole-plasmid amplification 
(Table 2-3). The annealing temperature was dependent on the specific primers used 
(listed in Table 2-2), and the extension time was dependent on the length of fragment 
generated by the reaction. 
 
Table 2-3. Thermocycling procedure for PCR. 
Cycle step Temperature Time Number of cycles 
Initial denaturation 98°C 30 seconds 1 
Denaturation 
Annealinga 
Extensionb 
98°C 
64-72°C 
72°C 
5-10 seconds 
10-30 seconds 
15-30 seconds/kb 
25-35 
Final extension 72°C 5 minutes 1 
a Annealing temperature was based on the primer used. 
b Extension time was changed according to the length of the template DNA. 
	  
2.2.3. Restriction digestion 
Restriction digests of DNA were performed using restriction endonucleases from 
NEB and completed using the appropriate buffer supplied with the enzyme: NEBuffer 
1 (10 mM Bis-Tris Propane-HCl, 10 mM MgCl2, 1 mM dithiothreitol, pH 7.0), 
NEBuffer 2 (10 mM Tris-HCl, 10 mM MgCl2, 50 mM NaCl, 1 mM dithiothreitol, pH 
7.9), NEBuffer 3 (50 mM Tris-HCl, 10 mM MgCl2, 100 mM NaCl, 1 mM 
dithiothreitol, pH 7.9) and NEBuffer 4 (20 mM Tris-acetate, 10 mM magnesium 
acetate, 50 mM potassium acetate, 1 mM dithiothreitol, pH7.9). The majority of 
reactions were completed using NEBuffer 4. The restriction digestions were incubated 
at 37°C for 1 hour using a MJ Research PTC-100 heat block. The amounts of DNA 
used per reaction ranged from 1 to 50 ng. 
 31 
2.2.4. Phosphorylation 
PCR products were phosphorylated using T4 polynucleotide kinase (NEB) in 66 mM 
Tris-HCl, 10 mM MgCl2, 1 mM dithiothreitol, 1 mM ATP, 7.5% (w/v) 
polyethyleneglycol (PEG6000), pH 7.6. The reaction was incubated at 37°C for 30 
minutes. 
 
2.2.5. Ligation 
DNA fragments and linearized plasmids were ligated using Quick Ligase (NEB) in 
the same buffer as the phosphorylation reactions (Section 2.2.4). Reactions were 
incubated at room temperature for 10 minutes. For the insertion of a DNA fragment 
into a plasmid, a three-fold molar excess of insert was used. 
 
2.2.6. Agarose gel electrophoresis 
Agarose gels were made by mixing the appropriate weight of agarose (Melford) to a 
volume of TAE buffer (40 mM Tris-acetate, 1 mM EDTA, pH 8.8) to make the 
required percentage agarose (0.8 – 1% (w/v)). Ethidium bromide (Melford) was added 
to a final concentration of 40 ng/mL to visualize the DNA. Prior to loading the gel, 
loading buffer (2.5% Ficoll-400, 11 mM EDTA, 3.3 Tris-HCl, 0.017% SDS (sodium 
dodecyl sulphate) and 0.015% bromophenol blue) was added to the DNA sample to 
be analyzed. Electrophoresis was performed at 120 V until sufficient separation of 
bands was achieved. DNA size was analyzed by comparison to either the 1 kb DNA 
ladder (NEB) or the 100 bp DNA ladder (NEB) standards loaded on the same gel. 
Bands were visualized using a GelDoc-It UV-transilluminator (Ultra-Violet Products, 
Cambridge, UK). 
 
2.2.7. DNA isolation and purification 
2.2.7.1. Plasmid DNA isolation 
Isolation and purification of plasmid DNA from cell cultures was performed using the 
QIAprep Miniprep kit (Qiagen). Cell cultures (5 mL) were centrifuged at 4000 rpm 
(2800 x g) to create a cell pellet. The pellet was then resuspended and lysed via 
alkaline lysis using the buffers supplied with the kit. The lysed cells were then spun 
again at 13000 rpm (15600 x g) to remove cell debris and genomic DNA. The plasmid 
DNA was extracted from the supernatant by binding to a silica membrane under low 
salt conditions, and then eluted under high salt conditions. 
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2.2.7.2. DNA extraction from agarose gel 
The extraction of DNA from an agarose gel matrix was performed using the 
QIAquick Gel Extraction Kit and protocol (Qiagen). The required DNA band was 
excised from the gel using a sterile scalpel and then extracted and purified according 
to the manufacturer’s instructions. 
 
2.2.7.3. DNA purification from enzymatic reactions 
The isolation and purification of DNA from enzymatic reactions such as 
phosphorylation and ligation was performed using the QIAquick MinElute kit and 
protocol (Qiagen).  
 
2.2.8. Transformation 
Electro-competent E. coli cells were transformed with plasmid DNA using a Flowgen 
Cellject electroporator. A 50 µL aliquot of electro-competent cells were thawed on ice 
and mixed with the desired plasmid DNA. The quantity of DNA used ranged from 10 
pg to 5 ng depending on the source of the DNA (e.g. plasmid DNA or ligation 
reactions). Cells were pulsed with 2400 V before recovery in 350 µL SOC medium at 
37°C for 1 hour. Cells were then plated onto LB Agar plates supplemented with the 
appropriate antibiotic and incubated at 37°C overnight. 
 
2.2.9. Sequencing 
All sequencing was done via the Cardiff University Molecular Biology Support Unit 
Sequencing Core. 
 
2.3. Mutagenesis modeling 
Putative mutations in TEM β-lactamase were modeled in silico using a combination 
of Swiss-Model (http://swissmodel.expasy.org - Swiss Institute of Bioinformatics) 
and Swiss PDB Viewer (http://spdbv.vital-it.ch) [97, 98]. Residues were mutated in 
silico to tyrosine using the mutation tool in Swiss PDB Viewer. The new sequence 
was then uploaded using the online server into the alignment mode in Swiss-Model 
along with the wild type sequence (PDB code 1BTL). The program aligns sequences 
using iterative least squares algorithms, scoring structures using force field energy and 
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steric hindrances, and then performs energy minimisation using the GROMOS96 
force field [99]. The results were returned in PDB file format and analyzed using 
Swiss PDB Viewer and PyMol. All images were generated using PyMol. 
 
2.4. Protein production 
2.4.1. Recombinant protein production 
E. coli Top10 cells containing the two required plasmids (pBAD/pBAK (see Section 
3.2.2) containing the gene of interest and pDULE containing the tRNA and the 
amino-acyl tRNA-synthetase) for protein production were grown in a 5 mL LB starter 
culture overnight. This starter culture was diluted 1/200 to inoculate 50 mL auto 
induction medium (Table 2-1) supplemented with 100 µg/mL ampicillin or 10 µg/ml 
kanamycin (depending on the protein produced), and 10 µg/ml tetracycline. For 
protein variants containing a TAG mutation, 1 mM AzPhe was added to the culture 
before incubation. Cultures were incubated at 37°C in a shaking incubator (200 rpm) 
for 24 hours.  Cultures were grown in the dark to prevent photolysis of the azide 
group. 
 
For the preparation of large cultures (>50 mL), the same method as above was used 
except for the following. A 10 mL starter culture (per 1 L main culture volume) was 
used to inoculate auto-induction medium. 
 
2.4.2. Cell lysis 
2.4.2.1. Cell lysis using BugBuster 
Small cultures were lysed chemically using BugBuster (Novagen) for quick analysis 
of protein expression. Cells were pelleted by centrifugation at 2800 x g in a 
microfuge. Cells were resuspended in 1 mL BugBuster and incubated at room 
temperature for 30 minutes in a shaking incubator. The mixture was pelleted by 
centrifugation at 17000 x g in a bench top centrifuge. The supernatant containing the 
cell lysate was recovered and the pellet was discarded. 
 
2.4.2.2. Cell lysis using sonication 
Sonication was used to lyse medium size cultures (50-200 mL). Cells were pelleted as 
above and then resuspended in phosphate buffered saline (PBS – 100 mM sodium 
phosphate, 300 mM NaCl, pH 8). Resuspended cells were then exposed to 8 cycles of 
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10 seconds high frequency sound waves (20 kHz, 40% amplitude) followed by 30 
seconds cooling. Cells were kept on ice at all times during sonication. 
 
2.4.2.3. Cell lysis using French press 
Lysis by pressure was used for all large cultures (>200 mL) using an American 
Instrument Company French press. Cells were pelleted and resuspended in PBS (as in 
Section 2.4.2.2) in an equivalent of a 50-fold dilution of the original culture volume. 
The cells were then passed through the French press two to three times at 1260 psi to 
ensure full lysis. Cell lysates were spun at 20000 x g and the pellet was discarded. 
 
2.4.3. SDS-PAGE electrophoresis 
SDS – polyacrylamide gel electrophoresis (SDS-PAGE) was used to analyze crude 
cell extracts and purified protein as described by Laemmli [100]. Electrophoresis was 
performed using a mini-PROTEAN 3 electrophoresis system (Bio-Rad). A 15% gel 
(to resolve proteins between 15 kDa and 60 kDa) was used throughout the work, and 
was made using the recipe shown in Table 2-4. 
 
Table 2-4. Components in SDS-PAGE stacking and resolving (15%) gels 
 Stacking Resolving 
Acrylamide/bis-Acrylamidea 5% (w/v) 15% (w/v) 
Tris-HClb 65 mM 0.375 mM 
SDS 0.2% (w/v) 0.1% (w/v) 
Ammonium persulphate (APS) 0.1% (w/v) 0.05% (w/v) 
TEMED 0.02% (w/v) 0.02% (w/v) 
a Acrylamide and N,N’-methylene bis acrylamide in a 37.5:1 (w/w) ratio 
b pH 6.8 and 8.8 Tris-HCl buffers were used in stacking and resolving gels 
respectively 
 
Prior to loading onto the gel, the samples were mixed with 5 x loading dye (final 
concentrations; 2% (w/v) SDS, 0.2 M Tris-HCl pH 6.8, 0.04% (w/v) bromophenol 
blue, 8% (w/v) glycerol, 10% (v/v) β-mercaptoethanol) and heated at 95°C for 5 
minutes. When loading whole cell extracts for analysis, cells were pelleted and then 
resuspended in 1 x loading buffer (same concentrations as above) to an optical density 
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of 10 (600 nm), before incubating at 95°C for 10 minutes. Samples were run with a 
broad-range, pre-stained protein marker (NEB) for estimation of band migration. Gels 
were stained using Coomassie blue stain (40% (v/v) methanol, 10% (v/v) acetic acid 
and 0.1% (w/v) Coomassie blue R250 (Fisher)) and destained using 40% (v/v) 
methanol, 10% (v/v) acetic acid. 
 
2.4.4. Protein purification 
2.4.4.1. Nickel affinity chromatography 
Nickel affinity chromatography was performed using a HisTrap column (GE 
Healthcare) connected to an AKTAPurifier (GE Healthcare). Cell lysates were spun at 
17000 x g to ensure no cell debris was loaded onto the column. The soluble fraction 
of lysed cells was loaded onto the column equilibrated with PBS. An imidazole 
(Fisher) gradient from 0 mM to 250 mM (in PBS) was then applied to the column 
over 20 column volumes to elute the protein. Eluted fractions were measured for 
absorbance at 280 nm (and 485 nm for sfGFP) and presence of protein was confirmed 
using SDS-PAGE and nitrocefin activity assays for β-lactamase activity (see Section 
2.5.1.1.). 
 
For small-scale protein purification, His SpinTrap columns (GE Healthcare) were 
used to purify the target protein. Purification was completed in a benchtop 
microcentrifuge at 100 x g, as per the supplier’s recommended protocol. Briefly, 
samples were bound to a nickel resin in PBS, washed in a low concentration of 
imidazole to remove weakly bound proteins from the resin, and then eluted at a higher 
concentration (500 mM) of imidazole. Fractions were analyzed using SDS-PAGE. 
 
2.4.4.2. Ion exchange chromatography 
To further purify sfGFP variants for crystallography, ion exchange chromatography 
was used after nickel affinity chromatography. Imidazole and NaCl were removed via 
buffer exchange using 3000 MWCO centrifugal concentrator units (Merck Millipore) 
prior to purification. The protein was then loaded onto a MonoQ anion exchange 
column (GE). The protein was then eluted using a concentration gradient of NaCl, 
from 0 mM to 500 mM over 20 column volumes. 
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2.4.5. Dialysis 
Dialysis was used to remove any unwanted solutes from fractions containing the pure 
protein. Fractions were pooled and applied to a SpectraPor dialysis membrane 
(Spectrum Labs). The dialysis tubing used for all pure proteins had a molecular 
weight cut off of 3500 Da. The tubing was closed at both ends using plastic clips and 
the membranes were left in a single rinse of 5 litres PBS overnight in a cold room. 
The buffer was kept stirring throughout. 
 
2.5. β-lactamase activity analysis 
All enzymatic activity analyses were performed using a Hewlett Packard 8452A 
Diode Array Spectrophotometer. Measurements were recorded using a 1 cm pathway 
in a QS quartz cuvette (Hellma). 
 
2.5.1. Nitrocefin hydrolysis assay 
TEM β-lactamase activity in cell lysates was initially analyzed by nitrocefin 
hydrolysis assay in reaction buffer (10 mM sodium phosphate, 100 mM NaCl, pH 7) 
at room temperature. Cell lysates (50 µL) were analyzed in 1 mL reaction volume. 
Reactions were initiated by addition of nitrocefin to a final concentration of between 
50-100 µM and monitored by an increase in absorbance at 485 nm. Concentration of 
hydrolysed nitrocefin was determined using an extinction coefficient of 14060 M-1 
cm-1 [101]. 
 
The activity of TEM β-lactamase variants after Click chemistry modification (see 
Section 2.8.1) was also analyzed using the nitrocefin hydrolysis assay. Click-modified 
TEM β-lactamase was diluted to a final concentration of 250 ng/µL in PBS. Reactions 
were initiated by addition of nitrocefin to a final concentration of between 50-100 µM 
and monitored by an increase in absorbance at 485 nm. 
 
2.5.2. Antibiotic hydrolysis 
The kinetics of β-lactamase-dependent β-lactam hydrolysis were determined using 
ampicillin (235 nm, Δ = 1500 M-1 cm-1) and cephalothin (262 nm, Δ = 7660 M-1 cm-1) 
as substrates. Hydrolysis assays were carried out in a 1 mL reaction volume. Purified 
enzyme was diluted to a final concentration of 250 ng/µL in 50 mM sodium 
phosphate buffer, pH 8 at room temperature. Reactions were started by addition of 
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either ampicillin or cephalothin and hydrolysis was measured by the decrease in 
absorption at the extinction wavelength of each antibiotic. Substrate concentrations 
ranged from 50 µM to 800 µM for ampicillin and from 10 µM to 150 µM for 
cephalothin. 
 
2.5.3. Kinetics analysis 
Kinetic parameters were calculated using initial rate of hydrolysis at each substrate 
concentration (n=3) and then fitting to the Michaelis-Menten equation (Equation 1) 
using GraphPad Prism.  
 ! = !!"#[!]!!! !   Equation 1 
 
This is a non-linear fitting equation that presents values for Vmax (maximum velocity) 
and KM (substrate concentration at which enzyme velocity is half Vmax – a constant that 
does not describe strength of binding, but rather a constant that addresses both 
substrate affinity and substrate hydrolysis). This equation assumes a linear production 
of product by a single enzyme and that substrate concentration sufficiently exceeds 
enzyme concentration so that the concentration of free substrate remains effectively 
the same throughout the assay. It also assumes there is no co-operativity of substrate 
binding. Catalytic turnover (kcat) was then determined using the calculated Vmax and 
the known enzyme concentration (Section 2.5.2.). 
 !" =    !!"#!!            Equation 2 
 
Catalytic efficiency (CE) was then determined using Equation 2. 
 
!!"!" = !!! ! + !!! !         Equation 3 
 
Relative errors for catalytic efficiency were determined using Equation 3 where a 
represents kcat, ea represent kcat error, b represents KM and eb represents KM error. 
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2.5.4. Photolysis of proteins 
TEM β-lactamase and the AzPhe-containing variants were irradiated with UV light 
using a UVM-57 handheld UV lamp (UVP) in 50 mM sodium phosphate buffer. 
Enzymes were irradiated for two minutes at a distance of 1 cm from the sample, 
unless otherwise stated, sampling a range of UV wavelengths (275 – 380 nm) at 4 
watts, as defined by the light source. Enzymes were irradiated at a concentration of 25 
µg/mL, prior to dilution for antibiotic hydrolysis experiments. 
 
2.6. Superfolder GFP (sfGFP) fluorescence spectroscopy 
Fluorescence spectroscopy was performed using a Varian Cary Eclipse 
spectrophotometer. Spectra were recorded at a scan rate of 600 nm/min with a slit 
width of 5 nm. Emission spectra were recorded up to 650 nm from a single excitation 
wavelength (485 nm). Excitation spectra were recorded by measuring emission at 511 
nm over a range of excitation wavelengths from 350 to 511 nm. For whole cell 
fluorescence, cells were pelleted and resuspended in TNG buffer (50 mM Tris-HCl, 
150 mM NaCl, 10% (v/v) glycerol, pH 8) to an OD of 0.1. Pure proteins were 
analysed at a concentration of 1 µM. 
 
2.6.1. Quantum yield determination 
Quantum yields of sfGFPHis148AzPhe were determined by comparison with fluorescein, 
a reference with a known quantum yield at a similar wavelength (496 nm). 
sfGFPHis148AzPhe and fluorescein were diluted to an A485 of 0.05 and emission spectra 
were recorded at the excitation maxima of sfGFPHis148AzPhe and integrated between 5 
nm above the excitation wavelength and 650 nm, and then inserted into Equation 4. 
 ϕ! =   ϕ!   . !"#!!"#! . (!!!!!!)       Equation 4 
 
ϕ is the quantum yield, Int is the integrated emission spectrum and η is the refractive 
index of the solvent. The subscripts x and R refer to the sample and reference 
respectively. Brightness was determined as a product of molar extinction coefficient 
and quantum yield. 
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2.7. X-ray crystallography 
Purified sfGFP containing AzPhe at residue 148 was dialyzed into 50 mM Tris, 150 
mM NaCl, pH 8, and concentrated to 10 mg/ml. Crystal formation was screened using 
the sitting drop vapour diffusion method across a variety of pH conditions (4-9 in 
steps of 0.5) and a variety of (NH4)2SO4 concentrations (50-90% saturation in steps of 
10%). Screens were set up in duplicate, at 4°C and at 25°C. Drops were set up with 
equal volumes of protein and precipitant solution (0.2 µl). The only condition to 
produce crystals was 50 mM MMT (Malic acid, MES, Tris), 60% saturation with 
(NH4)2SO4 (2.52 M), pH 8.5, which yielded two crystals. 1 mM ethylene glycol was 
added as a cryo-protectant before harvesting one of the crystals. The second crystal 
was then irradiated for 60 minutes using a UVM-57 handheld UV lamp (UVP). This 
second crystal was then harvested in the same manner. 
 
Data were collected by Dr. Pierre Rizkallah (Cardiff Medical School, Cardiff 
University) at the Diamond Light Source, Harwell, UK. Data were reduced using the 
XIA2 package [102], assigned a space group using POINTLESS [103], scaled using 
SCALA [103] and merged using TRUNCATE [104]. Structures were solved by 
molecular replacement with PHASER, using a previously determined sfGFP structure 
(PDB code 2B3P). Structures were then adjusted manually using COOT and refined 
by TLS restrained refinement using RefMac. All the above programs were accessed 
via the CCP4 package (http://www.ccp4.ac.uk/) [104]. 
 
2.8. Click Chemistry 
2.8.1. Strain-promoted azide-alkyne cyclo-addition (SPAAC) 
A full list of the strained ring alkyne reagents used is shown in Table 2-5. SPAAC 
reactions were performed on pure protein (5 µM – 15 µM) using a five-fold molar 
excess of Click modification to protein in PBS. Reactions were left overnight at room 
temperature (reactions involving DNA strands were left for 48 hours). DBCO-585 and 
DBCO-amine were obtained from Click Chemistry Tools, while DBCO-pyrene was a 
gift from S. Reddington. It was synthesized from DBCO-amine and 1-pyrenebutanoic 
acid, succinimidyl ester (Anaspec) via nucleophilic substitution in an argon 
atmosphere with TEA. The reaction was ended by addition of aqueous HCl (0.1 M) 
and extracted using EtOAc. DNA strands were sourced from ATDBio (University of 
Southampton). 
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Proteins modified with DNA oligonucleotides were separated from unmodified 
proteins using ion exchange chromatography. Proteins were applied to a MonoQ 
anion exchange column (GE). Successfully modified proteins bound to the column via 
the DNA and were eluted using a concentration gradient of NaCl from 0 mM to 500 
mM over 20 column volumes. 
 
Table 2-5. Chemical structures of the strained ring alkynes used for post-translational 
modification of proteins 
Name Structure 
DBCO-585 
 
DBCO-amine 
 
DBCO-pyrene 
 
DNA-
oligonucleotides 
 
R1 - GGTGGAGTGATGGATGGGAG  
R2 - TTTTTTACTCACATTAAT 
TGCGACCTGTCGTGCCAGCT 
N N
H
O2
S
O
N
N
O SO3
N
O
NH2
N N
H
O O
H
H
R
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2.8.2. Fluorescent imaging of clicked protein 
SPAAC reactions with DBCO-585 were analyzed via SDS-PAGE and subsequent 
imaging of the fluorescent dye. Proteins were separated via SDS-PAGE as per the 
standard procedure (see Section 2.4.3). Prior to staining, protein gels were visualized 
using a GelDoc-It (Bio-Imaging Systems). Band intensities were then quantified using 
ImageJ software (NIH). Gels were then stained with Coomassie blue as per the 
standard procedure to confirm the same quantity of protein was loaded into each well. 
 
2.8.3. Relative FRET efficiency calculation 
The relative FRET efficiency between the chromophore of sfGFPHis148AzPhe (donor) 
modified with DBCO-585 and the fluorophore of DBCO-585 (acceptor) was 
calculated experimentally using Equation 5, where IA and ID are the fluorescence 
intensities of the acceptor and donor respectively when excited at 400 nm. 
 !!"# =    !!!!!!!         Equation 5 
 
This equation determines the ratio between the emission intensities of the acceptor 
and the donor fluorophores. 
 
2.8.4. AFM imaging of proteins on carbon allotropes 
2.8.4.1. AFM imaging of proteins on HOPG 
HOPG (highly ordered pyrolytic graphite) was labeled with DBCO-pyrene prior to 
the addition of protein. Flakes of HOPG were immersed in 0.2 mM DBCO-pyrene in 
100% DMSO before washing with 100% DMSO and MilliQ water. TEM β-lactamase 
was then incubated with the HOPG for 10 minutes before washing as above. 
Additionally, HOPG was also incubated with pre-modified protein and washed as 
above. AFM imaging was performed by Ms. Athraa Zaki (School of Physics & 
Astronomy, Cardiff University). Measurements were taken in air using a Multimode 
microscope with a Nanoscope III controller (DI Veeco), using the tapping mode with 
polysilicon probes. 
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2.8.4.2. AFM imaging of proteins on graphene 
Graphene (on a copper base) was labeled with TEM β-lactamase already clicked to 
DBCO-pyrene (see Section 2.8.1 and Table 2-5). Flakes of graphene were immersed 
in clicked protein for 15 minutes before two washing steps. Firstly, the flakes were 
washed in two changes of 100% DMSO for a total of 10 minutes. Secondly, the flakes 
were rinsed with MilliQ water prior to imaging. Imaging was undertaken as above. 
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3. In silico modeling of TEM β-lactamase mutations and DNA 
cloning 
 
3.1. Introduction 
The incorporation of unnatural amino acids (uAAs) has great potential for introducing 
new and useful properties into proteins through expansion of the chemistry available. 
Protein engineering and more recently, synthetic biology utilizes two general 
strategies to generate protein mutants; directed evolution through the use of libraries 
comprised of randomly generated mutations [105], or the rational design of site-
specific mutations. Rational design requires the use of structural information (either at 
the linear amino acid sequence level or the 3-dimensional protein level) to aid the 
selection of the specific targets, because mutating every residue in a protein with 
every possible combination of mutations is, in practical terms, an impossible task. 
Additionally, the design of mutants increases the chance of introducing specific 
properties to proteins. In this chapter, the selection of potential variants was assessed 
using computer modeling to hypothesize, firstly, the effect of uAA incorporation on 
the target protein, and secondly to hypothesize the effect of subsequent novel post-
translational modifications on TEM β-lactamase activity. This was used in 
conjunction with existing literature to select a range of residues that when mutated 
and modified, may impact protein activity, either directly through the active site, or 
indirectly through interactions with the Ω-loop and the structure of the enzyme. 
 
Once suitable residues have been selected, the successful incorporation of uAAs 
requires the mutation of endogenous codons to the amber stop codon, TAG. The TAG 
codon is then reprogrammed through the use of engineered orthogonal tRNA and 
amino acyl-tRNA synthetase pairs, which incorporate uAAs in response to the TAG 
trinucleotide sequence (see Chapter 1.4). This enables the uAA to be incorporated into 
the protein during cellular protein synthesis in a variety of different organisms [54-
56]. This chapter will also detail the steps taken to modify existing vectors for use 
with an auto-inducible system of expression, used for high-yield production of TEM 
β-lactamase and sfGFP in E. coli, the two proteins studied in this thesis, and then the 
steps taken to introduce the amber stop codon into the target genes. 
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3.2. Results and discussion 
3.2.1. Modeling TEM β-lactamase mutations in silico 
3.2.1.1. Using Swiss-PDB Viewer/Swiss Model 
A rational design approach was chosen so that specific interactions caused by the 
incorporation of p-azido-L-phenylalanine (AzPhe) – and the subsequent post-
translational modification of the novel side chain – could be targeted. To facilitate this 
design process and residue selection, structural modeling of potential mutations were 
undertaken using a combination of Swiss PDB Viewer [97], to generate the mutations 
and visualize their effects, and the Swiss-Model online service [98] to hypothesize the 
effects that may occur by the substitution of the existing amino acid to a uAA. 
Although at the time this modeling was initiated it was not possible to use the 
structure of a uAA such as AzPhe, the structure of tyrosine is very similar, and so 
makes it a suitable replacement for this purpose. Both AzPhe and tyrosine are large, 
aromatic residues, with the only difference at the para position of the phenyl ring. 
Tyrosine has a hydroxyl group at this position whereas AzPhe has an azide group 
(N3). Individual residues were mutated to tyrosine in silico and energy minimization 
was performed to determine a structure that represents the most likely orientation of 
the mutated aromatic side chain. The modeling process not only looks at the effect 
placed on the selected residue alone, but also the local microenvironment surrounding 
the particular side chain. Mutation to a large, aromatic amino acid such as tyrosine, 
especially when the canonical amino acid is a small amino acid (e.g. glycine or 
alanine) can have a large impact on the surrounding residues, and the precise 
orientation of their side chains. 
 
Residues targeted for mutation were chosen based on three criteria; proximity to 
residues involved in catalysis, location within the Ω-loop, and/or positions that may 
have effects on the tertiary structure of the protein such as affecting Ω-loop flexibility, 
or affecting the formation of the domain interface where the active site lies. A full list 
of the residues chosen can be found in Table 3-1. 
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Table 3-1. List of residues chosen for mutation based on the three criteria; proximity 
to the active site, proximity to the Ω-loop and/or potential effects on tertiary structure. 
Residue Potential interactions Rationale 
Tyr105 Val216 Tyr105 forms a large part of the domain interface 
near the active site, mutation could reduce the 
space available for substrates 
Ala237 Tyr105 Ala237 is found in the active site and may have a 
role in substrate orientation during catalysis, 
mutation could disturb substrate binding 
Phe72 Glu166, water Found close to Ser70, could disrupt Glu166 or a 
conserved water involved in the catalytic process 
reducing catalytic turnover 
Ser235 Steric clashes Ser235 is found in the active site near Lys234 
which has a role in catalysis, mutation could 
cause steric clashes due to the larger side chain 
Arg164 Salt bridge network One of the residues that form salt bridges to 
maintain the structure of the Ω-loop, mutation 
could disrupt the structure of the Ω-loop 
Asp179 Salt bridge network One of the residues that form salt bridges to 
maintain the structure of the Ω-loop, mutation 
could disrupt the structure of the Ω-loop 
Trp165 Gly143 Found in the Ω-loop close to Glu166, mutation 
could induce an interaction with Gly143, 
reducing the flexibility of the Ω-loop 
Pro174 Gly267 Pro174 is found on the Ω-loop and may regulate 
flexibility by restricting an unstructured loop 
region, mutation could increase this flexibility 
Arg65 Asn175 Found behind the Ω-loop, mutation may result in 
crosslinking with the Ω-loop, reducing the 
flexibility of the loop 
Ala79 Glu145 Found buried in the core of the enzyme, mutation 
could result in crosslinking with Glu145 and 
disturb the positioning of Ser70  
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The residues directly involved in the catalytic mechanism of the TEM β-lactamase are 
Ser70, Glu166, Lys73, Lys234 and Ser130 [70]. Any positions that were selected for 
mutation due to their proximity to these catalytic residues are highlighted in yellow in 
Figure 3-1. A key feature of TEM β-lactamase is the Ω-loop, formed by residues 161 
to 179 [106]. This loop plays a major role in substrate recognition and defines access 
to the active site, and many TEM β-lactamase variants that hydrolyze synthetic 
antibiotics (increased spectrum mutants) have residue substitutions in this structure 
[82]. Residues chosen that are present on the Ω-loop are shown in pink on Figure 3-1. 
Many mutations that affect enzyme activity do not directly influence the active site, 
but help by increasing protein folding or stability [107, 108]. This is due to the 
complex network of interactions present in the tertiary structure of an enzyme that 
help to position and orientate the catalytic residues. Any disruption in these 
interactions can have a subsequent affect on activity. Any positions that are not in 
close proximity to the active site, or are not present on the Ω-loop, but fulfill this 
criterion are shown in orange on Figure 3-1. 
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Figure 3-1. Residues of TEM β-lactamase targeted for uAA incorporation. A. 
Structure of TEM β-lactamase highlighting the two-domain structure, with the active 
Ser70 residue (red) in the domain interface. The α-domain is shown in green and the 
α-β domain shown in cyan. The Ω-loop is shown in blue. Spheres represent residues 
chosen for site-directed mutagenesis; (i) due to their proximity to the active site 
(yellow), (ii) due to their location in the Ω-loop (pink), (iii) due to their effect on the 
tertiary structure (orange). B. Schematic of the structure of TEM β-lactamase showing 
the two-domain structure, Ser70 and the Ω-loop. This highlights the location of the 
mutations in the linear amino acid structure, surrounding both the active site and the 
Ω-loop primarily. 
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3.2.1.2. Residues directly impacting the active site 
The introduction of AzPhe into TEM β-lactamase accesses two potential methods of 
post-translational control of activity, photo-reactivity and Click chemistry. During the 
selection of potential mutations, particularly those residues that would directly 
influence the active site, these two routes of post-translational control were considered 
when selecting which residues to mutate. Four positions were selected that if AzPhe 
were to be incorporated, there could be interesting effects on the enzyme activity 
caused by photo-reactivity and/or Click modification. The first, Tyr105, forms one 
side of the active site cleft where the catalytic residues sit (Figure 3-2A). Any 
modification of the structure of the protein here is likely to have significant effects on 
substrate binding and access to the active site. Modeling was not performed (the 
residue is already a tyrosine) but the position of the tyrosine and the orientation of its 
side chain in the structure suggests a potential interaction upon photo-activation with 
Val216, located on the α-β domain on the other side of the cleft (Figure 3-2A – inset). 
Any crosslinking here (valine has no nucleophilic properties but insertion into carbon-
hydrogen bonds are possible) would affect the size and shape of the cleft, limiting the 
space for substrates to occupy. Additionally, modification of this residue via Click 
chemistry could significantly affect substrate binding as well. The addition of any 
chemical groups (such as those used in Cu-free Click chemistry) to the active site 
would leave little room for substrates to gain access to the active site, and could 
interfere with the orientation of residues responsible for hydrolysis and/or substrate 
binding. 
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Figure 3-2. A. Position of Tyr105 (yellow) in the folded protein. It sits along the 
cavity formed by the two domains near the active site. The active Ser70 residue is 
shown in red, the α-domain is shown in green, the α-β domain is shown in cyan and 
the Ω-loop is shown in blue. Val216 is present on the opposite side of the active site 
(inset). B-D. Modeling mutations at residues (B) Phe72, (C) Ala237 and (D) Ser235. 
B. Modeling a mutation at Phe72 (yellow) revealed potential interactions with Glu166 
(inset), which has a key role in the catalytic mechanism. C. Mutation to tyrosine at 
Ala237 highlights the impact a larger side chain may have in this position of the 
enzyme. D. Modeling the mutation at Ser235 reveals potential clashes with 
surrounding residues. The incorporation of a larger side chain could result in 
structural changes to accommodate the new side chain. 
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Phe72 represents a second potentially useful site due to its location two residues away 
from the catalytic Ser70 residue within the core α-helix. Mutation to tyrosine during 
modeling revealed a potential interaction with Glu166 upon photo-activation, a key 
residue in the proton shuttle cascade critical to catalysis (Figure 3-2B). The 
incorporation of the larger azide group may alter the position of Glu166, affecting this 
proton cascade. Additionally, upon photo-activation of the azide group, amine 
formation (see Figure 1-3) could cause an interaction with Glu166, in the same 
manner as the OH group of the mutated tyrosine (Figure 3-2B – inset). This 
interaction could also affect the proton cascade and thus activity. Thirdly, the 
hydroxyl group on the side chain of the glutamate could provide the nucleophile for 
attack on the activated nitrene species outlined in Chapter 1.5, resulting in 
crosslinking between the two residues. Alternatively, the conserved water molecule 
that is present between Glu166 and Ser70, thought to act as a shuttle for the proton 
during catalysis, could provide the nucleophile required for addition reactions. 
Interactions with this crucial water molecule could rob the enzyme of this relay 
system. The location of this residue near the core of the protein would make 
modification via Click chemistry difficult. Using NetSurfP [109] to estimate surface 
accessibility, Phe72 has a surface exposed area of 10 Å2 (relative surface area (RSA) 
of 0.05), compared to 113 Å2 (RSA = 0.53) for Tyr105. This highlights the buried 
nature of the residue and would suggest post-translational modification of this residue 
would be negligible. However, it has been shown in previous studies that surface 
accessibility is not the only factor in determining the likelihood of a successful Click 
reaction [110]. Other factors that were shown to impact Click modification efficiency 
were residue flexibility and the microenvironment surrounding a side chain. 
 
The third residue selected was Ala237. This residue sits in the catalytic pocket but has 
no direct role in the catalytic mechanism, however it has been shown to help orient 
the β-lactam ring of the antibiotic in the active site [111]. Alanine is one of the 
smallest amino acids available, so mutation to an aromatic uAA such as AzPhe is 
likely to have a large impact on the catalytic pocket and the ability for substrates to 
gain access to Ser70. The estimated orientation of the mutated tyrosine residue in the 
model suggests the catalytic pocket would be almost entirely closed by this mutation 
(Figure 3-2C). The side chain points towards Tyr105 on the α-domain and any 
interaction with this residue caused by photo-activation of the azide group would 
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completely block off the active site. Any post-translational modifications via Click 
chemistry would also limit substrate access to the active site and would likely have a 
negative impact on activity. The addition of chemical groups at this position could act 
as a novel inhibitor, as any modification may occupy the same space substrates 
occupy during catalysis. A fourth residue targeted to impact the catalytic mechanism 
is Ser235. Ser235 is part of a conserved triad of residues including Lys234 (which has 
a direct role in catalysis – [81]) that have been shown to be involved in the catalytic 
process [112]. The hydroxyl group of Ser235 has been shown to be important in both 
penicillinase activity and cephalosporinase activity. The side chain of the modeled 
tyrosine residue points away from the active site (even though the hydroxyl group of 
Ser235 points towards the active site), so mutation to a uAA here is likely to greatly 
impact catalytic activity. The orientation of the modeled tyrosine at Ser235 suggests 
potential steric clashes with nearby residues that may cause an effect on the 
positioning of other side chains in the local environment (Figure 3-2D). This could 
lead to subtle changes in the overall structure of the enzyme. The orientation of the 
predicted side chain suggests post-translational modification via Click chemistry is 
unlikely to occur, as the residue is buried in the enzyme with very limited 
accessibility to solvent (8 Å2). 
 
3.2.1.3. Residues on the Ω-loop 
A further four residues were selected that are present on the Ω-loop of TEM β-
lactamase. The first of these is Trp165, one residue N-terminal to the catalytically 
important Glu166 and one of the residues mutated in increased spectrum variants of 
TEM β-lactamase [83]. Substitution of this residue with tyrosine during modeling 
identified possible interactions with the carbonyl oxygen of Gly143 (Figure 3-3A – 
inset). Any interactions here caused by the photo-activation of the azide group would 
alter the flexibility of the Ω-loop, a characteristic that is integral to the function of this 
protein [113]. Glu166 plays a major role in the catalytic mechanism of the enzyme 
and is present on the Ω-loop, so any changes to the precise orientation of this residue 
may have a significant effect on activity. The orientation of the side chain in the 
model suggests post-translational modification would be possible, as the side chain of 
the modeled tyrosine points away from the core of the protein and is surface 
accessible, suggesting a high modification efficiency is possible. The addition of large 
chemical groups via Click chemistry so close to Glu166 and the other catalytic 
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residues is likely to result in decreases in activity caused by changes in the precise 
orientation of these residues. 
 
A second residue selected on the Ω-loop is Pro174. Although Pro174 is located on the 
Ω-loop, it is on the opposite side to Glu166 and the rest of the active site (Figure 3-
3B). Proline is a unique amino acid as it is the only secondary amine in the 20 
canonical amino acids. Proline is a highly rigid amino acid due to its unique structure, 
a feature that is likely to be important here. The Ω-loop is largely unstructured, save 
for a small α-helix, so a proline here is likely to have a role in regulating the 
flexibility of the loop. Mutation to tyrosine could potentially release some of this 
rigidity and increase the flexibility of the Ω-loop. Modeling revealed a potential 
interaction with Gly267 (Figure 3-3B – inset), which could have a further impact on 
the flexibility of the Ω-loop, and the orientation of Glu166. Due to the location of this 
residue on the Ω-loop, AzPhe-specific post-translational modifications are unlikely to 
have an impact due to the distance between the modified residue and the active site. 
 
A key feature of the Ω-loop is a network of salt bridges that are formed between four 
residues present in the structure [74]. Arg164, Asp 176, Arg178 and Asp179 all 
interact to stabilize the Ω-loop (Figure 3-3C). These salt bridges stabilize the structure 
of the Ω-loop and any disruption in these interactions destabilizes the enzyme, leading 
to a loss of activity against penicillins [114]. Two of these residues were targeted for 
mutation, Arg164 and Asp179. The initial incorporation of AzPhe will likely disrupt 
the interactions that maintain the structure of the Ω-loop, but these interactions may 
be reformed upon photolysis of the azide group and subsequent cross-linking. This 
could lead to an activity switch built into the enzyme accessible by light. Modeling 
the substitution of tyrosine for all four residues individually suggested the side chain 
orientations of Arg164Tyr and Asp179Tyr only would have potential for cross-linking, 
as modeling suggested the orientation of the phenol side chains at positions 176 and 
178 would render interactions unlikely. The models suggest that the mutated phenol 
side chain at position 164 would point in a similar direction to the side chain of the 
native arginine residue, whereas modeling the mutation at 179 suggested a slightly 
different side chain orientation, one that may yield interactions across the loop, with 
the backbone of Ala171 or Ile172. Modification of these residues via Click chemistry 
would remove the potential for restoring the interactions, as any suitable chemistry 
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introduced (such as amine groups that could form interactions with other residues) 
would be too far from the other residues to form useful interactions due to the size of 
the modification. 
 
 
Figure 3-3. Modeling mutations at residues (A) Trp165 and (B) Pro174, and (C) the 
network of interactions present on the Ω-loop. The active Ser70 residue is shown in 
red, the α-domain is shown in green, the α-β domain is shown in cyan and the Ω-loop 
is shown in blue. A. The position of Trp165 (pink) in the Ω-loop. B. Modeling the 
mutation at Pro174 (pink) highlighted a potential interaction with Gly267 (inset). C. 
The structure of the four residues that interact to form salt bridges that maintain the 
structure of the Ω-loop. 
 
 
 
C 
B 
Arg164 
Asp176 
Asp179 
Arg178 
A 
Trp165Tyr 
Gly143 
Pro174Tyr 
Gly267 
 54 
3.2.1.4. Other modeled residues 
Two more residues were selected in positions that may influence the activity of TEM 
β-lactamase through indirect interactions. Arg65 is located close to Ser70 in the linear 
structure but in the 3D structure of the protein is nearer to the Ω-loop (Figure 3-4A). 
Modeling the substitution of tyrosine for arginine highlighted a potential interaction 
with Asn175, which is located on the Ω-loop, but on the opposite side to Glu166 and 
the active site (Figure 3-4A – inset). Crosslinking between these two residues would 
have an impact on the flexibility of the Ω-loop, a key factor in determining 
accessibility to the active site. This could have an impact, not only on overall enzyme 
activity, but also on substrate specificity. A second residue selected for mutation was 
Ala79 (Figure 3-4B). As alanine is one of the smallest amino acids, the substitution to 
tyrosine represents a large change in side chain size. Ala79 is in the core of the 
enzyme and is not very surface accessible (8 Å2) so this change occurs near the 
hydrophobic core of the protein where there is limited space for the addition of a 
substantially larger amino acid side chain. These factors suggest this mutation would 
have an impact on the precise positioning of Ser70, however modeling suggested no 
change in the orientation of the α-helix, with Ser70 remaining in the same place. This 
is an ideal outcome as any change in the position of Ser70 would likely result in an 
inactive enzyme. Modeling also suggests a potential interaction with Glu145 (Figure 
3-4B). Glutamate presents an ideal partner for photo-crosslinking with AzPhe and any 
interactions between these two residues would have an impact on the flexibility of the 
Ω-loop. The buried nature of this residue means, novel post-translational 
modifications via Click chemistry are unlikely to occur at a high level of efficiency, 
making control of protein function in this manner unlikely. 
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Figure 3-4.  Modeling mutations at residues (A) Arg65 and (B) Ala79. The active 
Ser70 residue is shown in red, the α-domain is shown in green, the α-β domain is 
shown in cyan and the Ω-loop is shown in blue. A. Mutating Arg65 (orange) with 
tyrosine highlighted a potential interaction with Asn175 (inset) on the Ω-loop. B. The 
incorporation of tyrosine at position 79 (orange) identified a possible interaction with 
Glu145 on the Ω-loop. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A B 
Arg65Tyr 
Asn175 
Glu145 
Ala79Tyr 
 56 
3.2.2. Construction of pBAK vector 
Despite the technological advances in recent years that have allowed the incorporation 
of uAAs, the machinery used to do this, especially the engineered aminoacyl-tRNA 
synthetases (aaRSs), are not as efficient as the endogenous machinery and can often 
struggle to maintain reliable incorporation, especially when there is a sudden demand 
for increased protein production, such as that found with traditional IPTG-induced 
overexpression of target proteins (e.g. pET vectors). One way around this problem is 
to use a gentler, auto-induction approach, which enables a higher cell density and a 
slower, more gradual increase in protein production. This gives more time for the 
orthogonal aaRSs to incorporate the uAAs, resulting in an increased yield of target 
proteins that contain the uAA. 
 
To enable this proposed auto-induction approach, the bla gene encoding TEM β-
lactamase was cloned into the pBAD plasmid system (Invitrogen). This is a tightly 
regulated, auto-inducible system based around the PBAD promoter. Expression is 
controlled by the concentration of L-arabinose, which binds to AraC, a repressor 
protein of the PBAD promoter, resulting in a change in structure and subsequent 
activation of the promoter [115]. A secondary system of control mediated by cAMP 
allows a high cell density to be reached before protein production is switched on (for 
more information see Section 4.2.1.). These two aspects of arabinose-inducible 
expression are beneficial when using an expanded genetic code, as the orthogonal 
aaRS used to incorporate the uAA is not as efficient as the endogenous aaRSs that are 
responsible for incorporating the 20 canonical amino acids. Reducing the rate at 
which the target protein is produced increases the reliability of the uAA incorporation. 
Expression can also be tailored by optimizing the concentration of L-arabinose in the 
media. 
 
The selectable marker present in the pBAD vector confers ampicillin resistance so has 
similar activity to the target protein TEM β-lactamase. Therefore, to ensure all 
observed activity is due to uAA-containing variants of TEM β-lactamase alone, a new 
vector was constructed in which ampicillin resistance was replaced with kanamycin 
resistance (pBAK). Primers were designed so that ampicillin resistance could be 
removed from the pBAD vector, and simultaneously add specific restriction sites 
(NotI and SalI) to the PCR product (Figure 3-5A). Once a single PCR product was 
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generated, the resulting linear DNA was digested with NotI and SalI to produce sticky 
ends. A DNA cassette containing kanamycin resistance was digested with the same 
two enzymes (Figure 3-5B) and the two linear DNA fragments were ligated to 
produce a new kanamycin resistant vector termed pBAK (Figure 3-5C). PCR was 
then used to amplify the bla gene from another vector (Figure 3-5D). As before, 
restriction sites (NcoI and KpnI) were incorporated into the primers so that the linear 
DNA could be digested to produce sticky ends compatible with the multiple cloning 
site of the new vector. A C-terminal hexahistidine tag was also incorporated into the 
gene at this point to simplify protein purification. The vector DNA was also treated 
with NcoI and KpnI (both found in the multiple cloning site) to produce 
complimentary sticky ends (Figure 3-5E). These two linear fragments were then 
ligated together to complete the new, kanamycin resistant vector. The resulting vector 
(Figure 3-5F) contained the bla gene in the multiple cloning site and had removed any 
other source of ampicillin resistance from the vector. This enabled the vector to be 
used in the overexpression of TEM β-lactamase and the uAA-containing variants, and 
allow kanamycin to act as an independent selectable marker. A list of all the primers 
used for these steps can be found in Table 2-2.   
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Figure 3-5. Schematic of the steps taken to remove ampicillin resistance from pBAD 
and replace it with kanamycin resistance to form pBAK, and subsequently insert the 
bla gene into the multiple cloning site. A. With the pBAD vector as a template, 
primers annealed to either side of the AmpR gene and PCR was used to amplify the 
vector without the selectable marker. B. Digestion of pBAD with NotI and SalI (Lane 
1) created complimentary sticky ends with the KanR insert (Lane 2) that was digested 
with the same enzymes. C. KanR was ligated into the vector to form pBAK, a 
kanamycin resistant auto-induction compatible vector. D. PCR was used to amplify 
the bla gene from another vector (pNOM – [116]). E. NcoI and KpnI form 
complimentary sticky ends in both the pBAK (Lane 2 – Lane 1 is a single digest with 
NcoI) vector and the bla gene (Lane 3). F. The bla gene was ligated into the MCS of 
the pBAK vector.  
 
 
 
MCS 
araC 
PBAD 
AmpR 
NcoI KpnI 
bla 
bla KanR 
araC 
bla 
PBAD 
KanR 
araC 
PBAD 
MCS 
A B C 
F E D 
KanR 
NotI SalI 
4 kb 
1 kb 
4 kb 
1 kb 
pBAD 
 
4.9 kb (+ sfGFP) 
pBAK 
 
5.1 kb (+ KanR) 
pBAK 
 
5.0 kb (+ bla) 
1 2 
1 2 3 
 59 
3.2.3. Site-directed mutagenesis 
Now that a vector had been constructed for overexpressing TEM β-lactamase, and the 
desired mutations had been modeled and selected, the necessary amber stop codon 
(TAG) mutations were incorporated into the bla gene at the respective positions via 
site-directed mutagenesis. To do this, a whole-plasmid PCR approach was taken. This 
involves the use of two primers, one mutagenic and one normal, which are designed 
to amplify the vector back to back (no overlapping). This results in a linear fragment 
of DNA that can be blunt-end ligated to form the circularized vector complete with 
the mutated gene. This process eliminates the need for treatment of the template 
vector, which is required in other site-directed mutagenesis protocols, or any steps 
involved in re-cloning genes back into vectors. A list of all positions mutated, and all 
the primers used for this can be found in Table 2-2. 
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3.3. Conclusions and summary 
Modeling potential mutations in silico is a great resource when mutating target 
proteins by rational design. Several factors such as time and cost limit the number of 
mutations that can be introduced into a target protein so to ensure that the best 
mutation candidates are selected in the early stages of project design is of great 
importance. Many resources are available to model proteins in a variety of ways, such 
as online mutation tools (such as Rosetta) or molecular dynamics simulators (such as 
CHARMM [117]. In this chapter, an online server designed to hypothesize the likely 
side chain orientation of simple point mutations was used to aid the design of 
mutations to incorporate AzPhe, an unnatural amino acid with novel post-translational 
modification opportunities. This system was used to mutate a single amino acid to 
tyrosine, the closest available analogue of AzPhe, and hypothesize the effect of this 
mutation on the positioning of the mutated side chain. This is an important factor to 
appreciate, as any post-translational events that occur to AzPhe would occur at the 
para position of the aromatic ring, far away from the backbone of the same residue. 
 
Some potential mutations were not used in the subsequent analysis because the in 
silico models suggested no interactions with other residues. An example of this is 
Glu104. Next to Tyr105 in the protein, this was thought to present a similar 
opportunity to interact with the α-β domain on the other side of the catalytic cleft. 
However when tyrosine was incorporated in place of the native glutamate, the side 
chain was flipped out, pointing away from the rest of the molecule, suggesting no 
interactions with other residues would be likely. 
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4. Assessing the effect of AzPhe incorporation and novel post-
translational modifications on TEM β-lactamase activity 
 
4.1. Introduction 
Although uAA incorporation is a relatively new technique in biochemistry, much 
progress has been made in both the chemical synthesis of new and useful amino acids, 
and the methods used to incorporate them into proteins. This in turn has enabled many 
uAAs with chemically diverse and reactive side chains to be incorporated into a 
plethora of proteins, introducing new functionality. The orthogonal nature of uAA 
incorporation is an important feature that enables uAAs to be incorporated precisely 
by design. In this chapter, uAA incorporation into TEM β-lactamase will be 
described, including a demonstration of the reliability of uAA incorporation, and the 
purification of uAA-containing proteins. 
 
Due to its historic relevance to antibiotic resistance, TEM β-lactamase is a well-
studied enzyme in terms of its structure and function, including enzyme kinetic 
analyses to understand the mechanism of hydrolysis. Site-directed mutagenesis 
experiments have been performed historically to piece together the precise role that 
each residue in the active site has in the catalytic mechanism. In addition, mutagenesis 
has led to the generation of many variants that are active against a wide variety of 
substrates including naturally occurring antibiotics, such as penicillin, and many 
synthetic compounds, such as cephalosporin antibiotics, developed to counteract 
emerging resistance. In this chapter, I present the results of uAA-incorporation into 
TEM β-lactamase, including detailed kinetic analyses on uAA-containing variants to 
understand their influence on activity and on the catalytic mechanism. These detailed 
kinetic analyses will include the measurement of three kinetic parameters; kcat (a 
measure of catalytic turnover – how fast the enzyme hydrolyzes the substrate), KM (a 
measure of substrate affinity – how well the substrate binds) and catalytic efficiency 
(kcat/KM – a measure of total enzyme efficiency). 
 
One particular benefit of using uAAs is the novel mechanisms of protein control that 
become available, most notably through the use of non-natural post-translational 
modifications. By using p-azido-L-phenylalanine (AzPhe) two methods of post-
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translational control are available, control via phenyl azide photochemistry and 
control by adduct addition via Click chemistry. UV irradiation of the azide group 
results in loss of molecular nitrogen and the formation of a reactive nitrene species, 
which can then react with nucleophiles, carbon-hydrogen bonds and carbon-nitrogen 
bonds. The azide present in AzPhe can also undergo highly specific reactions with 
alkyne groups to form a stable triazole link. As neither the azide or alkyne groups are 
naturally present in proteins, this offers a very specific and highly selective method of 
post-translational control. In this chapter, both of these methods of post-translational 
control are explored, and their effect on TEM β-lactamase activity is determined.  
 
4.2. Results and discussion 
4.2.1. Production of AzPhe-containing TEM β-lactamase 
The theory behind the incorporation of uAAs into proteins is discussed in detail in 
Section 1.4. Briefly, to incorporate uAAs into proteins co-translationally, the gene of 
interest (under the control of an arabinose-inducible PBAD promoter) is mutated to 
place a TAG trinucleotide codon at the desired position, and the cell is provided with 
additional translational machinery on a second plasmid that allows incorporation of 
uAAs in response to the TAG codon (Figure 4-1). Description of the methods taken to 
modify the pBAD plasmid, and then insert the gene of interest (particularly the bla 
gene) can be found in Section 3.2.2. The pDULE plasmid, which contains the 
engineered translational machinery, is a constitutive system, with the genes for the 
amino-acyl tRNA-synthetase (aaRS) required to incorporate the uAA, and the tRNA 
engineered to work alongside this aaRS, under the control of a constitutive promoter. 
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Figure 4-1. Plasmid maps of the two plasmids used to incorporate uAAs into TEM β-
lactamase in E. coli. A. pBAK delivers the bla gene with a TAG codon into the cell. 
The PBAD promoter is an auto-inducible promoter in part controlled by AraC. B. 
pDULE delivers the engineered orthogonal tRNA/aaRS pair to the cell. Three copies 
of the tRNA are present on pDULE to increase incorporation efficiency.  
 
The PBAD promoter can be used very effectively in conjunction with an auto-inducible 
growth medium system. The auto-induction system used here relies on two things, the 
cell’s natural preference for different sugars, in this case glucose and arabinose, and 
the activation of the PBAD promoter by both AraC and cAMP. Glucose is the preferred 
sugar source for the cell, so in the early stages of cell growth arabinose is not used as 
an energy source and is not transported into the cell. Whilst glucose is used as the 
primary energy source, cAMP levels are kept low, reducing its ability to induce target 
protein expression through its interactions with cAMP receptor protein (CRP). As the 
cells use up glucose as their primary energy source, the switch in sugar usage from 
glucose to arabinose switches on production of the target protein. The influx of 
arabinose into the cell and its use as an energy source, also results in arabinose 
binding to the AraC repressor protein, which exists as a dimer and binds to the PBAD 
promoter preventing gene expression. Arabinose binding to AraC causes dissociation 
of the two subunits forming a monomer, which acts as an activator of expression 
[115]. At the same time, cAMP-CRP levels increase and help activate expression of 
the target protein [118]. These control mechanisms combine to tightly regulate the 
expression of the target protein. Slower and more continuous expression of the target 
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protein reduces the energetic impact protein production has on the cell, allowing the 
less-efficient orthogonal aaRSs more time to incorporate the uAA, increasing the 
yield of uAA-containing proteins. Due to the importance of the concentration of these 
two sugars, a specialized auto-induction medium is used to optimize the 
concentrations of both glucose and arabinose [96]. E. coli Top10 cells are used along 
with this auto-induction medium as they have the arabinose catabolism gene (araD) 
knocked out, allowing protein expression to be directly proportional to the arabinose 
concentration in the medium.  
 
To ensure that uAA (AzPhe) incorporation was reliable and with high fidelity, 
proteins were produced in the presence and the absence of AzPhe in the growth 
medium. In the presence of AzPhe, it is incorporated into the target protein by the 
orthogonal tRNA/aaRS pair supplied to the cell. If there is no AzPhe in the growth 
media, the TAG codon reverts to its natural function as a stop codon, and no 
functional protein should be produced. To determine the effect of the presence and 
absence of AzPhe in the growth medium had on functional target protein production, 
nitrocefin activity assays were performed on cell lysates. Cells were grown in small 
culture volumes, in the presence and absence of AzPhe, standardized to the same 
optical density at 600 nm, and then lysed using BugBuster. Activity in cell lysates was 
measured by changes in absorbance at 475 nm (Figure 4-2). 
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Figure 4-2. A. Structure of nitrocefin. Nitrocefin is a β-lactam that changes its 
absorbance from 395 nm to 475 nm upon hydrolysis. This change can be measured 
using spectrophotometry. B-F. Activity assays of (B) wild type TEM β-lactamase and 
four AzPhe-containing variants, (C) TEMTyr105AzPhe, (D) TEMArg164AzPhe, (E) 
TEMPhe72AzPhe and (F) TEMAla237AzPhe in the presence (solid line) and absence (dashed 
line) of AzPhe in the growth medium. Absorbance was measured at 475 nm over a 
time period of 5 minutes (wild type was diluted to enable visualization of the initial 
rate) or 2 minutes. 
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As expected, the activity of wild type TEM β-lactamase in both the presence and the 
absence of AzPhe were the same (Figure 4-2B), demonstrating that the presence of 
AzPhe, in the growth medium is not negatively affecting target protein production. 
The orthogonality of AzPhe incorporation was confirmed for all TAG-containing 
TEM β-lactamase variants (Figure 4-2 shows four examples to demonstrate). No 
nitrocefin hydrolysis activity was seen in the absence of AzPhe for any variant, 
proving that expression of full-length, active TEM β-lactamase is dependent on the 
presence of AzPhe in the medium. It also proves the engineered tRNA/aaRS pair are 
orthogonal, and do not incorporate any of the 20 canonical amino acids in response to 
the TAG codon. 
 
Several variants showed no activity, even in the presence of AzPhe in the growth 
medium (Figure 4-2D). TEMArg65AzPhe, TEMArg164AzPhe, TEMAsp179AzPhe and 
TEMSer235AzPhe all showed no activity in the nitrocefin hydrolysis assay. The side 
chains of Arg164 and Asp179 are key contributors to the formation of a hydrogen-
bonding network on the Ω-loop, a key structural feature of TEM β-lactamase that is 
involved in substrate specificity [73]. Therefore removal of the hydrogen bonding 
capabilities of the side chains at these positions has a detrimental effect on enzyme 
activity. Arg65, although not itself in the Ω-loop, is another residue that forms 
interactions with other side chains that help to stabilize the Ω-loop, in this case 
Asn175 [119]. Thus, the mutation of residues not on the Ω-loop can be equally as 
disruptive. Ser235 is located in the active site and plays a role in positioning 
substrates for hydrolysis [120]. Mutation of this serine to AzPhe could disrupt the 
catalytic mechanism. 
 
4.2.2. Impact of UV irradiation and Click chemistry on enzyme activity in cell 
lysates 
One of the benefits of incorporating AzPhe into proteins is the light-sensitive 
reactivity of the phenyl azide. When irradiated with UV light below 310 nm, 
molecular nitrogen is lost forming a reactive nitrene species (see Section 1.5). This 
can then undergo several reaction pathways including reduction, insertion into 
carbon-hydrogen bonds and addition reactions (Figure 1-3). After the effect of AzPhe-
incorporation on TEM β-lactamase was determined, further analysis was undertaken 
to determine the effect of UV irradiation on the activity of the AzPhe-containing 
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variants. Cell lysates were subjected to two and ten minutes of UV irradiation using a 
handheld lamp that emits a range of wavelengths from 275 nm to 380 nm. Cell lysates 
were irradiated in quartz cuvettes, with a constant distance between the lamp and the 
sample to standardize the intensity of UV irradiation. Upon irradiation with UV light, 
three variants showed changes in activity, TEMTyr105AzPhe, TEMPhe72AzPhe and 
TEMPro174AzPhe (Figure 4-3). Both TEMTyr105AzPhe and TEMPhe72AzPhe show decreases in 
activity after just 2 minutes of UV exposure (TEMPro174AzPhe has no reduction in 
activity after 2 minutes), and activity is reduced further for all three variants after 
extended times of exposure. Incorporation of AzPhe at Tyr105 and subsequent 
irradiation resulted in almost a 25% decrease in activity (Table 4-1; Figure 4-3A). 
TEMPhe72AzPhe suffered a 40% decrease in activity (Table 4-1; Figure 4-3B), and the 
activity of TEMPro174AzPhe decreased by almost 25%, but only after 10 minutes 
irradiation (Table 4-1; Figure 4-3C). One other variant, TEMAla79AzPhe also showed a 
decrease in activity, however this decrease was smaller (Figure 4-3D). TEMAla237AzPhe 
and TEMTrp165AzPhe showed very little decrease in activity (Figure 4-3E-F), proving 
loss of activity was not universal to all AzPhe variants. Of the variants that showed no 
activity after AzPhe incorporation (TEMArg65AzPhe, TEMArg164AzPhe, TEMAsp179AzPhe and 
TEMSer235AzPhe), none showed increases in activity upon UV irradiation. 
 
Table 4-1. Initial velocity of six AzPhe-containing variants of TEM β-lactamase after 
no irradiation, 2 minutes irradiation, and 10 minutes irradiation. 
 
 
 
 
 
Initial velocity (!M-1 min-1) 
  0min UV 2min UV 10min UV 
TEMTyr105AzPhe 238 180 76.4 
TEMPhe72AzPhe 186 115 87.3 
TEMTrp165AzPhe 313 314 256 
TEMPro174AzPhe 8.77 8.88 5.45 
TEMAla237AzPhe 18.3 21.3 17.0 
TEMAla79AzPhe 7.54 3.93 3.42 
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Figure 4-3. A-F. Effect of UV irradiation on (A) TEMTyr105AzPhe, (B) TEMPhe72AzPhe. 
(C) TEMPro174AzPhe, (D) TEMAla79AzPhe, (E) TEMAla237AzPhe and (F) TEMTrp165AzPhe in 
cell lysates.  
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In addition to its photochemical properties, the azide group of AzPhe can also 
undergo chemical modification via strain promoted azide-alkyne cycloaddition 
(SPAAC). This is a highly versatile technique as any number of novel chemical 
modifications can be added to the azide group, and as no other amino acids contain an 
azide group, the specificity offered by this type of modification is very high. Two 
modifications were used to determine the effect of SPAAC on TEM β-lactamase 
activity, one containing a large, hydrophobic dye (1 – Figure 4-4) and a second that 
can form long-range hydrogen bonds (2). 
 
TEMTyr105AzPhe and TEMAla237AzPhe both showed a large reduction in activity after 
modification with both adducts (Figure 4-4). After modification with 1, the activity of 
TEMTyr105AzPhe decreased by over 90% (Table 4-2; Figure 4-4A), and the activity of 
TEMAla237AzPhe decreased by 80% (Table 4-2; Figure 4-4E). TEMPro174AzPhe also 
showed a decrease in activity after Click modification, losing 60% of activity after 
modification with 1 (Table 4-2; Figure 4-4C). In each case, modification with 2, the 
smaller modification, resulted in a smaller decrease in activity. TEMPhe72AzPhe (Figure 
4-4B), TEMAla79AzPhe (Figure 4-4D) and TEMTrp165AzPhe (Figure 4-4F) all showed very 
little effect on activity when modified with either chemical adduct.  
 
Table 4-2. Initial velocity of six AzPhe-containing variants of TEM β-lactamase with 
no modification, and modified with 1 and 2 (Figure 4-4).  
 
Initial velocity (!M-1 min-1) 
  Unmodified 1 2 
TEMTyr105AzPhe 169 15.6 66.0 
TEMPhe72AzPhe 175 178 173 
TEMTrp165AzPhe 385 285 313 
TEMPro174AzPhe 8.77 3.39 5.94 
TEMAla237AzPhe 6.53 1.39 5.06 
TEMAla79AzPhe 7.54 1.91 4.80 
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Figure 4-4. Chemical structures of the two DBCO- (dibenzyl cyclooctyne)-based 
modifications used in click chemistry, DBCO-sulforhodamine 101 (1) and DBCO-
amine (2). A-F. Effect of Click modification on (A) TEMTyr105AzPhe, (B) 
TEMPhe72AzPhe. (C) TEMPro174AzPhe, (D) TEMAla79AzPhe, (E) TEMAla237AzPhe and (F) 
TEMTrp165AzPhe in cell lysates.  
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After the initial selection of mutations based on the in silico models, ten mutations 
were selected to be produced and tested using the nitrocefin activity assay. After these 
activity tests, six of the original ten mutations were then selected for further analysis 
via more detailed kinetic analyses; TEMTyr105AzPhe, TEMAla237AzPhe, TEMPro174AzPhe, 
TEMTrp165AzPhe, TEMAla79AzPhe and TEMPhe72AzPhe. The position of Tyr105 in the folded 
protein suggested that modification of this residue, especially using Click chemistry 
would result in a large decrease in activity. This hypothesis proved to be correct, as 
activity was largely reduced upon modification with both 1 and 2, however the change 
in activity after UV irradiation was not as great. The effect of UV irradiation on all of 
the variants was difficult to hypothesize in silico due to the uncertainty around nitrene 
reactivity. In practice, UV irradiation had a limited effect on activity, regardless of the 
mutation position. This is likely due to the relatively small changes in the structure of 
the phenyl azide caused by UV irradiation. Although many of the changes suggested 
by modeling, the scale of the changes was somewhat smaller. Mutation at Phe72 
suggested large changes in activity caused by UV irradiation in particular, however 
only a small decrease was observed, and no decrease when Click chemistry was used 
to modify the protein.  
 
Generally, the hypotheses presented after in silico modeling of the individual 
mutations proved to be correct, even if the changes were smaller than expected, 
however there were some exceptions. Modeling tyrosine at Trp165 suggested a large 
change in activity caused by modification due to the proximity of the residue to active 
residues such as Ser70 and Glu166. This proved to not be the case however, as 
modification with both UV irradiation and Click chemistry resulted in no changes in 
activity. Modeling mutations at Arg164 and Asp179 suggested the destruction of the 
salt bridges that maintain the structure of the omega loop. This assumption proved to 
be correct, however the hypothesis that activity may be regained via UV irradiation of 
the phenyl azide proved to be false. For this reason, both of these mutations were not 
selected for further analysis. As well as Arg164 and Asp179, Arg65 and Ser235 were 
not selected for kinetic analysis, as these variants were also inactive, even after post-
translational modification. 
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4.2.3. Purification of TEM β-lactamase 
After the general effect of AzPhe incorporation on enzyme activity had been 
determined in cell lysates, the active variants were produced in larger volumes (1 L) 
and purified using Nickel-affinity chromatography. This process involves the use of 
immobilized Ni2+ to bind the imidazole side chain of the histidine amino acid. A 
hexa-histidine tag (His-tag) was present at the end of the protein to accelerate the 
process of protein purification. Clarified cell lysates were passed over a column of 
Ni2+ immobilized beads. The target protein was then eluted using an elution buffer 
containing imidazole, which competes for the Ni2+ with the histidine residues. The 
elution buffer is applied to the column via a concentration gradient, to obtain protein 
with a high level of purity (Figure 4-5A). During the purification process, absorbance 
at 280 nm was monitored to track wild type elution from the column. As monitoring 
at 280 nm would likely result in photolysis of the phenyl azide, this was turned off 
during the purification of AzPhe-containing variants. After the purification of these 
variants (as well as wild type), a combination of SDS-PAGE and nitrocefin hydrolysis 
assays were used to determine the fractions containing the purified TEM β-lactamase, 
and their purity (Figure 4-5B-C). The fractions containing only TEM β-lactamase 
were pooled and buffer exchanged into PBS for more detailed analysis. Buffer 
exchange was performed via dialysis using a 3500 MWCO dialysis membrane. 
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Figure 4-5. Nickel-affinity chromatography purification of TEM β-lactamase. A. 
Absorbance at 280 nm monitoring wild type elution (black line) on application of an 
imidazole gradient (dashed line). The peak to elute during the gradient corresponds to 
non-specific binding of proteins to the Ni2+ matrix. The peak corresponding to TEM 
β-lactamase is indicated. B-C. SDS-PAGE analysis and activity analysis of TEM β-
lactamase-containing fractions from the purification of (B) wild type and (C) 
TEMTyr105AzPhe.  
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4.2.4. Kinetic analysis of AzPhe-containing TEM β-lactamase variants 
4.2.4.1. Effect of AzPhe incorporation on TEM β-lactamase activity 
After wild type TEM β-lactamase and the AzPhe-containing mutants were purified, 
detailed kinetic analysis was undertaken to determine the exact effect of AzPhe 
incorporation on the enzyme’s ability to both bind and hydrolyze the substrate. Whilst 
the colourimetric substrate nitrocefin was used in the preliminary analysis of the 
AzPhe-containing variants, two other, more clinically relevant, substrates were chosen 
for kinetic analysis, ampicillin and cephalothin. Both of these are β-lactam antibiotics, 
however ampicillin is a naturally occurring penicillin-based antibiotic which is 
hydrolyzed by TEM β-lactamase with a much greater efficiency, whereas cephalothin 
is a synthetic cephalosporin originally developed to overcome the evolution of 
resistance against penicillin-based antibiotics. They have disparate structures and 
interact with the protein in slightly different ways [119, 121].  
 
Incorporating AzPhe in place of Tyr105 had no negative impact on activity with 
regards to both ampicillin and cephalothin hydrolysis. Compared to wild type, 
TEMTyr105AzPhe kcat was slightly improved, indicating a small increase in catalytic 
turnover. However this was offset by a small increase in KM, suggesting a slight 
impact on substrate binding. The overall result was an enzyme with a very similar 
overall catalytic efficiency (kcat/KM) for both substrates to that of wild type TEM β-
lactamase (Table 4-3; Figure 4-6). The largely similar kcat and KM suggest the addition 
of an azide group at this position does not have a significant impact on the ability of 
the enzyme to bind and then hydrolyze either substrate. Tyr105 is an aromatic amino 
acid that contributes to the domain interface and is highly surface exposed (Figure 4-
7C). Despite this, it is not directly involved in the catalytic mechanism, however it 
does lie in close proximity to many of the residues that do have direct or indirect roles 
in substrate hydrolysis. As predicted by the original hypothesis (see Section 3.2.1.), 
the addition of a single atom at the para position of the phenyl ring (OH to N3), 
coupled with the surface exposed nature of the residue, suggests the incorporation of 
AzPhe here would not have a detrimental effect on enzyme activity, which is the case. 
It is possible the increased bulk caused by the azide group at the para position 
decreases binding efficiency by slightly reducing the space available for the substrate 
in the catalytic pocket. 
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Table 4-3. The effect of AzPhe-incorporation on TEM β-lactamase activity. 
 
1 kcat, KM and kcat/KM (overall catalytic efficiency) compared directly to wild type 
 
Whilst substituting Tyr105 with AzPhe had little impact on the catalytic efficiency of 
TEM β-lactamase, the same was not true for Ala237. When compared to the wild type 
enzyme, TEMAla237AzPhe has about 2% of the catalytic efficiency towards ampicillin 
with both kcat (~5 fold decrease) and KM (~10 fold increase) disrupted (Table 4-3; 
Figure 4-6). A similar trend is observed with cephalothin as the substrate. kcat is 
similarly decreased, however KM is not so severely disrupted. This results in an 
enzyme 10-fold less active towards cephalothin than wild type. Incorporation of 
AzPhe at Ala237 replaces a small amino acid, alanine, with a much larger, aromatic 
residue. Considering the position of Ala237 in the catalytic pocket (Figure 4-8C), 
increasing the size of a side chain from a single methyl group to a large phenyl azide 
is likely to cause large disruptions in the active site. During modeling this was 
suggested, as mutation to a tyrosine residue at Ala237 appeared to significantly 
reduce the size of the active site (Figure 3-2C). Additionally, the backbone amine of 
Ala237 is involved in substrate binding [111], so mutation here (even though the 
backbone amine is still present) is likely to decrease binding affinity due to movement 
of the protein backbone to accommodate the larger side chain. 
 
Ampicillin 
Wild type TEMTyr105AzPhe TEMAla237AzPhe TEMPro174AzPhe TEMTrp165AzPhe TEMLeu201AzPhe 
kcat (s-1) 550 ± 21 753 ± 17 98 ± 6.2 171 ± 13 406 ± 20 427 ± 20 
Relative 
kcat 1 
1.00 1.37 0.18 0.31 0.74 0.78 
KM (!M) 146 ± 15 183 ± 10 1340 ± 120 106 ± 29 185 ± 26 171 ± 23 
Relative 
affinity 1 1.00 0.80 0.11 1.38 0.79 0.85 
kcat/KM (!M-1 
s-1) 3.77 ± 0.11 
4.12 ±  
0.061 
0.0731 ± 
0.11 1.62 ± 0.28 2.19 ± 0.15 2.50 ± 0.14 
Relative kcat/
KM 1 
1.00 1.09 0.02 0.43 0.58 0.66 
 Cephalothin Wild type TEMTyr105AzPhe TEMAla237AzPhe TEMPro174AzPhe TEMTrp165AzPhe TEMLeu201AzPhe 
kcat (s-1) 78.7 ± 4.9 86.3 ± 4.1 12.1 ± 1.8 38.6 ± 2.3 121 ± 11 58.5 ± 5.3 
Relative 
kcat 1 
1.00 1.10 0.15 0.49 1.54 0.74 
KM (!M) 174 ± 17 212 ± 15 258 ± 54 144 ± 14 221 ± 32 151 ± 23 
Relative 
affinity 1 1.00 0.82 0.67 1.21 0.79 1.15 
kcat/KM (!M-1 
s-1) 0.45 ± 0.11 
0.41 ± 
0.084 
0.047 ± 
0.26 0.27 ± 0.11 0.55 ± 0.17 0.39 ± 0.18 
Relative kcat/
KM 1 
1.00 0.91 0.11 0.60 1.22 0.87 
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Figure 4-6. A-D. Effect of AzPhe-incorporation on TEM β-lactamase. Catalytic 
efficiency (µM-1 s-1) of wild type TEM β-lactamase and five AzPhe-containing 
variants against (A) ampicillin and (B) cephalothin. Chemical structures of (C) 
ampicillin and (D) cephalothin. E. Michaelis-Menten plot of TEMTyr105AzPhe. F. 
Lineweaver-Burke plot (double reciprocal plot) of TEMTyr105AzPhe. 
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Incorporation of AzPhe at Pro174 also has a negative impact on the catalytic 
efficiency towards both ampicillin and cephalothin (Table 4-3; Figure 4-6). Against 
ampicillin, TEMPro174AzPhe kcat is just over 30% of that of wild type, reducing to 171   
s-1, compared to 550 s-1 for wild type. This loss of catalytic turnover is somewhat 
offset by a slight increase in binding affinity which results in an overall catalytic 
efficiency against ampicillin that is less than half of wild type. When cephalothin is 
used as the substrate, a similar pattern of results emerges. kcat is halved compared to 
wild type, while there is a slight decrease in KM, resulting in an enzyme with 60% of 
the catalytic efficiency against cephalothin of wild type. Pro174 is located towards the 
C-terminal end of the Ω-loop (Figure 4-9C), a dynamic region that enables substrate 
entry into the active site [122]. The flexibility of the Ω-loop is essential for 
positioning Glu166, a key catalytic residue. Any change in the flexibility of the loop 
is likely to have a negative effect on the ability of Glu166 to perform its role in both 
the acylation and deacylation steps of the catalytic mechanism. Proline is a rigid 
amino acid due to its structure, so it is likely to regulate this flexibility (Pro167 is in 
another unstructured loop region of the Ω-loop). Mutation of Pro174 to AzPhe is 
likely to increase the flexibility of the Ω-loop, reducing the efficiency of Glu166 as a 
proton donor, hence the predominant impact to catalytic turnover. 
 
TEMTrp165AzPhe is one of the more active variants, retaining over half of the activity 
seen in wild type for ampicillin, and slightly more activity against cephalothin than 
wild type (Table 4-3; Figure 4-6). Catalytic efficiency is reduced by 144 s-1 compared 
to wild type and KM is increased by 40 µM, resulting in an enzyme with almost half of 
the activity of wild type for ampicillin. There is an increase in kcat when cephalothin is 
used as the substrate, from 79 s-1 to 121 s-1, however substrate binding is slightly 
decreased by over 45 µM compared to wild type. This results in an enzyme with an 
overall catalytic efficiency against cephalothin that is over 20% higher than wild type. 
Trp165 is found on the Ω-loop very close to the key residue Glu166 (Figure 4-10A). 
This puts it in a position where mutation is likely to have a large impact on the ability 
of the enzyme to breakdown its substrates. Mutation of Trp165 to AzPhe however 
only has a limited impact on catalytic turnover, reducing hydrolysis of ampicillin and 
increasing hydrolysis of cephalothin. These changes are only small however, so the 
prediction of a large impact on catalytic turnover is not realized. 
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Many mutations in proteins, and specifically enzymes, do not directly change or 
interact with the active site [108], impacting the activity of enzymes through indirect 
interactions, or by masking the effects of other deleterious mutations. Leu201 was 
chosen for mutation as it is not close to the active site (Figure 4-10B), and is not 
involved in substrate binding, but has been found to mask the effects of other 
deleterious mutations [107]. TEMLeu201AzPhe was one of the more active variants 
against ampicillin, but not as active as either wild type or TEMTyr105AzPhe (Table 4-3; 
Figure 4-6). TEMLeu201AzPhe retains 78% of the catalytic turnover of ampicillin 
compared to wild type (427 s-1 compared to 550 s-1), and KM in increased by 25 µM, 
resulting in an enzyme with two-thirds of the catalytic efficiency of wild type against 
ampicillin. When cephalothin is used as the substrate only small changes are seen. kcat 
decreases by 20 s-1 only and KM drops by 20 µM, producing an enzyme with a similar 
catalytic efficiency against cephalothin to wild type TEM β-lactamase. Leu201 was 
effectively chosen as a control to demonstrate that the incorporation of AzPhe has 
little effect on enzyme activity when the residue is far from the active site. As 
expected, incorporation of AzPhe at Leu201 had little effect on activity as it is far 
from the active site and doesn’t interact with the residues responsible for binding the 
substrate. 
 
4.2.4.2. Effect of UV irradiation on TEM β-lactamase activity 
Exposure of TEMTyr105AzPhe to UV light results in a decrease in activity. With 
ampicillin as the substrate, both kcat and KM are reduced by 25% (Table 4-4; Figure 4-
7A). This results in an enzyme with a catalytic efficiency 44% lower than the “dark” 
enzyme. With cephalothin used as the substrate, kcat decreases from 86 s-1 to 53 s-1 
after UV irradiation, which is offset by a slightly increased substrate affinity (KM 
decreases by 30 µM). This produces an enzyme that has a catalytic efficiency 71% of 
that of the dark enzyme (Table 4-4; Figure 4-7B). Upon UV irradiation, the azide 
group loses molecular nitrogen to form a reactive nitrene species [63], and from there 
it can go down many reaction pathways, forming many different end products. It is 
very difficult to predict the outcome of this reaction, especially when considering the 
variable microenvironments sampled in a protein structure, and the benign 
(physiological) reaction conditions. Expansion of the phenyl ring to form a 7-
membered dihydroazepine ring (Figure 1-3) could decrease the space available for 
substrates to bind. This change would also impact the SDN loop, a triad of amino 
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acids involved in maintaining the active site cavity [80]. Asn132 has also been 
suggested to be involved in substrate binding, and indirectly involved in catalysis 
[123], so perturbation of this residue would decrease catalytic turnover. 
 
Table 4-4. Effect of UV irradiation on the activity of TEMTyr105AzPhe against ampicillin 
and cephalothin. 
 
1 kcat, KM and kcat/KM (overall catalytic efficiency) compared directly to the dark form 
of TEMTyr105AzPhe 
 
Ampicillin Cephalothin 
Dark UV Dark UV 
kcat (s-1) 753 ± 17 568 ± 25 86.3 ± 4.1 52.6 ± 3.4 
Relative kcat 1 1.00 0.75 1.00 0.61 
KM (!M) 183 ± 10 248 ± 24 212 ± 15 182 ± 18 
Relative affinity 1 1.00 0.74 1.00 1.17 
kcat/KM (!M-1 s-1) 4.12 ± 0.061 2.29 ± 0.11 0.41 ± 0.084 0.29 ± 0.12 
Relative kcat/KM 1 1.00 0.56 1.00 0.71 
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Figure 4-7. Effect of UV irradiation on TEMTyr105AzPhe. A and B. Catalytic efficiency 
(µM-1 s-1) of un-irradiated (dark) and irradiated (UV) TEMTyr105AzPhe against (A) 
ampicillin and (B) cephalothin. C. Position of Tyr105 (yellow) in TEM β-lactamase 
(Ser70 is shown in red). 
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UV irradiation has very little impact on the ability of TEMAla237AzPhe to break down 
ampicillin. When this variant is exposed to UV light, kcat is slightly increased, but so 
is KM, resulting in an enzyme that has a similar catalytic efficiency to the dark form of 
the enzyme (Table 4-5; Figure 4-8A). When cephalothin is used as the substrate, the 
UV irradiated enzyme has a much lower kcat, (5 s-1). However KM is decreased by over 
100 µM, which offsets some of this decrease in catalytic turnover (Table 4-5; Figure 
4-8B), resulting in an enzyme that retains 72% of the activity of the dark enzyme 
against cephalothin. The low activity of this variant results in the errors associated 
with these data being relatively large, indicating the likelihood that UV irradiation is 
having little effect on the ability of the enzyme to hydrolyze the two substrates. It is 
very difficult to predict what happens to the phenyl azide upon irradiation so it is very 
difficult to present a hypothesis for this effect. It is possible that azide reduction to 
form an amine at the para position of the phenyl ring could contribute to the 
hydrogen-bonding network that positions cephalothin for catalysis. As there is no 
increase in ampicillin binding, this proposed interaction may not occur when 
ampicillin is used as the substrate. 
 
Table 4-5. Effect of UV irradiation on the activity of TEMAla237AzPhe against ampicillin 
and cephalothin. 
 
1 kcat, KM and kcat/KM (overall catalytic efficiency) compared directly to the dark form 
of TEMAla237AzPhe 
 
 
Ampicillin Cephalothin 
Dark UV Dark UV 
kcat (s-1) 97.8 ± 6.2 116 ± 6.7 12.1 ± 1.8 5.25 ± 0.25 
Relative kcat 1 1.00 1.18 1.00 0.44 
KM (!M) 1340 ± 120 1440 ± 110 258 ± 54 157 ± 12 
Relative affinity 1 1.00 0.93 1.00 1.65 
kcat/KM (!M-1 s-1) 0.073 ± 0.11 0.080 ± 0.097 0.047 ± 0.26 0.034 ± 0.090 
Relative kcat/KM 1 1.00 1.10 1.00 0.72 
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Figure 4-8. Effect of UV irradiation on TEMAla237AzPhe. A and B. Catalytic efficiency 
(µM-1 s-1) of un-irradiated (dark) and irradiated (UV) TEMAla237AzPhe against (A) 
ampicillin and (B) cephalothin. C. Position of Ala237 (yellow) in TEM β-lactamase 
(Ser70 is shown in red). 
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When TEMPro174AzPhe is irradiated with UV light, there are small, statistically 
insignificant changes to the activity for both substrates (Table 4-6; Figure 4-9). When 
ampicillin is used, kcat is reduced by 20% to 136 s-1, but there is no change in KM. 
When cephalothin was used as the substrate there was a 17% increase in kcat to 45 s-1, 
but there was also an increase in KM, from 144 µM to 204 µM. These factors combine 
to produce an enzyme that is 18% less active for ampicillin, and 17% less active for 
cephalothin than the dark enzyme. During the in silico modeling of TEMPro174AzPhe, 
several methods of control were suggested. The disruption of an interaction between 
Arg65 and Asn175 could increase the flexibility of the Ω-loop, disrupting the role of 
Glu166 in the catalytic process. Alternatively, the incorporation of AzPhe could 
introduce a new interaction with Gly267 to decrease the flexibility of the Ω-loop. The 
kinetic data indicate an equally small effect on both substrate hydrolysis and binding, 
suggesting that the flexibility of the Ω-loop is not greatly altered by UV irradiation of 
AzPhe. 
 
Table 4-6. Effect of UV irradiation on the activity of TEMPro174AzPhe against ampicillin 
and cephalothin. 
 
1 kcat, KM and kcat/KM (overall catalytic efficiency) compared directly to the dark form 
of TEMPro174AzPhe 
 
 
Ampicillin Cephalothin 
Dark UV Dark UV 
kcat (s-1) 171 ± 13 136 ± 10 38.6 ± 2.3 45.3 ± 3.8 
Relative kcat 1 1.00 0.80 1.00 1.18 
KM (!M) 106 ± 29 102 ± 27 144 ± 14 204 ± 25 
Relative affinity 1 1.00 1.03 1.00 0.71 
kcat/KM (!M-1 s-1) 1.62 ± 0.28 1.33 ± 0.28 0.27 ± 0.11 0.22 ± 0.15 
Relative kcat/KM 1 1.00 0.82 1.00 0.83 
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Figure 4-9. Effect of UV irradiation on TEMPro174AzPhe. A and B. Catalytic efficiency 
(µM-1 s-1) of un-irradiated (dark) and irradiated (UV) TEMPro174AzPhe against (A) 
ampicillin and (B) cephalothin. C. Position of Pro174 (yellow) in TEM β-lactamase 
(Ser70 is shown in red). 
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UV irradiation has very little effect on the ability of TEMTrp165AzPhe to hydrolyze 
ampicillin (Table 4-7). Small decreases in both kcat and KM somewhat offset, causing a 
slight reduction in the overall catalytic efficiency by 11%. UV irradiation had a larger 
effect on cephalothin hydrolysis, however all of the decrease seen is due to a 30% 
decrease in substrate binding. Trp165 does not have a direct role in either substrate 
hydrolysis or binding, so the limited effect of UV irradiation is not surprising. The 
mutation of a residue so close to other residues that do have key roles in the catalytic 
mechanism, particularly Glu166, shows that novel uAAs such as AzPhe can be 
tolerated in crucial domains of proteins, and not have a significant impact on activity. 
 
Exposure of TEMLeu201AzPhe to UV light has limited effect on both kcat and KM when 
ampicillin is the substrate (Table 4-7). Catalytic turnover is reduced by 15% to 364    
s-1, and KM is unchanged. When cephalothin is used as the substrate, kcat is increased 
by almost 30%, whereas binding affinity decreases by over 40% (to 263 µM). These 
combine to produce an enzyme with 73% of the overall catalytic efficiency of the 
dark variant. These small changes caused by UV irradiation are unlikely to cause a 
great change in the active site due to the distance between Leu201 and Ser70. 
 
UV irradiation had no effect on the ability of wild type TEM β-lactamase to 
hydrolyze both ampicillin and cephalothin. Both kcat and KM were unaffected by UV 
irradiation, proving UV irradiation did not inherently damage the enzyme’s ability to 
hydrolyze either substrate.  
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Table 4-7. Effect of UV irradiation on the activity of TEMTrp165AzPhe and 
TEMLeu201AzPhe against ampicillin and cephalothin. 
 
1 kcat, KM and kcat/KM (overall catalytic efficiency) compared directly to the dark form 
of TEMTrp165AzPhe 
2 kcat, KM and kcat/KM (overall catalytic efficiency) compared directly to the dark form 
of TEMLeu201AzPhe 
 
 
Figure 4-10. A-B. Position of (A) Trp165 (yellow) and (B) Leu201 in TEM β-
lactamase (Ser70 is shown in red). 
 
TEMTrp165AzPhe 
Ampicillin Cephalothin 
Dark UV Dark UV 
kcat (s-1) 406 ± 20 336 ± 23 121 ± 11 125 ± 13 
Relative kcat 1 1.00 0.83 1.00 1.03 
KM (!M) 185 ± 26 172 ± 36 221 ± 32 314 ± 44 
Relative affinity 1 1.00 1.07 1.00 0.70 
kcat/KM (!M-1 s-1) 2.19 ± 0.15 1.95 ± 0.21 0.55 ± 0.17 0.40 ± 0.18 
Relative kcat/KM 1 1.00 0.89 1.00 0.72 
 
TEMLeu201AzPhe 
Ampicillin Cephalothin 
Dark UV Dark UV 
kcat (s-1) 427 ± 20 364 ± 18 58.5 ± 5.4 74.8 ± 8.4 
Relative kcat 2 1.00 0.85 1.00 1.28 
KM (!M) 171 ± 23 171 ± 24 151 ± 23 264 ± 41 
Relative affinity 2 1.00 1.00 1.00 0.57 
kcat/KM (!M-1 s-1) 2.50 ± 0.14 2.12 ± 0.15 0.39 ± 0.18 0.28 ± 0.19 
Relative kcat/KM 2 1.00 0.85 1.00 0.73 
A B 
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4.2.4.3. Effect of SPAAC on TEM β-lactamase activity 
The activity of TEMTyr105AzPhe was largely influenced by Click modification. 
Modification with 1 resulted in large changes in both kcat and KM with ampicillin as 
the substrate (Table 4-8; Figure 4-11A). Catalytic turnover was reduced by 74% and 
KM was increased by 38%, indicating that both catalysis and substrate binding had 
been disrupted. Thus, modification with 1 resulted in a loss of 85% of the catalytic 
efficiency of the unmodified TEMTyr105AzPhe variant; a significant difference 
confirmed by comparison of the 95% confidence intervals for both kcat (719.5-771.9  
s-1 for unmodified and 172.8-216.0 s-1 for modified) and KM (161.7-203.7 µM for 
unmodified and 246.2-388.3 µM for modified). Similar changes were seen when 2 
was used, with a decrease of 47% in kcat, and a decrease of 45% in substrate affinity, 
producing an enzyme with a 71% drop in activity compared to the unmodified 
TEMTyr105AzPhe variant. With cephalothin as the substrate, there was a similar pattern 
of results with regards to kcat, but less so with KM (Table 4-8; Figure 4-11B). When 
TEMTyr105AzPhe was modified with 1, there was a large decrease in turnover, with a 
64% decrease in kcat. Catalytic turnover was also decreased upon modification with 2, 
but to a lower extent (25%), however there appears to be relatively little effect on 
cephalothin binding when the enzyme is modified with either 1 or 2.  
 
When modified with 2, the effects on the enzyme kinetics for ampicillin are very 
similar with the effect of UV irradiation, suggesting the amine group of 2 could be 
performing a similar role to the potential amine formed through UV irradiation of the 
azide group. However, the positions of the proposed amine groups would be quite 
different in the 3D structure of the enzyme, and so would likely make different 
interactions. The modification of TEMTyr105AzPhe with 1 had a similar pattern of results 
to modification with 2, however with larger decreases, particularly to kcat. 
TEMTyr105AzPhe modified with 1 had half the catalytic turnover of TEMTyr105AzPhe 
modified with 2 for both ampicillin and cephalothin. These decreases, in proportion 
with the size of the modification, suggest the size of the modification is the 
determining factor in kcat at this position. Modification with both 1 and 2 had a very 
similar impact on ampicillin binding, however neither had an impact on cephalothin 
binding. This result suggests that while the two modifications have an effect on 
substrate catalysis, irrelevant of the specific substrate used, it only has an effect on 
ampicillin binding. 
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Table 4-8. Effect of Click modification on the activity of TEMTyr105AzPhe against 
ampicillin and cephalothin. 
 
1 kcat, KM and kcat/KM (overall catalytic efficiency) compared directly to the 
unmodified form of TEMTyr105AzPhe 
 
 
Figure 4-11. Effect of Click modification on TEMTyr105AzPhe. Catalytic efficiency  
(µM-1 s-1) of unmodified TEMTyr105AzPhe, and TEMTyr105AzPhe modified with 1 and 2 
against (A) ampicillin and (B) cephalothin. 
 
 
 
 Ampicillin Cephalothin Unmodified 1 2 Unmodified 1 2 
kcat (s-1) 753 ± 17 194 ± 11 399 ± 31 86.3 ± 4.1 31.1 ± 2.2 64.9 ± 3.1 
Relative 
kcat 1 
1.00 0.26 0.53 1.00 0.36 0.75 
KM (!M) 183 ± 10 317 ± 35 332 ± 51 212 ± 15 198 ± 21 184 ± 13 
Relative 
affinity 1 1.00 0.58 0.55 1.00 1.07 1.16 
kcat/KM (!M-1 
s-1) 
4.12 ± 
0.061 0.61 ± 0.12 1.20 ± 0.17 
0.41 ± 
0.084 0.16 ± 0.13 
0.35 ± 
0.085 
Relative kcat/
KM 1 
1.00 0.15 0.29 1.00 0.39 0.87 
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When TEMAla237AzPhe was modified using Click chemistry, kcat was decreased for both 
substrates, however the effect on KM was different for the two substrates. With 
ampicillin as substrate, kcat was decreased while substrate affinity was increased, 
when either 1 or 2 was used to modify the enzyme (Table 4-9; Figure 4-12A). With 
cephalothin as the substrate, the impact on kcat is not so severe and there was no 
increase in substrate binding, with slight decreases seen with both 1 and 2 (Table 4-9; 
Figure 4-12B). These changes are very small and the errors associated with these data 
suggest there is no significant impact of Click chemistry on the activity of 
TEMAla237AzPhe. 
 
The fall in kcat correlates well with the size of the modification for both the hydrolysis 
of ampicillin and cephalothin as the biggest decrease was observed after modification 
with 1. This suggests the size of the modification is playing the key role in disrupting 
the catalytic mechanism. The proximity of Ala237 to the active site (Figure 4-8C) 
means that any modification is likely to sit in the cleft formed by the two domains, 
disrupting the interaction between the substrates and the residues involved in 
catalysis; the larger the modification, the larger this disruption. The increase in the 
binding affinity of ampicillin – but not cephalothin – when this variant is modified 
with 1 and 2 suggests a specific interaction between the modifications and ampicillin 
that doesn’t form when cephalothin is used as the substrate. The increase is present 
when the enzyme is modified with both the modifications, suggesting it may be the 
DBCO group itself, or the carbonyl group interacting with ampicillin as these groups 
are shared by the two modifications. 
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Table 4-9. Effect of Click modification on the activity of TEMAla237AzPhe against 
ampicillin and cephalothin. 
 
1 kcat, KM and kcat/KM (overall catalytic efficiency) compared directly to the 
unmodified form of TEMAla237AzPhe 
 
 
Figure 4-12. Effect of Click modification on TEMAla237AzPhe. Catalytic efficiency  
(µM-1 s-1) of unmodfied TEMAla237AzPhe, and TEMAla237AzPhe modified with 1 and 2 
against (A) ampicillin and (B) cephalothin. 
 
 
 
 Ampicillin Cephalothin Unmodified 1 2 Unmodified 1 2 
kcat (s-1) 97.8 ± 6.2 15.0 ± 2.1 21.3 ± 1.4 12.1 ± 1.8 6.70 ± 0.84 10.6 ± 1.4 
Relative 
kcat 1 
1.00 0.15 0.22 1.00 0.56 0.88 
KM (!M) 1340 ± 117 736 ± 180 418 ± 56 258 ± 54 329 ± 55 294 ± 52 
Relative 
affinity 1 1.00 1.82 3.20 1.00 0.78 0.88 
kcat/KM (!M-1 
s-1) 
0.073 ± 
0.11 
0.020 ± 
0.28 
0.051 ± 
0.15 
0.047 ± 
0.26 
0.020 ± 
0.21 
0.036 ± 
0.22 
Relative kcat/
KM 1 
1.00 0.28 0.70 1.00 0.44 0.77 
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When TEMPro174AzPhe was modified, both positive and negative modulation of enzyme 
activity was observed depending on which modification was used. When 1 was used, 
the catalytic turnover of ampicillin was decreased by 56% but binding affinity was 
increased by 52% (Table 4-10; Figure 4-13A). These produce an enzyme with 66% of 
the overall catalytic efficiency for ampicillin as the unmodified enzyme. When 
cephalothin was used as the substrate, there was no effect on kcat, but KM was 
increased by 20 µM (Table 4-10; Figure 4-13B). When 2 was used to modify the 
enzyme, catalytic turnover was more than doubled to 360 s-1 when ampicillin was 
used as the substrate, and KM was decreased to 83 µM, increasing the binding affinity 
of ampicillin. These two factors combine to produce an enzyme that when modified 
with 2 has nearly three times the activity of unmodified TEMPro174AzPhe. Comparison 
of the 95% confidence intervals shows only the difference in kcat (143.9-197.7 s-1 for 
unmodified and 334.9-385.7 s-1 for modified) is significant; the change in KM is not. 
With cephalothin as the substrate, kcat was similarly increased, however there was a 90 
µM increase in KM. This produced an enzyme with an overall catalytic efficiency 59% 
higher than the unmodified enzyme. 
 
The effect of SPAAC on ampicillin turnover is particularly interesting as the use of 
the larger modification results in a decrease in kcat, whereas the smaller modification 
results in an increase. For TEMTyr105AzPhe and TEMAla237AzPhe, the decrease in catalytic 
efficiency was proportional to the size of modification used, however for 
TEMPro174AzPhe, the two modifications cause opposite effects, which suggests it is the 
chemical differences between the two modifications that is causing the difference in 
activity. 1 has a large, hydrophobic dye structure whereas 2 only has a small amine 
group on the end of a short linker. The original mutation to TEMPro174AzPhe caused a 
decrease in activity, possibly caused by an increase in Ω-loop flexibility caused by the 
removal of a proline from the loop. This increased flexibility would have a negative 
impact on the positioning of Glu166, a crucial residue in the catalytic mechanism. The 
increase in activity back to wild type levels caused by modification with 2 suggests 
that the Ω-loop now has decreased flexibility, resulting in better positioning of 
Glu166 and an increase in catalytic turnover. The formation of a hydrogen bond 
between the amine present in 2 and the side chain of Gln269 could act as an anchor, 
tethering the Ω-loop to another region of the protein, increasing the stability of the Ω-
loop (Figure 4-13C-D). 
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Table 4-10. Effect of Click modification on the activity of TEMPro174AzPhe against 
ampicillin and cephalothin. 
 
1 kcat, KM and kcat/KM (overall catalytic efficiency) compared directly to the 
unmodified form of TEMPro174AzPhe 
 
Figure 4-13. Effect of Click modification on TEMPro174AzPhe. A-B. Catalytic efficiency 
(µM-1 s-1) of unmodfied TEMPro174AzPhe, and TEMPro174AzPhe modified with 1 and 2 
against (A) ampicillin and (B) cephalothin. C. Distance between the side chains of 
Gln269 and a tyrosine modeled at position 174. D. The size of DBCO-amine. 
 Ampicillin Cephalothin Unmodified 1 2 Unmodified 1 2 
kcat (s-1) 171 ± 13 74.3 ± 4.2 360 ± 12 38.6 ± 2.3 39.4 ± 4.1 99.4 ± 7.0 
Relative 
kcat 1 
1.00 0.43 2.11 1.00 1.02 2.58 
KM (!M) 106 ± 29 69.3 ± 17 82.7 ± 11 144 ± 14 165 ± 27 233 ± 24 
Relative 
affinity 1 1.00 1.52 1.28 1.00 0.87 0.62 
kcat/KM (!M-1 
s-1) 1.62 ± 0.28 1.07 ± 0.25 4.36 ± 0.14 0.27 ± 0.11 0.24 ± 0.19 0.43 ± 0.12 
Relative kcat/
KM 1 
1.00 0.66 2.69 1.00 0.89 1.59 
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Post-translational modification of TEMTrp165AzPhe via SPAAC caused little change in 
the breakdown of ampicillin (Table 4-11). Modifying the protein with 1 caused an 
increase in kcat, and a decrease in substrate binding, resulting in an enzyme with 87% 
of the catalytic efficiency of the unmodified variant. Modification with 2 had a much 
smaller effect on both kcat and KM (although a similar pattern was observed). This 
produced an enzyme with the same overall catalytic efficiency as the unmodified 
variant. Click chemistry had a larger effect on cephalothin hydrolysis (Table 4-11). 
Modification with 1 results in a 29% decrease in kcat to 87 s-1 and a 24% decrease in 
substrate binding, resulting in a near two-fold decrease in overall catalytic efficiency. 
Modification with 2 decreased kcat by 14% to 105 s-1, but KM was virtually unaffected. 
After the initial decrease in activity caused by the incorporation of AzPhe, post-
translational modification of AzPhe through Click chemistry (and by UV irradiation) 
does not result in large changes in overall catalytic efficiency against ampicillin. 
Trp165 is not directly involved in the catalysis of ampicillin, however it is very close 
to residues that are (e.g. Glu166). These two characteristics of TEMTrp165AzPhe make it 
an ideal candidate for associating the enzyme to carbon allotropes such as graphene 
(see Chapter 5). These materials are sensitive to electrostatic changes caused by the 
function of a variety of proteins [124]. The defined and oriented coupling of TEM β-
lactamase to graphene via SPAAC at a residue so close to the active site, but still 
remaining active, would present an ideal opportunity to monitor the effect of different 
substrates and inhibitors on the active site.  
 
Post-translational modification of TEMLeu201AzPhe with 1 has little effect on enzyme 
activity for both ampicillin and cephalothin (Table 4-11). When ampicillin is used as 
the substrate, both catalytic turnover and substrate binding are reduced by little over 
10%, kcat falling to 373 s-1, and KM increasing to 193 µM, however when cephalothin 
is used, neither the kcat nor the KM is significantly changed. Modification with 2 
affects the hydrolysis of both ampicillin and cephalothin in a similar manner. 
Catalytic turnover is decreased for both substrates, down to 308 s-1 for ampicillin and 
52 s-1 for cephalothin. Substrate binding is slightly increased however, up 18% to 145 
µM for ampicillin and 31% to 115 µM for cephalothin. These results show that 
modification of the protein does not result in a uniform change in activity, regardless 
of where the protein is being modified. 
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Table 4-11. Effect of Click modification on the activity of TEMTrp165AzPhe and 
TEMLeu201AzPhe against ampicillin and cephalothin. 
 
1 kcat, KM and kcat/KM (overall catalytic efficiency) compared directly to unmodified 
TEMTrp165AzPhe 
2 kcat, KM and kcat/KM (overall catalytic efficiency) compared directly to unmodified 
TEMLeu201AzPhe 
 
SPAAC had very little effect on the ability of wild type TEM β-lactamase to 
hydrolyze both ampicillin and cephalothin. Both kcat and KM were unaffected by 
modification with both 1 and 2, showing SPAAC does not have an effect on enzyme 
catalysis when there is no handle within the protein for modification.  
 
 
 
 
 
 
 
TEMTrp165AzPhe 
Ampicillin Cephalothin 
Dark 1 2 Dark 1 2 
kcat (s-1) 406 ± 20 572 ± 19 497 ± 38 121 ± 11 86.6 ± 6.0 105 ± 9.0 
Relative 
kcat 1 
1.00 1.41 1.22 1.00 0.71 0.86 
KM (!M) 185 ± 26 302 ± 20 223 ± 34 221 ± 32 289 ± 29 225 ± 28 
Relative 
affinity 1 1.00 0.61 0.83 1.00 0.76 0.98 
kcat/KM (!M-1 
s-1) 2.19 ± 0.15 
1.90 ± 
0.075 2.23 ± 0.17 0.55 ± 0.17 0.30 ± 0.12 0.46 ± 0.21 
Relative kcat/
KM 1 
1.00 0.87 1.02 1.00 0.54 0.84 
 
TEMLeu201AzPhe 
Ampicillin Cephalothin 
Dark 1 2 Dark 1 2 
kcat (s-1) 427 ± 20 373 ± 26 308 ± 20 58.5 ± 5.4 62.6 ± 4.2 52.2 ± 6.2 
Relative 
kcat 2 
1.00 0.87 0.72 1.00 1.07 0.89 
KM (!M) 171 ± 23 193 ± 22 145 ± 28 151 ± 23 153 ± 17 115 ± 24 
Relative 
affinity 2 1.00 0.88 1.18 1.00 0.99 1.31 
kcat/KM (!M-1 
s-1) 2.50 ± 0.14 1.93 ± 0.13 2.13 ± 0.21 0.39 ± 0.18 0.41 ± 0.13 0.45 ± 0.24 
Relative kcat/
KM 2 
1.00 0.77 0.85 1.00 1.06 1.17 
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4.3. Conclusions 
4.3.1. Kinetic analysis of TEM β-lactamase 
Full kinetic analysis of AzPhe-containing TEM β-lactamase variants revealed the 
protein activity can be regulated using chemical modifications through defined post-
translational modifications facilitated by uAA incorporation within a protein. While 
most of the post-translational modifications reduced enzyme activity (such as a drop 
in kcat, or an increase in KM), there were instances where activity was enhanced 
through improved turnover and/or substrate affinity. This proves that the designed 
incorporation of a uAA, combined with site-specific modification is a potentially 
powerful and versatile approach to protein modification. 
 
4.3.1.1. TEMTyr105AzPhe: enzyme inhibition through post-translation modification 
The initial incorporation of AzPhe at position 105 had no negative effect on the 
catalytic activity of the enzyme. UV irradiation had a small impact on the overall 
catalytic efficiency, reducing the kcat against both substrates. However, it was post-
translational modification by SPAAC that had the largest impact on enzyme activity. 
Modification of TEMTyr105AzPhe with 1 resulted in an 85% drop in activity against 
ampicillin, and a 60% drop against cephalothin. Modification with 2 resulted in 
smaller decreases, suggesting that the effect of Click chemistry is dependent on the 
size of the chemical adduct added to the protein. This effect of near total inhibition 
provides an excellent model for the use of novel post-translation modifications in the 
modulation of protein activity. By essentially switching off the enzyme after 
modification, a novel switch has been incorporated into this variant of TEM β-
lactamase.  
 
4.3.1.2. TEMAla237AzPhe: reduction of activity through AzPhe-incorporation 
TEMAla237AzPhe was only 2% as active as wild type TEM β-lactamase. This massive 
reduction in activity was the result of changing a small side chain, such as that found 
in alanine, for a large, aromatic side chain so close to the active site. UV irradiation of 
TEMAla237AzPhe had very little effect on the ability of the enzyme to hydrolyze 
ampicillin and had only a small impact on the catalytic turnover of cephalothin. When 
TEMAla237AzPhe was modified via SPAAC, activity against both substrates was reduced 
further. This variant highlights the need for good mutant design and strategic 
placement of a novel uAA. By introducing a large side chain so near to the active site, 
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activity was essentially destroyed, rendering any novel post-translational 
modifications moot. Computer-aided modeling of potential mutations and even the 
modeling of the novel post-translational modifications can aid this design process, and 
increase the likelihood of achieving novel protein control. 
 
4.3.1.3. TEMPro174AzPhe: positive modulation of activity through Click chemistry 
The effects of SPAAC on TEMPro174AzPhe were variable, depending on which adduct 
was used to modify the protein. Modification with 2 resulted in a large increase in 
activity against both substrates, particularly ampicillin. The modification of 
TEMTyr105AzPhe resulted in a large decrease in activity when modified with the same 
chemical adduct. By causing both an increase and a decrease in activity in two 
different variants of TEM β-lactamase using the same chemical adduct (DBCO-amine 
– 2) displays the versatility of these novel post-translational modifications. Achieving 
both positive and negative control over enzyme activity using a small chemical 
modification highlights the impact that combining uAAs and novel post-translational 
modifications can have on protein function and control. 
 
4.3.1.4. TEMTrp165AzPhe: defined and oriented association with carbon allotropes 
The limited effect of AzPhe incorporation, and subsequent post-translational 
modification via both UV irradiation and Click chemistry, at a position so close to the 
active site offers another facet to the use of uAAs and novel post-translational 
modifications, namely the opportunity to tether TEM β-lactamase to surfaces. The 
proximity of Trp165 to the active site means that the catalytic residues and the surface 
will be in close proximity, opening up the potential for measuring catalytic processes 
by using the electronic properties of carbon sp2-bonded materials, such as graphene 
and carbon nanotubes (see Section 5.2.3.). Novel post-translational modifications 
could then be used to enable analysis of the catalytic mechanisms of enzymes, with 
single molecule detail. 
 
4.3.1.5. TEMLeu201AzPhe: no negative impact caused by modification far from active 
site 
Both UV irradiation and SPAAC had very little effect on the activity of 
TEMLeu201AzPhe, providing a control to show that modification does not result in 
universal decreases in activity. This shows that mutations to cause a desired effect, 
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whether that be an increase or decrease in activity, can be designed, and are not just 
random events caused by the modification of the protein. 
 
4.3.2. Utility of in silico modeling of AzPhe-containing variants 
In Chapter 3 the use of in silico modeling to hypothesize the potential effects of 
mutating specific residues to tyrosine (used as a structural homologue of AzPhe) was 
described. This process mutated a specific residue to tyrosine and using energy 
minimization processes determined the likely orientation of the new side chain and 
any impact on the orientation on other side chains. These in silico models were then 
used to hypothesize effects on the activity of the enzyme caused by the incorporation 
of the uAA and the subsequent modification of the enzyme by both UV irradiation 
and Click chemistry. Through this process ten positions were selected for mutation 
based on the likelihood of them impacting the activity of the enzyme both positively 
and negatively. 
 
One of these ten positions selected, Tyr105, was not mutated in silico as the residue 
was already a tyrosine. The position of this residue in the protein alone was enough 
reason to select this position. Present in the domain interface that forms the active site, 
mutation of a tyrosine to AzPhe was suggested to not have a large impact on activity 
due to the structural similarities between the two amino acids, however any 
modifications to AzPhe at this positions would likely have an effect on activity due to 
its proximity to the active site. These two suggestions were both proved to be correct, 
as mutation to AzPhe resulted in no decrease in activity. However, upon post-
translational modification, especially via Click chemistry, large decreases in activity 
were seen. 
 
Conversely, the modeling of tyrosine at Ala237 suggested a large impact on activity. 
Ala237 samples a similar position to Tyr105 in that it forms part of the domain 
interface. The crucial difference between these two residues however is the size of the 
native amino acid, tyrosine being structurally similar to AzPhe, whereas alanine is 
not. The introduction of tyrosine at this position had a large impact on the size of the 
cleft available for substrate entry into the active site, predicting a large impact on 
activity. This prediction was again correct, as TEMAla237AzPhe retained only 2% of the 
 98 
activity of wild type against ampicillin. The activity was so low, that post-
translational modification only had a negligible impact on activity. 
 
Although these two variants represent times the in silico modeling proved to 
accurately predict the effect of mutation, there were times where the suggestions 
inferred from the models were incorrect. Modeling of a mutation at Trp165 suggested 
a potential negative impact on activity due to the proximity of this residue to Glu166, 
one of the key residues in the catalytic mechanism. Although the exchange of 
tryptophan for tyrosine/AzPhe represents a decrease in side chain size, any 
modification through Click chemistry was thought to likely have a large impact on the 
precise positioning of Glu166. This prediction proved to be false, as modification of 
TEMTrp165AzPhe by both UV irradiation and Click chemistry resulted in very little 
impact on enzyme activity. 
 
Two residues on the Ω-loop were also selected for mutation based on the results of the 
in silico modeling. Four residues on the Ω-loop, Arg164, Asp176, Arg178 and 
Asp179, all interact to help stabilize the structure and help position Glu166 for 
catalysis. All four of these positions were mutated to tyrosine in silico to determine 
which, if any, may result in useful mutations. This process suggested that mutating 
Arg164 or Asp179 might result in a variant that destroy the interactions initially, but 
then be able to reform these interactions via UV-induced photo-crosslinking of the 
phenyl azide side chain. The first part of this hypothesis proved to be correct, as both 
variants were completely inactive, suggesting the destruction of these interactions on 
the Ω-loop results in an inactive enzyme. However the second part proved to be 
incorrect, as no activity could be restored upon UV irradiation of either variant. 
 
Overall, the in silico modeling approach used in this study proved to be successful as 
many of the variants chosen for further study did result in the effects on enzyme 
activity initially suggested by the models. There were some occasions where effects 
suggested by the models were not observed experimentally, however this is be to 
expected in any in silico modeling approach. Of the ten mutations originally chosen 
from the modeling, all were studied using nitrocefin activity analyses, and four of 
them (Leu201 was chosen later) were studied in more detail using full kinetic analysis 
against two more clinically relevant substrates. Half the variants initially chosen 
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yielded interesting results, indicating the success of the in silico modeling approach in 
identifying potential mutations.  
 
4.3.3. uAA incorporation 
One of the major points when considering uAA incorporation into proteins is the 
efficiency at which they are incorporated. Much work has been done over a number of 
years to overcome the problem of poor uAA incorporation, and continually increase 
the efficiency of this technique. Original attempts to incorporate uAAs into proteins 
were not very successful, and even when proteins were produced containing simple 
uAAs, the yields of these proteins were not very high [125]. The optimization of the 
process of uAA incorporation has gone a long way to making this technique a viable 
method. However there remains some debate over the orthogonality of the engineered 
amino-acyl tRNA-synthetases (aaRSs) used to incorporate uAAs during cellular 
translation [41, 42]. This debate has led to the introduction of a number of 
technologies that aid the orthogonality of this system without the further engineering 
of the translational machinery, such as whole genome engineering, release factor 
removal and ribosome engineering. 
 
One of the first problems with the current system is the use of the amber stop codon, 
TAG, as the reprogrammed codon. It is the least used stop codon in the E. coli 
genome, so it is the obvious choice for reprogramming, however it is still the natural 
stop codon for ~7% of genes in E. coli. This means that the uAA will be incorporated 
at the natural C-terminus of these proteins instead of translation termination. This also 
results in read through of the stop codon, and can result in elongation products, which 
may have downstream effects on cellular function. In recent years, whole genome 
engineering has been used to produce strains of E. coli that have had every amber stop 
codon replaced in their genome [33, 34]. This removes the natural function of TAG as 
a stop codon, so that TAG becomes another codon that can be assigned an amino acid. 
By introducing the orthogonal tRNA/aaRS pair into the cell, the TAG can be assigned 
to a uAA. 
 
Removal of the natural function of the TAG codon as a stop codon also allows release 
factor 1 (RF1) to be deleted from the genome [126]. E. coli have two release factors 
whose role during translation is to decode the three stop codons. RF1 recognizes UAA 
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and UAG and RF2 recognizes UAA and UGA. By removing the TAG/UAG codon 
from the genome, RF1 can be removed as the remaining two stop codons are served 
by RF2. This now allows a reprogrammed TAG codon system that increases uAA 
efficiency through reduced premature translation termination, and allows multiple 
uAAs to be incorporated into the same target [127]. This latter aspect of uAA 
incorporation was always a problem using traditional methods as the introduction of 
two or more uAAs into a protein dramatically reduced target protein production due 
to premature termination [128]. 
 
Another avenue that has been exploited is ribosomal engineering. The lack of 
trinucleotide codons available for the incorporation of uAAs means quadruplet codons 
are being used more and more, however these are not decoded efficiently by 
ribosomes. Engineering the ribosome by mutating two residues to form an extended 
pocket where a four-base tRNA anticodon may bind, increases the decoding 
efficiency and allows the incorporation of uAAs in response to several quadruplet 
codons [53]. This technology not only increases the efficiency at which uAAs can be 
incorporated into proteins, but also allows two or more different uAAs into the same 
protein through the use of multiple blank codons. The availability of E. coli strains 
that have had the amber stop codon removed, or have an engineered ribosome that can 
decode multiple quadruplet codons increases the efficiency of uAA incorporation, and 
thus furthers the application of this technology. 
  
4.4. Summary 
This chapter introduced the technique of incorporating uAAs into proteins and the 
effects on enzyme activity that can be caused by the expansion of the genetic code. 
The effect on activity was variable depending on the position of AzPhe in the protein. 
Some positions were highly tolerated, with no impact on activity, whereas other 
positions had much reduced levels of activity, or even no activity. Even though uAA 
incorporation is a relatively new technique, a lot of work has been completed to 
increase the efficiency and reliability of this process, resulting in a technique that can 
be used to introduce novel functionality and reactivity into proteins reliably and 
repeatedly. This chapter briefly discusses the limitations of this technique, and how 
technological advances such as whole genome codon-replacement and ribosome 
engineering are improving this technique by removing the natural function of the 
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amber stop codon, or increasing the number of codons available for uAA 
incorporation. 
 
The incorporation of uAAs into TEM β-lactamase and their subsequent purification 
enabled in depth kinetic analyses to be performed on AzPhe-containing enzyme 
variants. Using this method, the impact of AzPhe incorporation could be determined 
to a detailed level. The incorporation of AzPhe produced a variety of effects on 
enzyme activity, some residues retaining a high level of activity when mutated to 
AzPhe and some becoming much less active. Incorporation of AzPhe at 
TEMAla237AzPhe resulted in a change in substrate preference, this variant having a lower 
KM when cephalothin was used as the substrate compared to ampicillin, the more 
natural substrate for this enzyme. The subsequent modification of the azide group in 
these enzyme variants, especially using Click chemistry, brought about much larger 
changes in activity. The post-translational modification of TEMTyr105AzPhe resulted in 
large decreases in activity, likely due to the proximity of this residue to the active site. 
Other residues positioned further from the catalytic residues had a much smaller effect 
on activity. The modification of TEMPro174AzPhe using Click chemistry had interesting 
effects on ampicillin hydrolysis. This variant lost some activity upon incorporation of 
AzPhe however after Click chemistry modified this residue to include an amine 
group, activity was restored to a level that exceeded wild type. 
 
The variety of the effects caused by AzPhe incorporation and modification highlight 
the ability of genetic code expansion and uAAs to incorporate novel functions and 
novel control into proteins. The variety of modifications available to biochemists for 
use in Click chemistry and SPAAC means there is an almost limitless supply of 
opportunity to incorporate desired changes. This work used a rational design approach 
as a way to introduce mutations that would result in changes in activity. The in silico 
approach used helped the identification of interesting variants that might lead to novel 
changes in activity upon both incorporation of the uAA and subsequent modification. 
However, many of the predicted effects proved to be smaller in practice. This 
highlights the complex interplay between residues in proteins, particularly in the 
active site of enzymes, and highlights the difficult nature of designing novel post-
translational effects into proteins using uAAs. 
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5. Using AzPhe-mediated non-natural post-translational modification 
to introduce new functionality into proteins 
 
5.1. Introduction 
The incorporation of p-azido-L-phenylalanine (AzPhe) into defined positions in a 
target protein enables the use of novel post-translational modifications that can 
modulate the function and control of a protein (see Chapters 4 and 6). However, these 
novel post-translational modifications can also be used to introduce additional 
functionality. The immobilization of proteins onto surfaces is a technique that has 
revolutionized the study of protein-protein interactions through the construction of 
high-throughput nanoarrays that allow the simultaneous analysis of large numbers of 
proteins [129], and the study of protein-substrate interactions, such as small molecule 
screening in drug discovery [130, 131]. As well as increasing the numbers of proteins 
that can be studied quickly, protein immobilization can also enable single-molecule 
studies [132, 133]. Original methods of attaching proteins to surfaces involved 
physical adsorption, whereby a protein would attach to a surface via unspecific 
interactions such as hydrophobic or electrostatic interactions [134]. This technique 
was replaced by covalent attachment via the functional side chains of particular 
residues such as lysines and cysteines, which improved the strength of the interaction 
but did not address specificity, as proteins (and the entire proteome) generally have 
multiple surface exposed side chains of this type. The use of AzPhe and Click 
chemistry can help overcome this lack of specificity. The incorporation of a single 
azide group at a defined position in the target protein via the use of AzPhe, and 
subsequent site-specific post-translational modification, enables attachment to a 
surface with increased specificity with regards to the orientation of the protein on the 
surface. This defined orientation is crucial in the surface-based study of enzymes, as 
access to active site and other allosteric binding sites must be consistent between 
different enzymes and enzyme variants. 
 
This chapter introduces two methods used to attach TEM β-lactamase to a surface. 
The first involves the post-translational modification of AzPhe with a functionalised 
pyrene group. This pyrene group is able to interact strongly with sp2-bonded materials 
such as graphene via a π-π stacking interaction [135]. Graphene is a highly useful 
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material as not only does it have a high strength-to-weight ratio, but it also has 
conductive properties that can aid the analysis of proteins [136]. The second method 
is through the use of DNA origami. DNA origami [137] is a technique whereby single 
stranded DNA is designed to self hybridize into complex 2- or 3-dimensional shapes, 
creating a scaffold that can be used to immobilize proteins. DNA is an ideal material 
to attach proteins to surfaces as the nature of DNA and its complementarity means 
proteins can be organized upon a surface. The protein organization benefits offered by 
DNA, and the protein orientation benefits offered by AzPhe and Click chemistry, can 
combine to form a highly useful method for surface-based protein analyses.  
 
When Click chemistry is being used to modulate the function of a protein, or 
introduce new functionality, the efficiency at which these chemical modifications 
occur (and what determines this efficiency in terms of the protein microenvironment) 
is of the utmost importance. If only a small percentage of the protein population is 
modified, the utility of the modification will be compromised. In this chapter the final 
modification efficiency of each AzPhe-containing TEM β-lactamase variant, and the 
rate at which each variant is modified is investigated, and using these results, the 
effects of incorporation site on the modification efficiency is discussed. 
 
5.2. Results 
5.2.1. Effect of AzPhe position on Click modification efficiency 
Click chemistry (and in particular strain-promoted azide-alkyne cyclo-addition – 
SPAAC) is able to modulate protein function, and even introduce new functionality 
into a variety of proteins via the defined, covalent triazole linkage between the azide 
group of AzPhe and an alkyne group. This cyclo-addition reaction, between the only 
azide group in the protein and the ring strained cyclo-octyne offers more specificity 
and selectivity over other methods of post-translational modification such as lysine or 
cysteine modification. However, the efficiency of this novel modification must reach 
a high level if the technique is to prove useful. If the majority of protein remains 
unmodified, then any effect that may be caused by the modification will effectively be 
lower and suffer from background effects caused by unmodified protein. To 
determine the effect of different positions on the efficiency of the SPAAC reaction, a 
coloured dye (1 – Figure 4-4) was used to modify TEM β-lactamase. A comparison of 
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the absorbance by the protein and by the dye can then be used to calculate the amount 
of protein that has been modified with the dye. 
 
5.2.1.1. Final modification efficiency 
It has previously been observed for sfGFP that residue position can determine the 
final extent to which a protein population is modified [110]. To see if this effect is 
repeated in TEM β-lactamase, the final extent of modification and efficiency was 
determined (Table 5-1). The most efficiently modified variant was TEMTyr105AzPhe, 
which reached a final efficiency of 83%. Three variants were modified to a similar 
extent to each other; TEMAla237AzPhe, TEMTrp165AzPhe and TEMLeu201AzPhe. These three 
variants were approximately 50% modified, the highest modification efficiency being 
60% for TEMTrp165AzPhe. The second variant that modified to ~50% was 
TEMAla237AzPhe, which reached a final modification of 55%. TEMLeu201AzPhe was 
modified to a similar extent again, reaching a final efficiency of 47%. TEMPro174AzPhe 
was modified to the lowest extent of all the variants tested, with a final modification 
efficiency of 33%. 
 
Table 5-1. Modification efficiency, surface exposure and flexibility of the five AzPhe-
containing TEM β-lactamase variants calculated using the absorbance of a DBCO-
modified dye  
 Efficiency of SPAAC 
modification (%) 
Surface 
exposure (Å2) 1 
B-factor 
(structure) 2 
TEMTyr105AzPhe 83 113 22.8 (loop) 
TEMTrp165AzPhe 60 74 8.5 (loop) 
TEMAla237AzPhe 55 26 5.5 (β-sheet) 
TEMLeu201AzPhe 47 107 15.9 (α-helix) 
TEMPro174AzPhe 33 54 12.2 (loop) 
1 Surface exposure was calculated using NetSurfP [109] to indicate the area of a 
particular residue that is accessible to solvent 
2 B-factor used to indicate the flexibility of a particular residue, or the likelihood of a 
residue sampling a single, fixed orientation 
 
5.2.1.2. Modification rate 
Determining the extent to which each AzPhe-containing TEM β-lactamase variant 
was modified showed that all the variants were modified differently, some reached a 
high level of modification whereas others did not. Another aspect to SPAAC 
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efficiency is modification rate. Post-translational mechanisms of protein control rely 
on a rapid event so to control protein activity quickly. If the reaction rate between the 
protein-borne azide and the cyclo-octyne is slow, the utility of the approach could be 
diminished, as protein activity requires rapid modulation. To determine the extent of 
modification over time and to determine at which point the reaction reaches 
completion, two methods were used. For those variants susceptible to changes in 
activity, enzyme activity was measured at several time points up to 24 hours after the 
addition of the DBCO adduct to determine modification rate. However, as not all the 
TEM β-lactamase variants are affected equally, an additional approach was used to 
directly measure modification. The absorbance of the conjugated dye was measured 
via fluorescence imaging of SDS-PAGE and subsequent analysis using image 
software. The combination of these two methods gives a good representation of the 
rate at which each variant is modified, and reaches its final point.  
 
As with the final extent of modification, the rate of modification was different for 
each variant. In general, a higher rate of modification corresponded with a higher final 
modification efficiency and vice versa. TEMTyr105AzPhe was modified to the highest 
efficiency of all the variants (Table 5-1), and it did so at the fastest rate (Figure 5-1A). 
After 10 minutes, there was a noticeable decrease in activity (from 360 µM min-1 with 
no modification to 186 µM min-1), and after 4 hours (116 µM min-1), there was no 
further decrease in activity. Analysis of the SDS-PAGE gel showed that the 
fluorescence of the modified protein increased to almost completion after just 10 
minutes of incubation with the dye (Figure 5-1D). Fluorescence increased slightly 
between 10 and 60 minutes, but after this time no increases in fluorescence are 
detected, suggesting modification had reached its final point after only 60 minutes. 
 
TEMAla237AzPhe reached a final modification efficiency of over 50%, however the rate 
of this modification was slower than TEMTyr105AzPhe. Activity dropped after every time 
point sampled, including the final time point used at 24 hours (Figure 5-1B). Analysis 
of SDS-PAGE showed increases in fluorescence up to 2 hours and then no further 
increases after this time (Figure 5-1E). Although there are no changes in fluorescence 
after 2 hours, the decrease in activity suggests modification is either not complete at 
this point or that secondary conformational changes occur after modification that 
result in changes in activity. TEMTrp165AzPhe is largely unaffected by modification, and 
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this is seen here, with little change in activity even after 24 hours of incubation with 
the chemical adjunct (Figure 5-1C). The initial rate of the variant before post-
translational modification is 490 µM min-1, and after 24 hours of incubation with the 
modification this only decreases to 433 µM min-1. Analysis of the SDS-PAGE gel 
showed increases in fluorescence all the way up to 6 hours, with a slight increase up 
to 24 hours (Figure 5-1F).  After two hours incubation with the dye there is very little 
modification occurring. It is only after 4 hours that there are large increases in 
fluorescence. 
 
 
Figure 5-1. Modification over time of TEM β-lactamase with a DBCO-modified dye. 
A, B and C. Nitrocefin activity analyses of (A) TEMTyr105AzPhe, (B) TEMAla237AzPhe and 
(C) TEMTrp165AzPhe. D, E and F. Fluorescence analysis of an SDS-PAGE gel with 
modified (D) TEMTyr105AzPhe, (E) TEMAla237AzPhe and (F) TEMTrp165AzPhe. Coomassie 
stained gels show equal loading in each lane.  
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TEMPro174AzPhe was modified with the lowest efficiency of all the TEM β-lactamase 
variants, reaching a final modification efficiency of 33% (Table 5-1). The rate of 
modification for this variant was also the slowest. The activity of the protein barely 
decreased at all after an hour of incubation with the dye (from 125 µM min-1 to 119 
µM min-1), with inhibition clearly observed after several hours of incubation (Figure 
5-2A). Analysis of gel fluorescence shows that there was no clear signal until after 4 
hours of incubation with the dye (Figure 5-2C). Fluorescence continues to increase 
after 6 hours, suggesting that the reaction may not have reached its completion after 
24 hours. The activity of TEMLeu201AzPhe was not affected by modification by the dye, 
as no decrease in activity was seen until after 24 hours of incubation, from 450 µM 
min-1 to 382 µM min-1 (Figure 5-2B). Analysis of gel fluorescence showed steady but 
small increases in fluorescence up to 6 hours, with very little increase after that 
(Figure 5-2D). This suggests that the modification takes between 6 and 24 hours to 
reach a final modification efficiency of 47%. 
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Figure 5-2. Modification over time of TEM β-lactamase with a DBCO-modified dye. 
A and B. Nitrocefin activity analyses of (A) TEMPro174AzPhe and (B) TEMLeu201AzPhe. C 
and D. Fluorescence analysis of an SDS-PAGE gel with modified (C) TEMPro174AzPhe 
and (D) TEMLeu201AzPhe. Coomassie stained gels show equal loading in each lane.  
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5.2.2. Attaching TEM β-lactamase to DNA origami 
The use of DNA as a tool to organize proteins on a surface was first suggested in 
1982 [138], and then developed into the method known as DNA origami in 2006 
[137]. The predictable nature of base pairing means DNA can be designed to form 
corners and junctions rather than double-stranded duplexes. This enables the DNA, 
with the aid of “staple” strands that solidify the structure, to form larger, more 
complex shapes (Figure 5-3). This characteristic of DNA means it can be used as a 
scaffold for the study of various biomolecules, through the use of complimentary 
DNA oligonucleotides. These DNA oligonucleotides can be designed to hybridize to 
the single stranded DNA origami “tile” at a single position, thereby specifically 
defining the position of a single biomolecule. The nature of DNA complementarity 
means several DNA strands can be designed to bind to the tile at different places, 
enabling the construction of protein networks such as signaling cascades or enzyme 
pathways.  
 
 
Figure 5-3. Schematic of DNA origami. Single stranded DNA folds, with the aid of 
small “staple” strands into a complex 2- or 3-dimensional structure. 
 
The conjugation of biomolecules to the DNA oligonucleotide is an important step in 
the success of DNA origami. This conjugation has been previously achieved through 
biotin-streptavidin interactions [139], histidine-NTA interactions [140, 141] and direct 
protein-DNA (aptamer) interactions [142]. The use of SPAAC to attach the protein to 
the oligonucleotide strands offers several benefits over the methods previously used. 
The use of AzPhe to conjugate the protein to a DNA oligonucleotide via SPAAC 
removes the need for large molecules such as biotin or a His-tag to be introduced to 
the protein of interest. Additionally, the site-specific nature of AzPhe-incorporation 
allows the orientation of a protein on the DNA origami tile to be precisely defined, as 
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well as the location of the protein on the surface. These benefits mean AzPhe-DNA 
interactions are an ideal method to isolate a protein on a DNA tile. 
 
5.2.2.1. Modifying TEM β-lactamase with DNA oligonucleotides 
Two DNA oligonucleotides were used, both modified at the 5’ end with a cyclo-
octyne for reaction with the azide group of AzPhe. These oligonucleotides are 
designed to bind to the DNA origami tile in different ways, and as such differ in the 
length of the nucleic acid chain, and therefore their molecular weight (Table 5-2). One 
of the strands (B5900) is designed to hybridize to one of the staple strands that are 
used to construct the tile, and the second DNA strand (B5963) is an extended staple, 
used to help the folding and formation of the DNA tile. Five TEM β-lactamase 
variants were modified with both oligonucleotides (Figure 5-4). Gel mobility shift 
assays were used to assess the protein-oligonucleotide conjugates. The migration of 
the protein-DNA conjugate through the SDS-PAGE gel varied depending on both the 
DNA oligonucleotide used, and the residue modified. Modification of TEM β-
lactamase at TEMPro174AzPhe and TEMTrp165AzPhe had the largest effect on the migration 
having a larger apparent molecular weight than other TEM β-lactamase variants 
modified at other positions (Figure 5-4). The pattern of migration is consistent for 
both DNA oligonucleotides used. Wild type was also incubated with both DNA 
oligonucleotides but no band shift was observed confirming that modification with the 
oligonucleotides had not occurred.  
 
Table 5-2. The structure of the cyclo-octyne conjugated to the 5’ end of the DNA 
staple oligonucleotides used and the sequences and molecular weights of those DNA 
strands. 
 
B5900. GGTGGAGTGATGGATGGGAG 
Molecular weight – 6.7 kDa 
B5963. TTTTTTACTCACATTAATTGCGACCTGTCGTGCCAGCT 
      Molecular weight – 11.9 kDa 
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Figure 5-4. SDS-PAGE analysis of five AzPhe-containing TEM β-lactamase variants 
modified with (A) B5900 and (B) B5963. 
 
As observed in Chapter 4, modification of TEM β-lactamase can influence activity, so 
the activity of each variant modified with the two DNA oligonucleotides was also 
determined via nitrocefin activity assays (Figure 5-5). The activity of TEMTyr105AzPhe 
was most affected by modification with the two DNA oligonucleotides, reducing the 
initial rate from 180 µM min-1 to 30 µM min-1 for B5900 and 20 µM min-1 for B5963 
(Figure 5-5A). This shows that the size of the DNA oligonucleotide conjugated to the 
protein does not have a great effect on the activity of the modified enzyme, as 
modification with both oligonucleotides resulted in similar decreases. The activity of 
Wi
ld 
typ
e 
Ty
r10
5A
zP
he
 
Ala
23
7A
zP
he
 
Trp
16
5A
zP
he
 
Pr
o1
74
Az
Ph
e 
Le
u2
01
Az
Ph
e 
25 kDa 
30 kDa 
46 kDa 
58 kDa 
Unmodified 
protein 
Modified 
protein 
Wi
ld 
typ
e 
Ty
r10
5A
zP
he
 
Ala
23
7A
zP
he
 
Trp
16
5A
zP
he
 
Pr
o1
74
Az
Ph
e 
Le
u2
01
Az
Ph
e 
25 kDa 
30 kDa 
46 kDa 
58 kDa 
Unmodified 
protein 
Modified 
protein 
A 
B 
 112 
TEMPro174AzPhe was not as effected by the modifications, modification with B5900 
reduced the initial rate from 100 µM min-1 to 80 µM min-1 and modification with 
B5963 reduced the initial rate to 75 µM min-1 (Figure 5-5C). Although the activity of 
TEMAla237AzPhe was decreased when modified with both of the DNA oligonucleotides 
(Figure 5-5E), the initial rate was lower when TEMAla237AzPhe was modified with the 
shorter staple strand (35 µM min-1) rather than the extended staple strand (55 µM  
min-1). Modification at Trp165 (Figure 5-5B) and Leu201 (Figure 5-5D) with either 
DNA oligonucleotide had very little impact on the activity of the enzyme. 
 
 
Figure 5-5. Nitrocefin activity analysis of five TEM β-lactamase variants modified 
with the two DNA staple strands. The activity of (A) TEMTyr105AzPhe, (B) 
TEMTrp165AzPhe, (C) TEMPro174AzPhe, (D) TEMLeu201AzPhe and (E) TEMAla237AzPhe was 
determined before modification, and after 24 hours incubation with the two DNA 
strands. 
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5.2.2.2. Approaches to separate modified TEM β-lactamase from unmodified 
For the attachment of the modified enzymes to the DNA origami tile, it is important to 
separate the modified proteins from the unmodified. As there was a large degree of 
separation between modified and unmodified enzymes on an SDS-PAGE gel, size 
exclusion chromatography was initially used to try and separate modified from 
unmodified protein (Figure 5-6A). A small peak eluted from the column before the 
main peak, suggesting that the modified protein was purified from the unmodified, 
however SDS-PAGE analysis of the two peaks revealed there was no separation, both 
the modified and unmodified proteins eluting in the main peak. Ion exchange 
chromatography was then used to separate the proteins using the negative charge of 
the DNA strand to bind to an anion exchange column (Figure 5-6B). Successful 
separation of modified and unmodified protein was confirmed using SDS-PAGE 
(Figure 5-7). 
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Figure 5-6. Separation of unmodified TEM β-lactamase from protein modified with 
the DNA staple strand. A. Size exclusion chromatography of TEMTyr105AzPhe modified 
with B5900. The small peak prior to the main peak did not contain modified protein 
after SDS-PAGE analysis (dashed line is unmodified TEMTyr105AzPhe). B. Ion 
exchange chromatography of TEMTyr105AzPhe modified with B5900. The negative 
charge of the DNA strand bound strongly to an anion exchange column and was 
successfully separated from the unmodified protein. 
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Figure 5-7. SDS-PAGE analysis of the ion exchange chromatography of modified 
TEMTyr105AzPhe and TEMTrp165AzPhe. The first two lanes are a mixture of modified and 
unmodified TEMTyr105AzPhe and TEMTrp165AzPhe respectively. These were then 
separated into different fractions using ion exchange chromatography. 
 
5.2.3. Attaching TEM β-lactamase to carbon allotropes 
Since the isolation and description of graphene in 2004 [143], numerous applications 
for the material have been suggested, from its use in touch screens and solar cells 
[144, 145], to a use in gas detection [146]. One potential use for graphene in a 
biological context is the immobilization of biomolecules onto a surface and their 
subsequent analysis [147, 148]. The conductive properties of graphene and other 
carbon allotropes means they are very sensitive to electronic changes in the proteins, 
and can communicate these changes to electrodes very quickly and efficiently [124]. 
This means that tiny changes in biomolecules such as charge and electrostatic changes 
that occur in protein-protein interactions, or protein-substrate interactions can be 
detected. Therefore, graphene is seen as an ideal material to which proteins can be 
tethered in a specific and defined manner, enabling the analysis of single molecules, 
and thus the measurement of individual biological events. One way of adhering 
proteins to a surface like graphene is through the use of pyrene, a planar, polycyclic 
hydrocarbon that can interact with the surface of graphene via a very strong π-π 
stacking interaction. The attachment of proteins to carbon allotropes has been 
accomplished using pyrene by coating a carbon nanotube with pyrene and then 
subsequently attaching a protein via cysteine chemistry [149]. Although this method 
allowed defined placement of the protein, it required extensive molecular biology to 
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remove all natural cysteines from the protein. The use of AzPhe removes this need, as 
only one will be present in the target protein, whilst maintaining the ability to 
specifically design the orientation of a protein on the surface. By functionalizing the 
pyrene group with a dibenzyl cyclo-octyne (Figure 5-8), it becomes SPAAC reactive 
and can be used to modify the unique azide group in the protein via AzPhe. 
 
5.2.3.1. Modifying TEM β-lactamase with pyrene 
To attach TEM β-lactamase to the surface of a carbon allotrope it first must be 
modified with pyrene. However pyrene itself cannot react with the azide group so it 
must be functionalized with a DBCO (dibenzyl cyclo-octyne) group to enable SPAAC 
between the azide group of AzPhe and the alkyne of the DBCO. Pyrene was 
synthesized using DBCO-amine (as used in Chapters 4 and 6) and pyrene butanoic 
acid, succinmidyl ester (Sam Reddington, personal communication – Figure 5-8). 
This yielded an azide-reactive pyrene-based chemical modification that can be used to 
reactive specifically with AzPhe.  
 
 
Figure 5-8. The synthesis of DBCO-pyrene. DBCO-amine and pyrene butanoic acid, 
succinmidyl ester were used to synthesize DBCO-pyrene that is able to react with the 
azide group of AzPhe. 
 
Two TEM β-lactamase variants that contained AzPhe near the active site were then 
modified with the DBCO-pyrene, TEMTyr105AzPhe and TEMTrp165AzPhe. Tyr105 forms 
one side of the active site whereas Trp165 is present on the Ω-loop, a crucial structure 
that sits over the active site (Figure 5-9A). Modification with pyrene resulted in two 
opposite effects, depending on where the DBCO-pyrene was conjugated to the 
protein. Modification of TEM β-lactamase at TEMTyr105AzPhe with DBCO-pyrene 
resulted in a decrease in activity, whereas modification at TEMTrp165AzPhe had no effect 
on the activity of the enzyme (Figure 5-9B-C). The modification of the variants was 
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confirmed using the absorption of the pyrene group, which has a distinctive λmax at 
346 nm (Figure 5-9D). These two positions exhibit differential effects of SPAAC and 
are excellent candidates for immobilization on graphene, as they are both close to the 
active site and in a position to link the charge and electrostatic changes that occur in 
the active site during catalysis and/or inhibitor binding to the conductive properties of 
graphene. 
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Figure 5-9. Modification of TEM β-lactamase with DBCO-pyrene. A. Positions of 
Tyr105 and Trp165 in TEM β-lactamase and the dimensions of the protein. B and C. 
Nitrocefin hydrolysis activity analysis of (B) TEMTyr105AzPhe and (C) TEMTrp165AzPhe 
modified with DBCO-pyrene (Figure 5-8). D. Absorption spectrum of TEMTrp165AzPhe 
modified with DBCO-pyrene (λmax = 346 nm). 
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5.2.3.2. Attaching TEM β-lactamase to graphite 
To mimic the graphene surface, highly ordered pyrolytic graphite (HOPG) was used 
in initial experiments with TEMTyr105AzPhe. Two main methods were used to form a 
stable interaction between the pyrene and the HOPG, binding DBCO-pyrene to the 
surface with no protein, and binding protein already modified with the DBCO-pyrene. 
Two further methods were then used to incubate the protein with HOPG, drop-casting 
whereby 20 µL of protein is dropped onto the HOPG surface and immersion where 
the HOPG is submerged in 100 µL of protein. Protein concentration was varied from 
0.01 µM to 5 µM and incubation time was varied from 5 – 30 minutes. Wash 
conditions were also varied. The surfaces were then imaged using atomic force 
microscopy (AFM) courtesy of A. Zaki, Martin Elliot and Emyr MacDonald, Cardiff 
University School of Physics. 
 
Of all the combinations used, the best results were seen when pyrene was laid down 
on the surface prior to modification with the protein. 0.2 mM pyrene was incubated 
with the HOPG for 15 minutes and then the surface was washed with 100% DMSO, 
then rinsed with water and dried with N2 gas. The HOPG with pyrene was then 
immersed in 100 µL TEMTyr105AzPhe and wild type TEM β-lactamase (both 1 nM) for 
10 minutes and then rinsed with water and dried with N2 gas as before. AFM can 
measure height profiles much more accurately than it can measure lateral dimensions, 
so in the analysis of the surfaces, the heights of objects found on the surface were 
primarily analyzed, rather than the 2-dimensional size of the object. Initially the 
surface labeled with only the pyrene was imaged (Figure 5-10A). The height profile 
of this image shows the expected height and pattern of pyrene laid down on the 
HOPG surface. When proteins were incubated with the surface, the height profiles of 
suspected proteins matched the expected values of between 3 and 4 nm (Figure 5-
10B-C). When wild type TEM β-lactamase was incubated with the surface, no objects 
were seen on the surface (Figure 5-11). 
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Figure 5-10. AFM images and height profiles of pyrene and TEMTyr105AzPhe on HOPG. 
A. Image and height profile of DBCO-pyrene laid down on HOPG prior to protein 
binding. B and C. Images and height profiles of TEMTyr105AzPhe bound to the HOPG 
pre-labelled with DBCO pyrene. 
 
A 
B 
C 
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Figure 5-11. AFM image of wild type TEM β-lactamase incubated with HOPG. 
 
5.2.3.3. Attaching TEM β-lactamase to graphene 
Once TEM β-lactamase was successfully attached to HOPG, two variants, 
TEMTyr105AzPhe and TEMTrp165AzPhe, were then used to bind to graphene. For binding to 
graphene, TEM β-lactamase already modified with the DBCO-pyrene was used to 
attach to the surface, so as not to cover the graphene surface with pyrene, 
desensitizing the surface. Drop-casting with 5 nM TEMTrp165AzPhe pre-modified with 
DBCO-pyrene resulted in single proteins being imaged on the surface, with the 
expected height of 3-4 nm (Figure 5-12A-B). TEMTyr105AzPhe was also attached to the 
surface using the same method and the same protein concentration (Figure 5-12C). 
Modified protein shows excellent persistence on the surface, remaining attached to the 
graphene after multiple scans using AFM tapping mode. The bond between the 
pyrene and graphene is therefore very strong, and is not easily disrupted via 
mechanical forces. When wild type in incubated with graphene, proteins are knocked 
off the surface after a few scans (Figure 5-12D), showing the interaction between the 
pyrene and the graphene is stronger than other, non-specific interactions between the 
protein and the surface. 
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Figure 5-12. AFM images of TEM β-lactamase on graphene. A-B. AFM image (A) 
and height profile (B) of TEMTrp165AzPhe pre-modified with DBCO-pyrene on 
graphene. C. AFM image of TEMTyr105AzPhe pre-modified with DBCO-pyrene on the 
surface of graphene. D. AFM image of wild type TEM β-lactamase incubated with 
graphene.  
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5.3. Discussion 
5.3.1. Effect of residue position on SPAAC efficiency 
Post-translational modifications using AzPhe via SPAAC have been shown to be able 
to modulate the function of enzymes, and also introduce new functionality to proteins 
[150, 151]. However, the efficiency of these reactions has been shown to vary 
substantially between different proteins, and even different variants of the same 
protein [110]. Proteins are highly complex and dynamic biomolecules that sample a 
wide range of microenvironments across their structure due to the different residues 
(and chemistry) that make up a protein at each point of their structure. It is very 
difficult to predict the influence of these unique microenvironments on the SPAAC 
reaction, mainly because very little work has been done in this area. By modifying 
several AzPhe-containing variants of a protein and analyzing the rate, and final 
modification efficiency, the effect of these microenvironments can be evaluated.  
 
TEMTyr105AzPhe was modified at the quickest rate and to the highest extent of all the 
TEM β-lactamase variants sampled. Tyr105 is a surface exposed residue (113 Å2) that 
is located in the cleft formed between the two domains of TEM β-lactamase and 
forms a key part of the substrate binding pocket. The two closest residues to the side 
chain of Tyr105 are Met129 and Ser130, one hydrophobic, and one hydrophilic 
residue (Figure 5-13A). Other residues within 4 Å of Tyr105 include Glu104, Asp131 
and Asn132. Residues Ser130, Asp131 and Asn132 are more commonly known as the 
“SDN” loop and are known to have a function in interacting with substrates [80]. The 
position of Tyr105, so close to a feature of a protein that is designed to accept 
substrates, is likely to be more accommodating to chemical adjuncts that are trying to 
react with the azide group of AzPhe, in a manner that is not entirely dissimilar to 
substrates trying to gain access to the active site. This could contribute to the high 
final modification efficiency seen, and the high rate of reaction. 
 
Ala237 is another residue that is found in the active site of TEM β-lactamase. The 
final modification efficiency when AzPhe was incorporated at Ala237 was just over 
50%, and the rate of reaction was slower than that of TEMTyr105AzPhe. Ala237 is 
relatively buried (26 Å2), however the size difference between alanine and AzPhe 
means that on mutation the side chains are likely to sample different 
microenvironments, so the azide group of AzPhe is likely to be in the cleft between 
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the two domains, increasing the effective surface exposure of the residue. Ala237 is 
also flanked by two small glycine residues (Figure 5-13B) that could provide extra 
space for the DBCO-adduct to approach the side chain of AzPhe, potentially 
increasing the modification efficiency, despite the limited surface exposure. 
 
TEMTrp165AzPhe is also modified to a good level, reaching a maximum efficiency of 
60%. Trp165 is a large amino acid that is surface exposed (74 Å2) with one face of the 
indole side chain facing the solvent and one facing the protein. It is present on the Ω-
loop, a loop structure that sits over the active site, and is adjacent to a catalytic residue 
(Glu166). Despite the proximity of Trp165 to the active site, particularly Glu166, 
modification at this residue did not greatly affect the activity of the enzyme. The 
closest residues to the side chain of Trp165, Asn136 and Thr140, both have polar 
groups on their side chains, which could disrupt the interaction between AzPhe and 
the hydrophobic DBCO group (Figure 5-13C), however the surface exposed nature of 
the residue is likely to promote accessibility aiding modification. 
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Figure 5-13. The surrounding residues and microenvironments of (A) Tyr105, (B) 
Ala237, (C) Trp165, (D) Pro174 and (E) Leu201. 
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TEMLeu201AzPhe is found far from the active site, and as expected, modification here 
has been shown to have very little effect on activity. This variant was modified to a 
similar extent as TEMTrp165AzPhe and TEMAla237AzPhe, reaching a highest final 
modification efficiency of 47% and a lowest of 35%. Leu201 is surface exposed (107 
Å2) and found at the end of a α-helix so the DBCO would have no problem gaining 
access to the side chain, however it is surrounded by charged residues (Figure 5-13E), 
which may reduce the ability of the hydrophobic DBCO group to approach the azide.  
 
The position that was modified the least of all the variants tested was TEMPro174AzPhe, 
another variant that is present on the Ω-loop. Modification of this variant only reached 
a final efficiency of 33%. This residue is located on the opposite side of the Ω-loop to 
Trp165 and the active site. It is partially surface exposed (54 Å2) with one face of the 
cyclic ring facing the solvent, and surrounded by a mixture of hydrophobic and 
hydrophilic residues (Figure 5-13D). On the surface, it samples a similar 
microenvironment to both Tyr105 and Trp165, however it is modified to a much 
lesser extent. In Chapter 4 I hypothesized that the mutation of Pro174 to AzPhe 
removed a regulator of the flexibility of the Ω-loop. By increasing the flexibility, the 
activity of the protein was negatively affected. Here, by increasing the flexibility of 
the loop, the modification efficiency has been negatively affected. The modification 
of Trp165 reaches a higher final efficiency, as there is still a proline at position 174 
(and one at position 167), modulating the flexibility of the loop as a whole, holding 
Trp165 in place so that it can be modified. The increase in flexibility caused by 
removal of the proline at position 174 could result in the lower modification 
efficiency. 
 
By ranking the variants in the order of most modified to least modified 
(TEMTyr105AzPhe > TEMTrp165AzPhe > TEMAla237AzPhe > TEMLeu201AzPhe > TEMPro174AzPhe) 
we can try and determine some of the factors that may influence modification by 
looking at the characteristics that these variants have in common. The flexibility 
sampled by TEMPro174AzPhe could explain why this variant is modified so little, 
however Tyr105 is also located in the middle of a large loop region of the protein with 
no defined secondary structure. However this position is likely to be held in place 
much more effectively due to its proximity to the active site, whereas Pro174 is 
situated in an inherently flexible domain of the protein. Two of the residues modified 
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with the highest final efficiency, Tyr105 and Trp165, are surface exposed, whereas 
Ala237 is similarly modified but less surface exposed (26 Å2 compared to 113 Å2 and 
74 Å2 for Tyr105 and Trp165 respectively). The change in size between AzPhe and 
alanine would most likely increase the surface exposure from 26 Å2, but would likely 
not be comparable to Tyr105. Leu201 is the second most exposed residue sampled, 
but this residue is modified to a lesser extent. There appears to be no pattern in the 
surrounding residues of each variant; most variants have a variety of residues around 
them with a combination of polar and non-polar groups. These findings underline the 
difficulty in predicting which positions may be modified to a great extent and which 
would be modified poorly as there is no single factor that correlates with the findings. 
 
5.3.2. Using SPAAC to attach proteins to surfaces 
The immobilization of proteins on surfaces is an ideal method to study proteins as it 
unlocks the potential of measuring single molecules. By studying many millions of 
proteins in solution, individual effects on substrate binding and catalysis can be 
averaged out and lost. By focusing on the smallest possible number of individual 
proteins, a more detailed analysis of temporal processes can be investigated. Protein 
immobilization has been previously achieved via a variety of methods, many of which 
rely on the intrinsic properties of a protein, such as hydrophobic areas on its surface to 
adsorb to a surface, or a lysine residue on its surface. Whilst these methods can attach 
a protein to a surface, it is also wholly unspecific, as proteins often have numerous 
hydrophobic regions or inherent functional groups on their surface. In previous cases, 
all other surface exposed cysteine residues (a relatively uncommon amino acid) have 
been removed from the target protein [149]. However this is an extensive undertaking, 
and can introduce significant changes to the protein’s structure and function as 
cysteine residues often play important structural and functional roles.  
 
By using specific unnatural amino acids with unique reactive groups, such as AzPhe, 
the need for such changes to the target protein is removed. Using this method, only 
one mutation was introduced into TEM β-lactamase, which can be designed to have 
little or no effect on activity, as is the case for TEMTrp165AzPhe. The use of novel post-
translational modifications has been previously used to tether proteins [65] and cells 
[152] to a surface, however these methods failed to benefit from the novel reactivity 
of AzPhe and the functional significance of graphene. The combination of AzPhe and 
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SPAAC offers many benefits over existing methods of protein immobilization. By 
using different adducts that react with AzPhe in the same manner, and by using 
different surfaces with different properties, different strategies for immobilizing 
proteins on a surface can be exploited using a single mutation. 
 
The modification of AzPhe at two defined positions of TEM β-lactamase with a 
functionalized pyrene group (which allows proteins to interact with carbon allotropes 
such as graphene and carbon nanotubes (CNTs)) resulted in different effects on the 
activity of the enzyme. Modification at TEMTyr105AzPhe with DBCO-pyrene resulted in 
a slight decrease in activity whereas modification at TEMTrp165AzPhe had no effect. 
These results are the same as those seen with other DBCO-based adducts (Section 
4.2.4.3.). TEMTrp165AzPhe in particular represents an ideal opportunity to interface TEM 
β-lactamase with graphene or CNTs, making use of the conductive properties of these 
materials. The limited effect on activity means the catalytic process is not interfered 
with, and the proximity of the mutation to the active site means any charge changes 
during catalysis can alter the electronic signature of graphene or CNTs. AFM imaging 
of tightly bound proteins on the surface showed single molecules of expected 
dimensions. The successful interfacing of TEM β-lactamase with both graphite and 
graphene in a defined manner using pyrene represents the first step towards this 
technology, allowing precise and repeatable measurements of atomic level details in 
biological processes such as enzyme-substrate binding and protein-protein 
interactions. The ability to analyze single molecules in such a manner would increase 
our understanding of such events greatly. 
 
The modification of AzPhe-containing variants of TEM β-lactamase with a DNA 
oligonucleotide containing a cyclo-octyne opens up the possibility of attaching an 
enzyme to a DNA-based surface with high levels of specificity and organization. 
DNA origami uses the complementarity of DNA bases to organize proteins on a 
surface. By attaching a DNA oligonucleotide to a protein in a defined position, the 
protein can be immobilized on the surface in a highly specific and defined manner, 
and the position of the tethered protein can be controlled with a high degree of 
precision. As a DNA origami “tile” is a large piece of single stranded DNA (~7 kb), 
DNA strands can be designed that anneal to different parts of the surface, allowing 
multiple proteins to be tethered to the surface at the same time in a designed and 
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organized manner [153]. The modification of these AzPhe-containing variants with 
two different DNA oligonucleotides with limited effects on activity in some cases, 
and the successful separation of modified protein from unmodified, opens the door for 
the assembly of enzyme pathways or signaling cascades on a DNA origami tile. If two 
different enzymes in a specific reaction pathway, or two different kinases in a 
signaling cascade are modified with different DNA oligonucleotides, they can be 
designed to reside in series on a surface, thus recreating the pathway or cascade in 
vitro, so that the product of one reaction is fed directly into the active site of the next 
protein in the enzyme pathway, or a chemical signal is propagated along a series of 
receptor proteins. 
 
5.4. Summary 
This chapter introduced the addition of novel functionality to proteins via the use of 
unnatural amino acids and Click chemistry. By incorporating AzPhe into TEM β-
lactamase and modifying the azide with two different chemical adjuncts, two different 
methods of attaching a protein to a surface were explored. The modification of TEM 
β-lactamase with pyrene enabled the protein to be deposited in a highly defined and 
specific manner onto a surface that can be used to detect the changes in a protein 
caused by substrate binding or protein-inhibitor interactions. By exchanging the 
pyrene group in the chemical modification with a DNA strand, the AzPhe-containing 
protein can then be attached to a DNA origami “tile” that allows precise organization 
of multiple proteins on a single surface. The effect of modification of TEM β-
lactamase with two different DNA strands was determined, and then the modified 
protein was purified from the unmodified protein. 
 
Post-translational modifications are an important facet to protein function, and they 
rely on an ability to affect protein activity or function immediately. Although SPAAC 
is experimentally compatible with biological systems, if the reactions do not occur 
rapidly enough, their biological relevance will be negligible. In some cases, this was 
clearly evident and outlines why it is important to design potential variants. The effect 
of the site of AzPhe incorporation on SPAAC efficiency was explored, and the factors 
that may determine the success of a reaction were discussed. This chapter highlights 
that SPAAC is an adaptable technique that can be used to not only affect the function 
of a protein, but can introduce novel methods of protein analysis. 
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6. The impact of AzPhe incorporation and modification on sfGFP 
structure and function 
 
6.1. Introduction 
The incorporation of unnatural amino acids (uAAs), especially p-azido-L-
phenylalanine (AzPhe), has been shown to be a useful tool for introducing new 
functional properties into proteins [154]. In Chapter 4, the use of AzPhe as a tool for 
modulating enzyme activity using novel post-translational control was demonstrated. 
In this chapter, the generality of the approach is explored by transferring the idea to a 
second protein, superfolder GFP (sfGFP). sfGFP is an intrinsically fluorescent protein 
(see Section 1.7) that has been shown to tolerate the incorporation of uAAs [87]. 
AzPhe in particular has proved to be particularly useful, introducing photo-activation, 
photo-deactivation and fluorescence shifts through covalent modification of AzPhe 
[23]. The structure and fluorescence properties of sfGFP have been characterized with 
the roles of many residues, both within the chromophore itself and those residues 
surrounding it contributing towards fluorescence, investigated. This chapter focuses 
on the incorporation of AzPhe into sfGFP at His148 (Figure 6-1), a position that is 
involved in the complex hydrogen-bonding network that interacts with the 
chromophore and defines the fluorescence properties of the protein [88]. It details the 
effect of AzPhe incorporation, and the effect of subsequent UV irradiation on the 
fluorescence characteristics of sfGFP. It goes on to assess the effect of post-
translational modifications via Click chemistry on sfGFP fluorescence. To provide a 
detailed molecular insight into how AzPhe incorporation at His148 affects 
fluorescence and how the subsequent photo-control is exerted, the protein structure in 
the dark and irradiated states was solved by X-ray crystallography. The original 
sfGFP structure [92], together with recent uAA-containing variants [23], have 
provided an excellent insight into the effects of UV irradiation on AzPhe in sfGFP, 
and the precise mechanisms by which novel photo-control can influence the 
behaviour of sfGFP fluorescence. 
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Figure 6-1. Interaction between Tyr66 of the chromophore and His148 
 
6.2. Results 
6.2.1. Production and purification of AzPhe-containing sfGFP 
A detailed description of the approach used to produce proteins containing uAAs can 
be found in Sections 1.5 and 4.2.1., and the methods are outlined in Section 2.4.1.. 
Briefly, E. coli Top10 cells were transformed with two plasmids, pBAD containing 
the sfGFP gene with a TAG codon inserted at His148, and pDULE containing the 
translational machinery required for uAA incorporation. sfGFPHis148AzPhe was then 
purified in two steps. The first step was Nickel-affinity chromatography using a hexa-
histidine tag (His-tag) at the C-terminus of the protein. During purification, protein 
elution was monitored at 280 nm, to monitor all proteins in the cell lysate, and at 485 
nm, for the specific monitoring of sfGFP elution. Upon application of the imidazole 
gradient, monitoring at 280 nm was stopped to avoid any potential photolysis of the 
phenyl azide group in AzPhe (Figure 6-2A). Secondly, the protein was purified using 
anion exchange chromatography, with elution only monitored at 485 nm (Figure 6-
2B). After purification, SDS-PAGE was used to determine the purity of 
sfGFPHis148AzPhe. The protein was then concentrated into PBS and buffer exchanged 
using a 3000 MWCO centrifugal concentrator. 
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Figure 6-2. Purification of sfGFPHis148AzPhe. A. Nickel-affinity chromatography 
purification elution profile. Absorbance at 280 nm monitoring protein elution (black 
line) and absorbance at 485 nm monitoring sfGFP elution (green line) on application 
of an imidazole gradient (dashed line). B. Anion exchange chromatography elution 
profile. Absorbance at 485 nm monitoring sfGFP elution (green line) on application 
of a NaCl gradient (dashed line). 
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6.2.2. Spectral analysis of sfGFPHis148AzPhe 
The chromophore of GFP can exist in two states that normally correlate with two 
different excitation peaks, 395 or 475 nm, corresponding to the neutral phenol or the 
deprotonated phenolate form of the chromophore respectively [155]. Only one 
emission peak exists at 511 nm, corresponding to the phenolate form. The generation 
of sfGFP through directed evolution results in the peak at 485 nm dominating (ε = 
49000 M-1 cm-1 [23]), and the peak at 395 nm only representing a small shoulder in 
the excitation spectrum (Figure 6-3A). When AzPhe is incorporated at His148, a 
position that hydrogen bonds to Tyr66 in the wild type structure, the two excitation 
peaks switch intensities, with the phenol peak at 400 nm (red shifting 5 nm from 395 
nm) becoming the predominant peak (ε = 35600 M-1 cm-1), and the 485 nm peak 
virtually disappearing (Table 6-1; Figure 6-3A). There is a small peak at 500 nm but 
is much less intense than either the 400 nm peak in sfGFPHis148AzPhe, or the 485 nm 
peak in wild type sfGFP. There is no change in the emission spectra of 
sfGFPHis148AzPhe. 
 
Table 6-1. Effect of UV irradiation on the spectral properties of sfGFPHis148AzPhe 
 
1 Values taken from [23] 
 
 
Variant State !max (nm) !em (nm) 
" (M-1 
cm-1) 
Quantum 
yield 
Brightness 
(M-1 
cm-1) % sfGFP 
His148AzPhe 
Dark 400 511 35600 0.64 22800 62 
Dark 500 511 20300 0.46 9400 25 
UV 400 511 12500 0.37 4600 13 
UV 490 511 40400 0.48 19500 53 
Wild type 1 - 485 511 49000 0.75 36800 100 
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Figure 6-3. Effect of UV irradiation of the fluorescence spectra of sfGFPHis148AzPhe. A. 
Comparison of the excitation spectra of wild type sfGFP and sfGFPHis148AzPhe prior to 
irradiation (emission was monitored at 511 nm). B. Effect of UV irradiation on the 
excitation spectrum of sfGFPHis148AzPhe. The protein was irradiated for 8 minutes, and 
fluorescence was measured at multiple time points (emission was monitored at 511 
nm). C. Absorption spectra of sfGFPHis148AzPhe before  (dark) and after (UV) UV 
irradiation.  
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Upon UV irradiation of sfGFPHis148AzPhe, the intensity of the two peaks switch, 
resembling the fluorescence of wild type sfGFP. The peak at 400 nm becomes less 
intense and a peak appears at 485 nm that grows more intense after more UV 
exposure (Table 6-1; Figure 6-3B). After 10 seconds of UV irradiation, the peak at 
400 nm decreases in intensity, and fluorescence at ~490 nm increases, but no clear 
peak emerges. As exposure time increases, a clear peak around 485 nm starts to 
emerge. After 8 minutes of UV irradiation, the peak at 400 nm is barely evident, 
whereas the peak at 485 nm has reached its highest intensity (ε = 40400 M-1 cm-1). 
Beyond 8 minutes of irradiation, no further increase in excitation at 485 nm or 
decrease at 400 nm is observed. UV irradiation also causes no change in the emission 
wavelength, which remains at 511 nm, but does have an effect on the intensity. When 
wild type sfGFP is irradiated with UV light, there is no change in the fluorescence 
spectrum after 8 minutes of exposure. 
 
The azide group (N3) of AzPhe can also be used to attach novel chemical entities to 
the protein via strain-promoted azide-alkyne cyclo-addition (SPAAC). The azide 
group can undergo highly specific and selective cyclo-addition reactions with alkyne 
groups, resulting in a stable triazole link [156]. Two different modifications; 1, a 
large, fluorescent rhodamine dye based on the commonly used probe Texas Red (λem 
= 600 nm, ε = 97000 M-1 cm-1), and 2, an amine attached to a short linker, were used 
to determine the effect of novel post-translational modifications on the fluorescence 
of sfGFP (Table 6-2; Figure 6-4). When sfGFPHis148AzPhe is modified with either of the 
two different adducts, two different effects occur depending on which modification is 
used. Modification with 1 results in the main excitation peak remaining at 400 nm, 
indicating the modification is having little effect on the chromophore environment as 
the phenol form of the chromophore predominates (Figure 6-4A). Click modification 
with 1 does provide sfGFP with a compatible FRET (Forster resonance energy 
transfer) partner. His148 is located near the chromophore of sfGFP so modification at 
this site with a fluorescent dye whose spectral characteristics overlap with that of 
sfGFP (1 has an excitation maxima at 584 nm) could result in FRET. Upon excitation 
of sfGFPHis148AzPhe at both 400 nm and 485 nm, there is detectable emission at 610 
nm, which corresponds with the emission characteristics of the dye used (Table 6-2; 
Figure 6-4B). When sfGFPHis148AzPhe is excited at 400 nm, the emission at 610 nm is 
much less intense than the emission when the protein is excited at 485 nm. 
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Modification with 2 has a more direct and significant effect on sfGFP function (Table 
6-2; Figure 6-4A). Modification of sfGFPHis148AzPhe with 2 results in a switch in the 
main excitation from 400 nm to 485 nm. The excitation spectrum resembles that of 
the irradiated sfGFPHis148AzPhe, and of wild type sfGFP. 
 
Table 6-2. Effect of SPAAC on the spectral properties of sfGFPHis148AzPhe 
 
1 Values taken from [23] 
a sfGFPHis148AzPhe modified with 1 (Figure 6-2) 
b sfGFPHis148AzPhe modified with 2 (Figure 6-2) 
 
Variant !max (nm) !em (nm) 
" (M-1 
cm-1) 
Quantum 
yield 
Brightness 
(M-1 
cm-1) % sfGFP 
His148AzPhe 
400 511 35600 0.64 22800 62 
500 511 20300 0.46 9400 25 
His148AzPhe1 a 
400 511 19400 0.50 9600 26 
490 511 29300 0.26 7700 21 
His148AzPhe2 b 
400 511 24600 0.23 5600 15 
490 511 37400 0.49 18300 50 
Wild type 1 485 511 49000 0.75 36800 100 
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Figure 6-4. Effect of SPAAC on the fluorescence spectra of sfGFPHis148AzPhe. A. 
Comparison of the excitation spectra of unmodified sfGFPHis148AzPhe and 
sfGFPHis148AzPhe modified with 1 and 2. B. Emission spectra of sfGFPHis148AzPhe 
modified with 1, excited at both 400 nm and 485 nm. C. Absorption spectra of 
unmodified sfGFPHis148AzPhe and sfGFPHis148AzPhe modified with 1 and 2.  
 
 
 
 
 
 
 
0 
200 
400 
600 
800 
350 400 450 500 
E
xc
ita
tio
n 
(A
U
) 
Wavelength (nm) 
1 
2 
N N
H
O2
S
O
N
N
O SO3
N
O
NH2
A B 
0 
50 
100 
150 
200 
500 550 600 650 
E
m
is
si
on
 (A
U
) 
Wavelength (nm) 
400 nm 
485 nm 
C 
0 
0.2 
0.4 
0.6 
350 400 450 500 550 600 650 
A
bs
or
ba
nc
e 
(A
U
) 
Wavelength (nm) 
Unmodified 
1 
2 
 138 
6.2.3. X-ray crystallography of sfGFPHis148AzPhe 
6.2.3.1. Protein crystallization 
Key to understanding how photolysis of AzPhe in sfGFP exerts its effects on 
fluorescence, it is important to define the molecular events that occur upon conversion 
from the dark to the irradiated state. Furthermore, understanding these changes will 
allow us to use the photochemistry of AzPhe to control the activity of proteins more 
generally. Therefore, the crystal structures of the dark and irradiated states of 
sfGFPHis148AzPhe were determined.  
 
Protein was produced and purified as previously stated and concentrated to 10 
mg/mL. Other AzPhe-containing variants of sfGFP had been previously crystallized 
[23], so the successful screen conditions for those studies were used as a starting 
point. Initial screens varied pH (7-9) and ammonium sulphate concentration (50-90% 
saturation – 2-3.7 M) in 50 mM Tris, but yielded no crystals. The screen was then 
extended to cover a wider range of pH (4-9), with MMT (Malic acid, MES, Tris) 
buffer replacing Tris. This screen yielded two crystals at a single condition; pH 8.5, 
2.52 M (NH4) 2SO4 (Figure 6-4A). 1 mM ethylene glycol was then added as a cryo-
protectant prior to crystal harvesting. One of the two crystals was harvested in the 
dark so that the azide group remained intact, while the second crystal was irradiated 
for 1 hour in crystallo.  
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Figure 6-5. Protein crystals and X-ray diffraction pattern. A. The two crystals in the 
tray, visualised under red light. Images of (B) dark sfGFPHis148AzPhe and (C) UV 
irradiated sfGFPHis148AzPhe on the beamline (red crosshair). D. Diffraction pattern 
generated from X-ray irradiation of dark sfGFPHis148AzPhe (2.0 Å). 
 
 
 
 
 
 
A B C 
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6.2.3.2. Structure determination and refinement 
Diffraction data (Figure 6-5D; Table 6-3) were collected at the Diamond Light Source 
(Harwell, UK) by Dr. Pierre Rizkallah (Cardiff Medical School, Cardiff University). 
Data were reduced using the XIA2 package [102], assigned a space group using 
POINTLESS [103], scaled using SCALA [103] and merged using TRUNCATE 
[104]. Structures were solved by molecular replacement with PHASER, using a 
previously determined sfGFP structure (PDB code 2B3P – [92]). Structures were then 
adjusted manually using COOT and refined by TLS restrained refinement using 
RefMac. Initially, the structures were assigned the tetragonal space group P 41 21 2, 
however this was reassigned to P43 21 2 during refinement for both crystals. Both the 
dark and the irradiated crystals contained two molecules in the asymmetric unit, and 
were determined to a resolution of 2.0 Å (dark state) and 2.1 Å (irradiated state). 
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Table 6-3. Crystal structure refinement statistics of dark state and irradiated state 
sfGFPHis148AzPhe 
 
1 Rmerge = Σh Σj (Ihj  – <Ij>) / Σh Ihj 
2 Rfactor = (Σh |Fh,obs – Fh,calc|) / (Σh Fh,obs) 
3 Rfree is calculated from a set of 5% randomly selected reflections that were not 
included in the refinement 
 
 
 
  DARK LIGHT 
Data collection   
Wavelength 0.92 0.92 
Beamline Diamond I04-1 Diamond I04-1 
Space group P4(3)2(1)2 P4(3)2(1)2 
a (Å) 135.6 135.14 
b (Å) 135.6 135.14 
c (Å) 69.23 69.56 
Resolution range 42.88 - 2.03 56.24 - 2.14 
Total reflections measured  
(outer shell) 600948 (42383) 525718 (37806) 
Unique reflections (outer shell) 42237 (3082) 36124 (2621) 
Completeness (%) (outer shell) 100 (100) 100 (100) 
I/! (outer shell) 16.7 (3.9) 22.9 (4.0) 
R (merge)1 (%) (outer shell) 10.3 (72.6) 7.9 (68.8) 
B(iso) from Wilson (Å2) 39.4 42.2  
Refinement statistics   
Protein atoms excluding H 4079 4002 
Solvent molecules 350 274  
R-factor2 (%) 17.2 17.1 
R-free3 (%) 20.4 20.7 
Rmsd bond lengths (Å) 0.018 0.018 
Rmsd angles (°) 2.029 2.059 
Ramachandran plot statistics   
Core region (%) 97.3 97.03 
Allowed region (%) 2.47 2.97 
Additionally allowed region (%) 0 0 
Disallowed region (%) 0.22 0 
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6.2.3.3. Comparison of sfGFPHis148AzPhe dark state and wild type 
Mutating His148 to AzPhe does not affect the ability of the protein to fluoresce, so no 
major changes at the whole protein level are expected. This was confirmed when 
comparing the general structure to that of sfGFP (Figure 6-6A). When the solved 
structure for the dark state of sfGFPHis148AzPhe is compared with wild type sfGFP (PDB 
code 2B3P), the two structures are very similar, with RMSD values of 0.432 Å, 0.418 
Å and 0.432 Å for Cα, backbone atoms and all atoms respectively for one of the 
molecules in the asymmetric unit. The other molecule in the asymmetric unit gave 
essentially the same values (0.474 Å, 0.461 Å and 0.474 Å). These values represent 
small deviations away from the structure of the wild type protein, but no gross 
changes. 
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Figure 6-6. Structure of the dark form of sfGFPHis148AzPhe A. Backbone alignment of 
dark state sfGFPHis148AzPhe (cyan) with wild type sfGFP (PDB code 2B3P – green). B-
C. B factor representation of (B) wild type sfGFP (PDB code 2B3P) and (C) the dark 
state of sfGFPHis148AzPhe. B-factors are shown in a relative scale based on thickness 
(thin = low, thick = high) and colour (blue = low, red = high). The chromophore and 
His148/His148AzPhe is shown as sticks on both structures. 
A 
B C 
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B-factors (otherwise known as the Debye-Waller factors or the temperature factors) 
are a good indicator of flexibility in a particular region of a protein or peptide. 
Comparison of per-residue B-factors in the dark state compared to that of the same 
residues in the wild type showed small but significant differences (Figure 6-6B-C). 
Five regions of the wild type sfGFP structure have high B-factors. The C-terminus has 
a high degree of flexibility, a common trait shared by many proteins. Four other 
regions also exhibit a high degree of flexibility, Thr49 to Lys52, Asp155-Asn159, 
Glu172-Gly174 and Lys209-Arg215. These regions of sfGFP comprise loop regions 
on the outside of the protein, primarily at the top or bottom of the β-barrel. When 
these regions are directly compared to the dark state of sfGFPHis148AzPhe, the four 
internal regions and the C-terminus have lower B-factors in the dark state of 
sfGFPHis148AzPhe than the wild type, particularly Glu172-Gly174 and Lys209-Arg215. 
One region of sfGFPHis148AzPhe, Ile188-Val193, has increased B-factors compared to 
wild type sfGFP (Figure 6-6C). 
 
Although RMSD values and B-factors give a good indication of the gross structural 
changes to the whole protein caused by the incorporation of AzPhe, it is subtle 
conformational changes caused by the incorporation of AzPhe that likely gives rise to 
the functional effects. His148 in sfGFP interacts with the hydroxyl group of Tyr66 in 
the chromophore via the Nδ of the imidazole ring [92]. Mutation to AzPhe removes 
this interaction, as there is no electron-accepting group at an equivalent position 
(Figure 6-7A). Another residue that interacts directly with Tyr66 is the hydroxyl 
group in the side chain of Thr203. The side chain of Thr203 in sfGFPHis148AzPhe is 
rotated and shifted so that the hydroxyl group in the side chain is no longer in a 
position where it can interact with the hydroxyl group of Tyr66 (Figure 6-7B). In wild 
type sfGFP, the distance between the two hydroxyl groups of Tyr66 and Thr203 is 2.7 
Å, easily within the range of a hydrogen bond (2.3 – 3.2 Å). After AzPhe is 
incorporated into the protein, the distance between these two chemical groups 
increases to 4.8 Å, 1.6 Å over the upper limit for a hydrogen bond.  
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Figure 6-7. Effect of AzPhe incorporation on sfGFP structure. A. An alignment of the 
residues surrounding the chromophore in wild type sfGFP (green) and dark 
sfGFPHis148AzPhe (cyan). B. The change in distance between the hydroxyl groups of 
Tyr66 and Thr203. C. The shift in the backbone position of β10 caused by AzPhe 
incorporation. 
 
Thr203 resides in strand β10 and His148 is in β7, two β-sheets that lie close to each 
other in the folded protein. In sfGFP, Thr203 and His148 interact with each other via 
two backbone hydrogen bonds (the carbonyl of Thr203 and the amide of His148, and 
the carbonyl of His148 and the amide of Thr203). These interactions between the two 
β-sheets help stabilize the structure of the protein and maintain the precise positioning 
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of the side chain of Thr203. The incorporation of AzPhe at position 148 and the 
resulting increase in the size of the side chain causes a shift in the positioning of these 
two β-sheets, disrupting the precise orientation of Thr203 (Figure 6-7C). This slight 
shift upwards results in the side chain of Thr203 rotating, taking the hydroxyl out of 
reach of Tyr66 and breaking the hydrogen bond network. The removal of the 
hydrogen bonds between Tyr66 and His148, and between Tyr66 and Thr203 disrupts 
the hydrogen bond network that promotes the phenolate state (exciting at 485 nm). 
Thus, this provides a rationale for the predominant peak in the spectrum to 400 nm, 
which corresponds to the neutral phenol form of Tyr66. 
 
6.2.3.4. Comparison of sfGFPHis148AzPhe  dark state and the irradiated state 
An alignment of the dark and irradiated states of sfGFPHis148AzPhe shows that there are 
no large changes to the structure of the protein after an hour of in crystallo UV 
irradiation. Direct alignment of the two molecules in the asymmetric unit of the dark 
and irradiated states gave RMSD values of 0.330 Å for all atoms, 0.326 Å for 
backbone atoms and 0.325 Å and Cα atoms only (Figure 6-8A). These values 
represent very little change between the two structures. When the irradiated state of 
sfGFPHis148AzPhe is compared with wild type, similarly small changes are seen overall. 
One molecule of the asymmetric unit gives RMSD values of 0.384 Å, 0.373 Å and 
0.384 Å for Cα atoms, backbone atoms and all atoms respectively. The second 
molecule gives slightly higher values; 0.416 Å, 0.420 Å and 0.416 Å. When B-factors 
are compared, the areas of high flexibility in the irradiated state correlate with the 
dark state (Figure 6-8B-C). The same unstructured loop regions at the top and bottom 
of the β-barrel show some flexibility and the majority of the β-barrel is highly 
ordered. The N- and C-termini of both structures are similarly flexible, however two 
fewer residues were observed at the C-terminus in the irradiated state than in the dark 
state due to decreased electron density in this region. Of the four regions mentioned 
earlier, Asp155-Asn159, Glu172-Gly174, Ile188-Val193 and Lys209-Arg215, the 
irradiated state is only slightly more flexible. The Asn155-Asn159 loop occupies a 
slightly different orientation in the two crystal structures but the similarly high B-
factors indicate this region is highly flexible and any single conformation in a crystal 
does not represent a final orientation. 
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Figure 6-8. Structure of the irradiated form of sfGFPHis148AzPhe A. Backbone alignment 
of dark state sfGFPHis148AzPhe (cyan) with irradiated sfGFPHis148AzPhe. B-C. B factor 
representation of (B) the dark state of sfGFPHis148AzPhe and (C) the irradiated state of 
sfGFPHis148AzPhe. B-factors are shown in a relative scale based on thickness (thin = 
low, thick = high) and colour (blue = low, red = high). The chromophore and 
sfGFPHis148AzPhe is shown as sticks on both structures. 
C B 
A 
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Irradiation of the azide group with UV light results in the loss of molecular nitrogen 
and the formation of a reactive nitrene group. This radical can then proceed down 
several reaction pathways and result in several different structures (see Section 1.5). 
When looking at the electron density around the side chain of AzPhe at position 148 
in both the molecules in the asymmetric unit, there is a clear difference between the 
two (Figure 6-9). In one of the molecules (Mol-1) there is clear density around the 
para position of the phenyl ring, which is absent in Mol-2 (Figure 6-9). One potential 
end point of the reactions involving the nitrene radical is the formation of an amine 
group at the para position so this structure was modeled into Mol-1. However, it 
should be noted that even in the dark state, no electron density is seen beyond the Nα 
of the azide group, which may indicate the azide group has no fixed orientation. In 
Mol-2, there is no clear density at the para position, however the electron density 
surrounding the phenyl ring itself is larger (Figure 6-9B). A second reaction pathway 
is the formation of a 7-membered ring (a dihydroazepine ring) so this was modeled 
into Mol-2. The difference in the density that surrounds the side chain at position 148, 
and the subsequent difference in the modeling had a slight effect on the surrounding 
residues as well. The B-factors of Asn146 and Ser147 are slightly higher when the 7-
membered ring is modeled in Mol-2, compared to an NH2 group at the para position 
in Mol-1. 
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Figure 6-9. Difference in the electron density surrounding the side chain of AzPhe in 
the two molecules of the UV irradiated sfGFPHis148AzPhe structure. A. Amine group at 
the para position modeled into Mol-1 of irradiated sfGFPHis148AzPhe. B. 7-membered 
ring modeled into Mol-2 of irradiated sfGFPHis148AzPhe. 
 
The main difference between the sfGFP structure (PDB code 2B3P) and the dark state 
of sfGFPHis148AzPhe was the orientation of the side chain of Thr203 and this is thought 
to contribute to the change in the fluorescence spectrum of the AzPhe variant. In the 
irradiated state of sfGFPHis148AzPhe, the side chain of the threonine is still rotated 
compared to sfGFP so the hydroxyl group cannot form a direct interaction with 
Tyr66. However, there is a water molecule in between the two residues that connects 
the hydroxyl of Tyr66 and the backbone carbonyl of Thr203 (Figure 6-10A) to reform 
the hydrogen-bonding network that potentially promotes the phenolate form of Tyr66 
This water molecule is present in both Mol-1 and Mol-2 in the asymmetric unit, and 
the side chain of Thr203 occupies the same conformer in both. 
 
A B 
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Figure 6-10. Effect of UV irradiation on Thr203 A. Electron density of water 
molecule bridging Tyr66 and the backbone carbonyl of Thr203. B-C. Comparison of 
the positions of β10 in dark sfGFPHis148AzPhe (green) and UV irradiated sfGFPHis148AzPhe 
when modeled with (B) an amine group and (C) a 7-membered ring at position 148. 
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The irradiation of AzPhe results in a shift in the position of the backbones of β7 
(containing position 148) and β10, which allows the interaction between Tyr66 and 
Thr203 to be reformed (Figure 6-10B-C). The original effect of the incorporation of 
AzPhe resulted in a large shift upwards, breaking the hydrogen bond between the 
Tyr66 and Thr203. The second shift caused by irradiation of the side chain results in a 
small shift in the opposite direction, bringing Thr203 closer to Tyr66, enabling the 
formation of a hydrogen bond between the two residues, via a water molecule. There 
is a difference in the position of the β-strands depending on what is modeled into the 
electron density surrounding position 148. When an NH2 group is modeled into the 
para position of the phenyl ring (Mol-1), there is only a very small shift in towards 
the chromophore (0.3 A). However, when the 7-membered ring is modeled in (Mol-
2), the shift is doubled (0.6 A). 
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6.3. Discussion 
6.3.1. Molecular basis of the spectral shift of sfGFPHis148AzPhe 
While replacing His148 does not destroy fluorescence, it changes the excitation 
profile significantly from that of sfGFP (Table 6-1; Figure 6-3A). The change in 
major excitation peak from 485 nm in sfGFP to 400 nm in sfGFPHis148AzPhe represents 
a shift back to that originally seen in the first GFP protein discovered in A. victoria 
[86]. This protein had a complex excitation spectrum with the major peak at 395 nm 
and a minor peak at 475 nm, indicating a mix of the phenol and phenolate forms of 
the chromophore, with the former the predominant. The mutations introduced into 
sfGFP resulted in a simplification of the fluorescence spectrum, notably a switch in 
peak intensities, with the phenolate form now being the dominant form of the 
chromophore, with the proton shuttled through a local charge transfer network. [92]. 
In wild type sfGFP, Tyr66 is kept in the phenolate form by a hydrogen-bonding 
network, with His148 a major contributor [88]. The mutation of histidine to AzPhe 
removes this interaction with Tyr66, thus disrupting the proton relay system around 
the chromophore preventing deprotonation in the ground state (Figure 6-11). 
 
 
Figure 6-11. Removal of a hydrogen bond between Tyr66 and His148 upon 
incorporation of AzPhe. 
 
Tyr66 
His148 
His148AzPhe 
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In addition to the interaction between Tyr66 and His148, Tyr66 also forms a direct 
interaction with the hydroxyl side chain of Thr203 in sfGFP. In the dark form of 
sfGFPHis148AzPhe, the side chain of Thr203 has been rotated so that the distance 
between the two hydroxyl groups is increased by two angstroms (Figure 6-7B). The 
incorporation of AzPhe and the resultant increase in side chain size and bulk causes a 
shift in the positioning of the two β-sheets that contain His(AzPhe)148 and Thr203. 
This shift in backbone position, and rotation of the side chain increasing the distance 
between the two hydroxyl groups removes the interaction between Thr203 and the 
chromophore, potentially pushing Tyr66 into its phenol form. This contributes to the 
changed excitation spectrum of sfGFPHis148AzPhe, as two of the interactions involving 
Tyr66 that maintain the chromophore predominantly in its phenolate form have been 
removed. Tyr66 has a third interaction in sfGFP with a water molecule. This 
interaction is also present in the dark form of sfGFPHis148AzPhe. 
 
On irradiation of sfGFPHis148AzPhe, the two peaks representing the phenol and the 
phenolate forms of Tyr66 switch intensity so that the predominant peak is now at 485 
nm. This is similar to the excitation and emission profile of wild type sfGFP. This 
suggests that the hydrogen bond and charge transfer network between Tyr66 and 
His148, and between Tyr66 and Thr203 are re-established. It is the Nδ of His148 that 
interacts with Tyr66 in the chromophore and no matter which reaction pathway the 
azide group undergoes upon UV irradiation, there is no possibility of forming an 
equivalent interaction with AzPhe. Therefore the irradiation of AzPhe is not going to 
produce a direct interaction with the chromophore. The electron density that 
surrounds the side chain of AzPhe suggests that there are no interactions with the 
chromophore via water molecules either. This suggests that on irradiation of the 
phenyl azide group, the final photochemical product is not directly altering the 
interaction with Tyr66. 
 
The other disrupted interaction in the dark state is between the chromophore and 
Thr203. In the irradiated state of sfGFPHis148AzPhe, the side chain of Thr203 does not 
change orientation compared to the dark state, so there are no interactions between the 
side chain of Thr203 and the chromophore. However there is a slight shift in the 
position of β10, the β-sheet where Thr203 resides. This small shift downwards 
reduces the effect of the original shift caused by the incorporation of AzPhe and 
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allows the backbone carbonyl group of Thr203 to interact with the hydroxyl group of 
Tyr66 via a water molecule (Figure 6-10A). This backbone shift allows the hydroxyl 
group of Tyr66 to form one of the two interactions it makes with other residues in the 
wild type structure. The reformation of this interaction is likely to push the 
chromophore towards its phenolate state, which excites at 485 nm, and from its 
phenol form, reducing the excitation at 400 nm. 
 
6.3.2. Effect of SPAAC on sfGFPHis148AzPhe fluorescence 
When Click chemistry is used to modulate fluorescence, there are two different 
outcomes depending on the molecule used to modify the protein (Table 6-2; Figure 6-
4A). When 1 is used to modify the protein, the predominant peak remains at 400 nm 
whereas when the protein is modified with 2, the wavelength of the predominant peak 
switches to 485 nm in a result similar to the effect of UV irradiation. Through the 
structural studies we know that the incorporation of AzPhe disrupts the hydrogen-
bonding network around Tyr66, pushing the chromophore into its phenol state, and 
thus exciting predominantly at 400 nm, and we know UV irradiation partially reforms 
this hydrogen-bonding network, which results in the shift in excitation wavelength 
back to 485 nm. These details allow us to hypothesize that modification with 2 is 
having a similar impact on the hydrogen-bonding network, as the phenotypic result of 
modification with 2 is very similar to modification with UV light. The structure of 2 
contains an amine group at the end of a short linker that connects it to the dibenzyl 
cyclo-octyne (DBCO) group that is used to react with the azide group during SPAAC. 
This amine group would be able to participate in a hydrogen-bonding network 
provided it was close enough to another side chain. The side chain of AzPhe at 
position 148 is near the surface of the protein with the azide group pointing away 
from the core of the protein. The short linker, part of the structure of 2, is likely to be 
flexible so it is possible that the amine group could bend back towards the protein 
surface and contribute, directly or indirectly, to the hydrogen-bonding network around 
Tyr66. Without any crystal structure of the modified protein, or of any computer 
modeling or molecular dynamics simulations of the modification, it is very difficult to 
know precisely how the chemical modification is interacting with the chromophore 
and how it is effecting the hydrogen-bonding network. 
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Modification with 1 does not result in the same shift in fluorescence, the predominant 
peak remains at 400 nm. The sheer size of the modification suggests it would remain 
outside the β-barrel that protects the chromophore from the surrounding environment. 
From here it would be unable to impact the hydrogen-bonding network that occurs 
inside the β-barrel. This would leave the chromophore in its phenol state, exciting at 
400 nm. However, the position of AzPhe incorporation means the fluorophore, which 
is part of the structure of 1, is close enough to the chromophore of the protein for 
energy transfer. The quantum yield of sfGFPHis148AzPhe modified with 1 is lower than 
the dark state of the same variant when excited at both 400 nm and 485 nm (Table 6-
1), suggesting that some of the energy has been transferred to the fluorophore in 1, 
which emits at 610 nm. The excitation of sfGFPHis148AzPhe modified with 1 at 400 nm 
or 485 nm results in the emission of light energy at 511 nm, which is then used as the 
excitation energy for the fluorophore of 1 (excitation maxima 584 nm), resulting in 
emission at 610 nm. When the protein is excited at 400 nm, there is only a small 
emission at 610 nm. There is an increase in emission at 610 nm when the modified 
protein is excited at 485 nm. As the wavelength of excitation is so close to the 
emission of sfGFP (511 nm), it is likely some of the emission at 610 nm is caused by 
direct excitation of the fluorophore by the light source, not by energy transfer.  
 
An approximate relative FRET efficiency, calculated experimentally using the 
fluorescence spectra was calculated as 9% using Equation 2 (Section 2.8.3.). This 
used the emission profile of the sfGFP chromophore (donor) and the fluorophore of 1 
(acceptor) when excited at 400 nm, as excitation at 485 nm is likely to result in some 
direct excitation of the acceptor fluorophore. Theoretical calculations were impossible 
due to the unknown distance between the two fluorophores. Therefore, only a small 
amount of energy transfer is seen between the chromophore and the fluorophore. The 
difference between the emission maxima of sfGFP, 511 nm, and the excitation 
maxima of the fluorophore, 584 nm is quite large, and as a result the efficiency of 
energy transfer between the two is probably quite low. Similarly, the linker between 
the DBCO and the fluorophore is quite flexible, which would limit the efficiency at 
which energy transfer occurs due to the lack of a consistent orientation between the 
two chromophores [157]. Without any modeling of the modification it is very difficult 
to estimate the exact distance between the two chromophores, however it is likely to 
be too large to result in high levels of energy transfer.  
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6.3.3. Effects of UV irradiation on AzPhe 
The sensitivity of azide groups to UV light has been widely studied over many years, 
however much of this understanding relies on the use of extreme temperatures and 
reaction conditions to achieve specific products, such as using methanol to push the 
reaction to form a nitrenium ion [63]. The incorporation of the azide group into 
proteins via an amino acid, and the study of these proteins removes such extreme 
conditions as a possibility, and therefore removes much of the control when managing 
the reactivity of azide groups. This means that the result of irradiating an azide group 
in a protein setting is difficult to predict, with multiple factors affecting the outcome, 
such as buffer conditions and the residue microenvironment. Recently, sfGFP 
containing the azide group has been crystallized and this has aided the prediction of 
potential reaction pathways and shown the variety of outcomes that are possible [23]. 
 
The change in excitation spectra in the dark form of sfGFPHis148AzPhe due to the 
incorporation of AzPhe, and the further change in excitation due to irradiation of the 
azide group have been explained in molecular terms thanks to crystallization of the 
protein, however the exact effect on AzPhe remains unclear. The difference in the 
electron density that surrounds the phenyl ring of AzPhe, particularly the para 
position, in the two molecules of irradiated sfGFPHis148AzPhe raise questions over the 
end result of UV irradiation on the azide group. In one of the molecules, clear density 
can be seen around the para position, whereas the second molecule has no such 
density. In this molecule the density that corresponds to the phenyl ring is slightly 
larger, which would accommodate a 7-membered ring. These two molecules were 
modeled differently during refinement and no problems were encountered during the 
process, indicating both structures were tolerated. It is possible that there are multiple 
outcomes during the irradiation process, however as both molecules are sampling the 
same environment this is unlikely. It is also possible, due to the in crystallo irradiation 
conditions, that the two different structures represent two different points of the 
reaction. The first step in the reaction after UV irradiation is the loss of molecular 
nitrogen to form a nitrene structure that closely resembles the electron density seen in 
the first molecule of the asymmetric unit. It is possible that upon freezing of the 
crystal for data collection, the reaction was trapped at this stage. The second molecule 
then samples a further stage of the reaction pathway, at which point the nitrene radical 
has joined the phenyl ring to form a 7-membered ring (the dihydroazepine ring). The 
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positioning of β10 in the two models also suggests this may be the case. When the 
density around the para position is filled with an amine group (the first step), there is 
only a small shift in the backbone position of Thr203. When the 7-membered ring is 
modeled in (the second step), there is a larger shift in the backbone position, bringing 
Thr203 into closer proximity to the chromophore. These structures could represent 
two stages of the reduction of the azide group, bringing Thr203 closer to Tyr66. 
 
6.4. Summary 
In this chapter I have introduced the control of protein fluorescence using two 
different types of novel post-translational modification. Superfolder GFP (sfGFP) has 
a well-known excitation and emission spectra and has been shown previously to be 
sensitive to single amino acid changes [158]. The incorporation of AzPhe into sfGFP 
resulted in a shift in excitation wavelength from 485 nm in sfGFP to 400 nm in 
sfGFPHis148AzPhe. This corresponds in a change in the chromophore, from the phenolate 
form of Tyr66 to its neutral phenol form. This change was reversed upon UV 
irradiation of the azide group. Crystallography was used to try and determine the 
precise molecular effects of UV irradiation on AzPhe itself and on the sfGFP 
chromophore. In the dark form of sfGFPHis148AzPhe, two hydrogen bonds that form 
between Tyr66 of the chromophore and His148 and Thr203 were removed, causing 
the chromophore to exist predominantly in its phenol state. In the irradiated state, the 
hydrogen bond between Tyr66 and Thr203 was reformed via a water molecule, 
shifting the chromophore back to its phenolate form, moving the main excitation peak 
to 485 nm. Of the two molecules in the irradiated crystal structure, the electron 
density around AzPhe differed. One showed density around the para position and one 
accommodated a larger, 7-membered ring. These two structures were modeled 
separately, and could highlight two steps of the photolysis reaction. Click chemistry 
had a variable effect on excitation depending on the modification used. When a 
modification containing an amine group was used, the excitation was the same as that 
of the irradiated form, exciting primarily at 485 nm. When another modification was 
used that had no amine groups, but replaced it with a large fluorophore, the main 
excitation peak remained at 400 nm. For all of the post-translational modifications 
used, the emission spectra of the protein were unchanged, remaining at 511 nm. 
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7. Discussion 
 
Unnatural amino acids (uAAs) are an ideal method to introduce new functionality into 
proteins as they can be designed and tailored to suit very specific needs. They can be 
used to modulate the function of a protein, or even access novel functionality not 
normally present in the protein. In this thesis, the uAA p-azido-L-phenylalanine 
(AzPhe) was used to modulate the activity of TEM β-lactamase (Chapter 4), a 
clinically relevant enzyme that is the most widespread resistance marker [159]. 
Beyond incorporation of the uAA, two novel methods of protein control, UV 
irradiation and Click chemistry, were used to post-translationally modify the activity 
of the enzyme, with both positive and negative effects. As well as affecting activity, 
the incorporation of AzPhe and novel post-translational modification via Click 
chemistry was used to enable the defined and oriented immobilization of the protein 
onto two different, biologically relevant surfaces (Chapter 5). The interaction between 
pyrene and graphene was used to interface TEM β-lactamase with an electronically 
sensitive surface that could be used to analyze tiny changes in the enzyme active site 
[136]. Strain-promoted azide-alkyne cyclo-addition (SPAAC), a form of Click 
chemistry, was also used to attach DNA oligonucleotides to the protein to enable 
attachment of the protein to a DNA origami “tile”. This technology allows multiple 
proteins to be immobilized in defined positions on a single surface [153]. In addition 
to the control of TEM β-lactamase, AzPhe was also incorporated into sfGFP and 
modified to modulate the protein’s intrinsic fluorescence (Chapter 6). X-ray 
crystallography was used to determine the precise molecular impact of AzPhe 
incorporation and the effect of UV irradiation on the novel side chain. 
 
7.1. The efficiency of uAA incorporation 
The use of uAAs present many benefits over other synthetic biology approaches, 
namely its versatility. Hundreds of uAAs have been designed and tailored to suit 
individual purposes, such as mimicking phosphorylation [20, 21] or enabling photo-
control [160], resulting in a vast library of novel amino acids that can be used to 
introduce novel functionality and control into proteins. There are many ways to 
incorporate uAAs into proteins, from chemical synthesis and cell-free synthesis 
through to chemical modification of existing amino acids, however the best method is 
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co-translational incorporation via an expanded genetic code. Producing proteins in 
vivo is cheaper, and results in far greater yields compared to chemical synthesis. The 
key question that remains however is the efficiency of co-translational uAA 
incorporation. Translation has evolved into a highly reliable and accurate cellular 
process and the adaptation of this system is a difficult task. Many different cellular 
machines interact to convert DNA to protein, and the precise interplay between these 
molecules makes “hijacking” this process a difficult task to accomplish without 
negatively affecting global protein translation. 
 
Much work has been done to overcome the issues associated with co-translational 
incorporation of uAAs and ensure that they are incorporated with the utmost 
reliability and accuracy. The choice of which codon to reassign to the uAA presents 
the first problem. Despite TAG/UAG being the least common codon in the E. coli 
genome, it is still the stop codon for 7% of the genes, so reassigning this to a sense 
codon for uAAs causes extended translation in these proteins. Also, by using a 
trinucleotide codon, the number of codons that can be reassigned is limited to one, as 
all of the other 63 sense codons play a key role during translation. Several methods 
have been used to eliminate each of these problems. Whole genome engineering 
approaches have been used to remove all natural TAG codons from the E. coli 
genome [33, 34], and release factor-1 has been removed to recode TAG to a sense 
codon [126, 127]. Both of these approaches have increased the efficiency of uAA 
incorporation in response to TAG, but do not address the issue of limited codon 
choice. To address this issue, four-base codons have been used along with an 
engineered ribosome that keep TAG as a stop codon [53]. The change to using four-
base codons is a good way of not affecting any of the trinucleotide codons, and 
increasing the number of uAA codons that can be used simultaneously. 
 
 A second issue is the fidelity of the evolved amino-acyl tRNA synthetases (aaRSs) 
that are used to incorporate the uAAs co-translationally. A positive and negative 
selection strategy has been used to generate a library of evolved aaRSs that are 
capable of incorporating uAAs in response to the amber stop codon, however detailed 
studies have thrown questions over their efficiency and fidelity [41, 42]. The 
structural differences between large uAAs and the natural amino acids that are 
normally incorporated by these tRNA/aaRS pairs often results in issues with 
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recognition and binding, reducing the efficiency of co-translational uAA 
incorporation [161]. This problem is being eased by the expansion of the template 
aaRSs used to incorporate uAAs. Previously, only tyrosyl aaRSs were evolved to 
incorporate uAAs, however more and more aaRSs are being generated using other 
aaRSs as the building blocks. However, the efficiency of these evolved aaRSs at 
incorporating uAAs remains some way off what is seen with endogenous aaRSs. 
Computer-based modeling approaches may aid the directed evolution of these aaRSs 
by identifying sites within the protein which may increase the binding efficiency of 
uAAs whilst decreasing the binding efficiency of the natural amino acid that partners 
the particular aaRS [162]. Work has been done on other factors that influence the 
charging of tRNAs, such as elongation factors (EF-Tu) and their interactions with 
both the tRNA [163] and the uAA [164]. It has also been suggested that a designer 
EF-Tu, alongside the designer tRNA and aaRS could increase the efficiency of tRNA 
charging and uAA incorporation [51].  
 
Although the efficiency of uAA incorporation is not comparable to endogenous amino 
acid incorporation, the benefits of using uAAs far outweigh the negatives. The ability 
to control protein function through novel post-translational modifications is a 
powerful technique that can be used in many proteins and in many organisms. It 
offers huge variety in terms of both the uAA that can be used, and the method of 
control that can be accessed, such as light and chemical modification.  
 
7.2. Comparison of UV irradiation and Click chemistry as a means to introduce 
protein modulation via uAAs 
The use of uAAs opens up novel methods of post-translational protein control, and the 
use of p-azido-L-phenylalanine (AzPhe) in particular opens up two such methods. The 
phenyl azide group present in AzPhe is photo-reactive, and can undergo cyclo-
addition reactions with alkynes [68]. Light is a suitable method to post-translationally 
modify proteins, as it is non-invasive, can be controlled spatially and temporally with 
high precision and is cheap. When AzPhe is exposed to UV light, molecular nitrogen 
is lost from the azide group resulting in a reactive nitrene radical. This can then 
undergo numerous reactions and form several different chemical products, the result 
of which can be a very difficult task to predict in a protein environment. The cyclo-
addition of azides and alkynes (SPAAC) can be used to modify AzPhe in a highly 
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defined and specific manner, and can be used to mimic the process of natural post-
translational modifications such as phosphorylation whereby a specific residue is 
modified chemically to either increase or decrease protein activity. The versatility of 
this technique is virtually unmatched as an alkyne group can be incorporated into 
almost any chemical modification, enabling SPAAC.  
 
In this thesis both UV light and SPAAC were used to modify proteins, and both 
resulted in changes to protein function and control. UV light had a very limited effect 
on the activity of TEM β-lactamase; of the ten AzPhe-containing variants of TEM β-
lactamase studied, UV light caused no large changes in activity. UV irradiation had a 
more significant impact on the fluorescence of an AzPhe-containing variant of sfGFP 
however. UV irradiation caused a change in the excitation spectra of sfGFP, shifting 
the λmax. X-ray crystallography was used to determine the precise effects of UV 
irradiation and discovered a subtle change in protein structure caused by both the 
initial incorporation of AzPhe and the subsequent irradiation of the side chain. 
Modification via SPAAC on the other hand had a much larger impact on the activity 
of TEM β-lactamase. Modification of AzPhe via SPAAC resulted in both increases 
and decreases in enzyme activity, and was then used to attach the protein onto a 
surface in a defined and controlled manner. 
 
Although it would appear from the results in this thesis that Click chemistry is by far a 
more powerful approach to modify proteins post-translationally via uAAs, light can 
offer many useful approaches. Many other uAAs not used in this work have been 
designed that utilize light to change their structure, from photo-caged tyrosines [20] 
and serines [21] to photo-isomerizable residues [17] that can alternate between cis and 
trans bond formations. The use of light to control proteins is a growing field, and light 
sensitive uAAs have a role to play in this growth. The uAA p-benzoyl-L-
phenylalanine in particular has been extensively used in studying protein-protein 
interactions [24, 165] and protein-DNA interactions [25] due to its photo-reactive side 
chain and predictable photochemistry. The variety of photo-sensitive uAAs available 
means the use of light to impart novel post-translational control over protein 
behaviour and activity is a very useful technique. 
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7.3. Use of Click chemistry to modulate protein function 
The versatility and variability presented by Click chemistry make it an ideal method 
to induce novel post-translational control over proteins. The Huisgen dipolar cyclo-
addition reaction [166] between azides and alkynes is one of the most popular 
variations of Click chemistry due to the stability of the azide group [66]. Original 
forms of azide-alkyne cyclo-addition required a copper catalyst, and this method was 
widely used to modify proteins in vitro. The use of this reaction is prevalent in both 
drug discovery and medicinal chemistry [167, 168], such as the use of Click 
chemistry to generate enzyme inhibitors using in situ proteins [169, 170]. Copper-
catalyzed azide-alkyne cyclo-addition has also been used to label cell surfaces via the 
specific interaction between chemicals containing an alkyne group, and a membrane 
protein harbouring a genetically encoded azide. This technique has been used to label 
bacterial cell surfaces [171] and enable to the site-specific PEGylation of proteins on 
the cell surface [172]. The ability to genetically encode the azide means azide-alkyne 
cyclo-addition reactions can be performed in vivo, if the need for the cytotoxic copper 
catalyst could be alleviated. This was achieved with the introduction strain-promoted 
azide-alkyne cyclo-addition (SPAAC) [173]. SPAAC has been used to successfully 
attach proteins to surfaces [65] and enable the in vivo imaging of biomolecules [174, 
175]. The combination of uAAs and SPAAC in vivo represents a great step forward in 
the progress of this technology, and the versatility of this novel chemical genetic 
approach means many more applications are likely to be found in the near future. 
 
7.4. The use of SPAAC to attach proteins to surfaces in a defined orientation 
The desire for the simultaneous analysis of many biomolecules, or the enhanced detail 
gained from analyzing individual biomolecules, has led to the development of 
surface-based protein analysis. The ability to immobilize many thousands of 
biomolecules on a surface has greatly increased the speed at which many protein-
based studies, such as small molecule screening, can be completed. Conversely, the 
ability to immobilize a single protein onto a surface and to measure a single 
biomolecule increases the insight we can gain into the atomic events that occur within 
proteins. Protein immobilization has been historically achieved using protein 
adsorption or lysine/cysteine modification, both of which result in heterogeneous 
orientation and positioning of the biomolecule on the surface. The use of SPAAC, and 
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the benefits of specificity and selectively that it offers, can result in the homogeneous 
immobilization of proteins onto a surface with a single, defined orientation.  
 
In this thesis, AzPhe and SPAAC were used to attach TEM β-lactamase onto 
graphene, a carbon-based sp2-bonded material [143], and two DNA oligonucleotides, 
that can be used to attach the protein onto DNA origami, a 2D structure formed using 
single-stranded DNA [137]. To achieve this, only one mutation was required, utilizing 
the versatility of SPAAC to enable immobilization on both surfaces. The modification 
of AzPhe at two defined positions of TEM β-lactamase with a functionalized pyrene 
group resulted in the immobilization of the protein on graphene. The conductive 
properties of graphene and carbon nanotubes (CNTs) make them hugely valuable 
tools in protein analysis, as it can be used to detect atomic changes caused by protein-
protein interactions [176] or enzyme catalysis [177, 178]. AFM (atomic force 
microscopy) imaging of proteins on the surface showed single molecules of expected 
dimensions, indicating the successful interfacing of TEM β-lactamase with graphene 
in a defined manner. The pyrene-graphene interaction is an ideal method to attach 
proteins to graphene, as it is a very strong interaction that does not disrupt the 
electronic properties of graphene. Direct insertion of the protein onto the graphene 
surface via the photo-reactivity of AzPhe is also a possible avenue of attachment, as 
azides have previously been used to functionalize graphene [179]. This method would 
provide a more intimate link between the protein and the graphene, and change the 
conductive properties of the graphene surface [180].  
 
The modification of TEM β-lactamase with two DNA oligonucleotides is the first step 
in attaching a protein to DNA origami. The nature of DNA complementarity means 
proteins can be attached to the DNA origami “tile” in a defined position. By 
modifying an active enzyme with two different oligonucleotides, the first step towards 
creating enzyme pathways in vitro via SPAAC has been successfully completed. This 
approach (without the use of SPAAC) has been used to site-specifically immobilize 
two different enzymes onto a surface with a controlled distance between them [153]. 
The use of DNA as a surface to construct protein circuits is a growing field with 
exciting potential [181]. 
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7.5. Future work 
Unnatural amino acid incorporation can be applied to many proteins, so much of the 
work done in this thesis can be repeated in other proteins. The introduction of uAAs 
into other enzymes or other proteins such as membrane proteins and their subsequent 
control using light and Click chemistry would be an interesting addition to the work 
presented here. To build upon the work in this thesis, protein crystallography could be 
used to determine the exact effects of uAA incorporation and novel post-translational 
modification on TEM β-lactamase. X-ray crystallography was successfully used to 
define the precise molecular events that led to the spectral change seen in 
sfGFPHis148AzPhe caused by the UV irradiation of AzPhe (Chapter 6), and this 
technique could be duplicated to determine the effects of Click chemistry. SPAAC 
modification caused novel changes in two AzPhe-containing TEM β-lactamase 
variants, namely the large decrease in activity seen when TEMTyr105AzPhe was 
modified, and the increase in activity seen when TEMPro174AzPhe was modified with a 
DBCO-amine. SPAAC also resulted in an interesting effect on the fluorescence 
spectrum of sfGFPHis148AzPhe when modified with the same DBCO-amine. 
Crystallization and determination of the structures of these three modified proteins 
could help explain the precise effects on TEM β-lactamase and sfGFP caused by 
modification via SPAAC. 
 
The immobilization of TEM β-lactamase onto graphene lays the foundation for 
further work to build on these advances (Chapter 5). The immobilization of proteins 
onto graphene enables the measurement of single molecules using the conductive 
properties of the surface. The interactions between TEM β-lactamase and different 
substrates/inhibitors could be defined using this technology and tiny atomic 
differences between their binding could be detected. This could provide highly 
sensitive measurement of protein-protein and protein-ligand interactions. 
Additionally, the immobilization of an enzyme onto DNA origami opens up the 
prospect on constructing enzyme pathways in vitro on a 2D or 3D surface. The 
defined placement of multiple enzymes on a single DNA origami “tile” would require 
the modification of proteins with different DNA oligonucleotides, a technique 
displayed in this thesis (Chapter 5). The isolation of these modified proteins onto the 
surface would then enable the construction of these protein networks. 
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Chapter 3 introduced a method whereby potential uAA incorporation sites were 
modeled in silico to help determine possible effects. Although the method used in this 
thesis was relatively basic, relying on the similar structure of tyrosine to imply the 
potential effects of UV irradiation or Click chemistry, the advances made in mutation 
modeling and specifically uAA mutation modeling allows increased complexity to be 
introduced in silico [182]. The power of this method is therefore greatly enhanced and 
can be used to help create novel protein variants that can have designed effects upon 
novel post-translational incorporation and modification. 
 
7.6. Summary 
Chapter 3 presented the use of in silico modeling as a means to determine which sites 
for uAA incorporation were most likely to produce novel effects caused by the post-
translational modification of the azide side chain in AzPhe via UV irradiation and/or 
Click chemistry. It detailed the steps taken to replace the natural amino acid with 
tyrosine, the closest available structural analogue of AzPhe, and the interpretation of 
any changes to the precise orientation of residue side chains around the mutation site. 
Using this method, ten positions were selected for the incorporation of AzPhe in TEM 
β-lactamase. Chapter 3 also detailed the molecular biology required to adapt an 
expression vector for the over-expression of TEM β-lactamase containing uAAs. 
 
Chapter 4 introduced the production of TEM β-lactamase containing uAAs and the 
coarse control over protein function gained by using uAAs; when the uAA was not 
provided in the growth medium, no protein activity was observed. The chapter went 
on to describe the steps taken to purify the proteins so that detailed kinetic analyses 
could be performed on the enzymes. The measurement of kcat, KM and overall catalytic 
efficiency of five AzPhe-containing variants was used to determine the precise effects 
of uAA incorporation on enzyme catalysis, and the subsequent effects of UV 
irradiation and Click chemistry. This revealed a variant (TEMTyr105AzPhe) that had no 
change in activity upon uAA incorporation, but large changes in activity after 
modification, a variant whose activity was greatly affected by uAA incorporation 
(TEMAla237AzPhe), a variant whose ability to hydrolyze its substrates increased upon the 
specific modification of the uAA (TEMPro174AzPhe) and two variants (TEMTrp165AzPhe 
and TEMLeu201AzPhe) that had limited effects on enzyme activity before and after 
modification. 
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Chapter 5 continued the use of Click chemistry as a means to modify proteins post-
translationally, but transferred the technique into another area. SPAAC was used to 
modify TEM β-lactamase with two different modifications that can enable 
immobilization on two different surfaces; modification with pyrene allowed 
association with graphene, and modification with a DNA oligonucleotide represents 
the first step toward immobilization on a DNA origami “tile”. TEM β-lactamase 
associated with both graphite and graphene via pyrene modification was successfully 
imaged using AFM. 
 
Chapter 6 introduced the effects of uAA incorporation and novel post-translational 
modifications on a second protein, sfGFP. AzPhe was incorporated into sfGFP at a 
single position (His148) and the effects of its incorporation and subsequent 
modification using both UV irradiation and Click chemistry were determined via 
fluorescence spectroscopy. This found that incorporation of AzPhe at His148 resulted 
in a change in the excitation spectrum of the protein, changing the λmax from 485 nm 
to 400 nm. Modification of AzPhe using UV irradiation then resulted in a shift in λmax 
back to 485 nm. Modification via Click chemistry had different results depending on 
which chemical modification was used. Modification with a large, fluorescent dye had 
no effect on the fluorescence of the protein but did result in FRET. Modification with 
DBCO-amine resulted in the same effect as UV irradiation, changing the λmax back to 
485 nm. The dark and irradiated states of sfGFPHis148AzPhe were then crystallized so 
that the precise molecular events that led to the change in excitation spectrum could 
be determined. This found a disruption in the hydrogen-bonding network that involves 
the chromophore, His148 and Thr203 caused by incorporation of AzPhe. This 
hydrogen-bonding network was then partially reformed upon photolysis of the azide 
group, explaining the changes in fluorescence.  
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